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Abstract 
 
Context: Medical management for head and neck cancer (HNC) often includes neck dissection 
surgery, a side effect of which is shoulder dysfunction. There is no consensus for which patient-
reported outcome measure (PRO) is most appropriate to quantify shoulder dysfunction in this 
population. 
Objective: The aims of this research study were to: (1) use Rasch methodologies to assess 
construct validity and overall appropriateness of test score interpretation of Disability of the 
Arm, Shoulder and Hand (DASH), QuickDASH, Shoulder Pain and Disability Index (SPADI) 
and Neck Dissection Impairment Index (NDII) in the HNC population; (2) determine 
appropriateness of use of University of Washington Quality of Life (UW-QoL) shoulder subscale 
as a screening tool for shoulder impairment; (3) recommend a new PRO, or combination of 
PROs, that more accurately portrays the construct of shoulder dysfunction in the HNC 
population. 
Design: One hundred and eight-two individuals who had received a neck dissection procedure 
within the past 2 weeks to 18 months completed the PROs. Rasch methodologies were utilized to 
address the primary aim of the study through consideration of scale dimensionality [principal 
components analysis, item and person fit, differential item functioning (DIF)], scale hierarchy 
(gaps/redundancies, floor/ceiling effects, coverage of ability levels), response scale structure, and 
reliability (person and item reliability and separation statistics). The secondary aim was 
addressed through correlational analysis of the UW-QoL (shoulder subscale), DASH, 
QuickDASH, SPADI and NDII. 
Results: The DASH did not meet criteria for unidimensionality, and was deemed inappropriate 
for utilization in this sample. The QuickDASH, SPADI and NDII were all determined to be 
 
 
 
unidimensional. All scales had varying issues with person and item misfit, DIF, coverage of 
ability levels, gaps/redundancies, and optimal rating scale requirements. The NDII meets most 
requirements. All measures were found to meet thresholds for person and item separation and 
reliability statistics. The third aim of this study was not addressed because the NDII was 
determined to be appropriate for this population. 
Conclusions: Rasch analysis indicates the NDII is the most appropriate measure studied for this 
population. The QuickDASH and SPADI are recommended with reservation. The DASH and the 
UW-QoL (shoulder subscale) are not recommended. 
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Chapter 1: Introduction 
Introduction to the Chapter 
 This chapter will provide an introduction to the study, including a statement of the 
problem that was investigated and aims of the investigation. This chapter also provides a 
rationale for the relevance and need for the study, a list of study questions, and definitions of key 
terms.  
Problem Statement and Study Aims 
A patient with a diagnosis of head and neck cancer (HNC) often requires a neck 
dissection procedure to remove the lymph nodes from the neck, a common site of metastasis. 
This procedure may damage the spinal accessory nerve (SAN) resulting in trapezius muscle 
weakness or atrophy and impaired shoulder mobility.1 Although there are nearly fifty patient-
reported outcome measures (PROs) related to shoulder function used in the literature,2 there is no 
widely accepted PRO for patients presenting with shoulder dysfunction following neck 
dissection surgery for HNC.  
In 2013, Goldstein and colleagues published a review of the six PROs used in the 
research literature to quantify shoulder function in patients with HNC. Only one of the measures, 
the Neck Dissection Impairment Index (NDII), was specifically designed for use in HNC.3 The 
NDII, a measure of quality of life (QOL), must be used with caution because it was not 
developed using sound methodology and has limited testing of its psychometric properties.3,4 
The remaining five PROs described in the review, the Shoulder Pain and Disability Index 
(SPADI), Shoulder Disability Questionnaire (SDQ), Constant’s Shoulder Score (CS), American 
Shoulder and Elbow Surgeons Standardized Form (ASES), and the Disabilities of the Arm, 
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Shoulder and Hand Questionnaire (DASH), must also be used with caution. Although these 
measures have demonstrated strong validity and responsiveness across musculoskeletal 
populations, they have not been adequately tested in patients with HNC.3  
The Academy of Oncologic Physical Therapy of the American Physical Therapy 
Association (APTA) established a Task Force as part of the Evaluation Database to Guide 
Effectiveness (EDGE) initiative to explore the appropriateness of various outcome measures for 
use in HNC. A systematic literature review specific to shoulder-related PROs has been 
completed.2 Using pre-established criteria for recommendations, the Task Force recommends the 
DASH and its shortened version the QuickDASH, the NDII, SPADI, and a shoulder subscale of 
the University of Washington Quality of Life scale (UW-QoL). Although the Task Force took 
steps to decrease potential bias, the validity of the recommendations must be questioned because 
of limitations in methodology, limited research related to treatment intervention, minimal 
research establishing the appropriateness of PROs specific to the HNC population, and the Task 
Force’s reliance on reporting psychometrics based on the traditional Classical Test Theory 
(CTT). Outcome measures analyzed using CTT allow for valid-population based research, 
however must be generalized to the individual patient with caution.5 
Research Study Aims 
The aims of this study were three-fold:  
• Use Rasch methodology to assess the construct validity and overall appropriateness of 
test score interpretation of the DASH, QuickDASH, SPADI, and the NDII in patients 
experiencing shoulder dysfunction following neck dissection surgery for HNC; and 
• Determine the appropriateness of use of the UW-QoL (shoulder subscale) as a screening 
tool for shoulder-related impairment.  
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• Based on these findings, suggest a combination of outcome measures, or a new outcome 
measure, that more accurately portrays shoulder disability in patients who experience 
shoulder dysfunction following a neck dissection surgery for HNC 
Relevance, Significance, and Need for the Study 
Rasch analysis is gaining popularity in physical therapy research because it allows for a 
more thorough psychometric analysis of an instrument on a test item or individual level.5 Recent 
studies have analyzed frequently used PROs, including the DASH and QuickDASH, using Rasch 
analysis resulting in a better understanding of how the outcome measure functions on an item 
level, and its construct validity.6-18  
Rasch analysis of the DASH and QuickDASH suggests limitations in construct validity 
related to item fit, dimensionality, item response option thresholds, response scale structure, and 
residual correlations in patients with musculoskeletal complaints, patients with multiple 
sclerosis, stroke, and in patients with Dupuytren’s contracture.10,11,13,14,18 The usefulness of the 
QuickDASH has been further questioned based on unresolved weaknesses found in the analysis 
of the DASH specific to misfit of two items, tingling and sexual activity, one of which, tingling, 
is also used in the QuickDASH.10,14 Preliminary Rasch analysis of the DASH and QuickDASH 
in 131 patients with HNC confirms limitations of the ability of both scales to measure mild to 
moderate disability levels in patients presenting with shoulder dysfunction following unilateral 
neck dissection. In addition, both tools demonstrate problems with item misfit, test item 
redundancy, and ceiling effects.19  
The SPADI was analyzed using Rasch analysis in a population of surgical and non-
surgical patients presenting to a private practice orthopedic surgery clinic with upper extremity 
complaints. The authors report misfit of three test items. In addition, the SPADI was found to 
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have poor precision measuring shoulder dysfunction at the low and high ends of the scale. The 
tool, however, demonstrates good precision in patients with mid-range function indicating that 
the items tend to measure mid-level ability related to shoulder dysfunction.20  
The Task Force chose to recommend the UW-QoL (shoulder subscale) and the NDII 
because they were developed specifically for the HNC population with shoulder dysfunction and 
have shown promising reliability and validity using CTT methodology. Stuiver and colleagues 
used a one-parameter logistic Rasch model to study the psychometric properties of a measure 
that combines the SPADI and the NDII in a population of 107 subjects who were within one to 
eight months from neck dissection surgery. Rasch analysis supported the unidimensionality of 
the combined scales, but showed disordered response scale structure, gaps in scale hierarchy, and 
redundancies.21 The psychometric properties of the SPADI, and NDII have not been individually 
assessed using Rasch analysis. 
The use of Rasch analysis to study the psychometric properties and scale functioning of 
the DASH, QuickDASH, SPADI, and the NDII will provide the physical therapist with a better 
understanding of how the tools function when used in the HNC population, in addition to their 
construct validity, and the appropriateness of test score interpretation. In addition, Rasch analysis 
will provide a better understanding of which PRO, or combination of PROs, are best suited to 
quantify shoulder function in patients undergoing neck dissection for HNC. The single-item 
nature of the UW-QoL (shoulder subscale) prohibits its inclusion in the Rasch analysis, however 
further assessment of his relationship and usability as a screening tool for physical therapy would 
be of benefit. 
The current culture of health care requires a healthcare provider to demonstrate value, 
which is determined by the benefit of the intervention (change) divided by the cost to provide 
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that intervention. A healthcare provider must accurately measure change in a patient’s condition 
resulting from the intervention provided. Although PROs have been in existence for decades, 
recent Medicare mandates for functional outcome reporting have increased the awareness and 
use of PROs within the physical therapy profession.22 Physical therapists can use PROs to 
quantify change resulting from an intervention. The appropriate use and interpretation of PROs 
requires that adequate construct validity, reliability, and responsiveness to change have been 
demonstrated in the population of interest. Many of the PROs available for use in the HNC 
population have not been appropriately researched to allow for accurate use and interpretation of 
function and change scores. 
The APTA’s EDGE Task Force on Head and Neck Cancer has recommended the DASH, 
QuickDASH, SPADI, NDII, and the shoulder subscale of the UW-QoL for use in this patient 
population.2 This research study will provide the physical therapist with an unbiased, statistically 
sound understanding of the extent that these PRO test scores can be utilized in quantifying 
disability related to shoulder dysfunction in patients following a neck dissection procedure for 
HNC. If the analysis shows that the measures are not appropriate, recommendations will be made 
as to which combination of measures, or whether a newly developed measure, would be more 
acceptable. 
Research Questions to be Investigated  
To answer the primary research question, “Which of the recommended outcome 
measures demonstrates acceptable psychometric characteristics allowing for accurate test score 
interpretation in patients presenting with shoulder disability in the setting of HNC?,” construct 
validity and reliability of the DASH, QuickDASH, SPADI and the NDII will be analyzed using 
Rasch methodologies for the following investigational questions:  
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Questions for Construct Validity  
Scale Dimensionality 
1. Does Principle Component Analysis (PCA) support the assumption of 
unidimensionality? 
2. Are there sub-scales within the measure that should be considered for analysis 
separately? 
3. Is there test item misfit to suggest the presence of additional constructs within the 
PRO? 
4. Is there person misfit to suggest flaws in the intended item hierarchy? 
5. Do individuals answer test items differently based on age or gender (DIF)? 
Scale Hierarchy 
1. Does the scale hierarchy cover the entire spectrum of the construct of shoulder 
dysfunction?  
2. Are there gaps and/or redundancies?  
3. Does the scale hierarchy demonstrate the presence of floor and/or ceiling effects?  
4. Which test items are considered to be the easiest or most difficult? 
Response Scale Structure 
1. Are there at least 10 responses per response option category? 
2. Are response options equally utilized? 
3. Are there disordered response options or step calibrations?  
4. Are the average measures ordered? 
5. Are there response category outfit MNSQ values that exceed 2.0? 
6. Does collapsing the response categories improve: 
a. Item and person reliability and separation indices, 
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b. Response option utilization, 
c. Ordering (step calibration, average measures), and  
d. Outfit MNSQ values? 
Reliability 
1. Does person separation suggest a good ability to separate individuals based upon 
ability level? 
2. Does item separation verity item hierarchy? 
3. Does person reliability meet expected cut-off values for individual-level analysis? 
4. Does item reliability verify item hierarchy?  
CTT methodologies, including correlational analysis of the UW-QoL (shoulder subscale), will be 
utilized to address the usability of the single test item as a screening tool for shoulder 
dysfunction in this population. 
Guide to Abbreviations for the Dissertation 
ADL Activities of Daily Living 
APTA American Physical Therapy Association 
ASES Modified American Shoulder and Elbow Surgeons standardized form 
AUC Area under the curve  
BMI Body mass index 
cASES Modified American Shoulder and Elbow Surgeons standardized form 
– clinician completed section 
CAT Computerized Adaptive Testing 
CI Confidence interval 
cm Centimeter 
CMS  Centers for Medicare and Medicaid Services 
CS Constant’s Shoulder Score 
CT Computed tomography 
CTT Classical Test Theory 
DASH Disabilities of the Arm, Shoulder and Hand 
DIF Differential item functioning 
EDGE Evaluation Database to Guide Effectiveness 
EHR Electronic health record 
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EMG Electromyography 
EORTC European Organisation for Research and Treatment of Cancer  
ES Effect size 
HIPAA Health Insurance Portability and Accountability Act 
HNC Head and neck cancer 
HPV Human papilloma virus 
HRQOL Health-related quality of life 
ICC Intraclass correlation coefficient 
ICF International Classification of Human Functioning and Health  
IJV Internal jugular vein 
IRB Institutional Review Board 
IRT Item Response Theory 
MCID Minimal clinically important difference 
MDC Minimal detectable change 
MID Minimal important difference 
MNSQ Mean-square 
MRND Modified radical neck dissection 
MS Multiple Sclerosis  
NDII Neck Dissection Impairment Index 
OA Osteoarthritis 
pASES Modified American Shoulder and Elbow Surgeons standardized form 
– patient reported section 
PCA Principle component analysis 
PRET Progressive resistance exercise training 
PRO Patient-reported outcome measure 
PROMIS® Patient Reported Outcomes Measurement Information System  
QOL Quality of life 
RA Rheumatoid arthritis 
RCT Randomized controlled trial 
RND Radical neck dissection 
ROC-curve Receiver operating characteristic curve  
ROM Range of motion 
r Spearman’s and Person’s correlation coefficient 
SAN Spinal accessory nerve 
SCCA Squamous cell carcinoma 
SCM Sternocleidomastoid muscle 
SD Standard deviation 
SDQ Shoulder Disability Questionnaire 
SDQ-NL Shoulder Disability Questionnaire-Netherlands 
SDQ-UK Shoulder Disability Questionnaire-United Kingdom 
SE Standard error 
SEM Standard error of the measure 
SF-36 Medical Outcomes Short Form 36  
SIP Sickness Impact Profile  
SND Selective neck dissection 
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SPADI Shoulder Pain and Disability Index 
SRM Standardized response mean 
SST Simple Shoulder Test 
ULFI Upper Limb Functional Index 
UW-QoL University of Washington Quality of Life Questionnaire  
UW-QoLv4 University of Washington Quality of Life Questionnaire, version 4 
VAS Visual analog scale 
ZSTD z-standard 
α Cronbach’s alpha 
 
Summary of the Chapter 
 This chapter outlines the framework for the research study through defining the specific 
research aims and investigational questions to be addressed. 
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Chapter 2: Review of the Literature 
Introduction to the Chapter 
 
Chapter 2 will include an overview of topics related to head and neck cancer (HNC), 
including a definition, risk factors, incidence and prevalence, and medical management 
strategies. The chapter will also include a review of the relevant anatomy with emphasis on the 
Spinal Accessory Nerve (SAN), cervical plexus, and the trapezius muscle, followed by a 
discussion regarding the implications for HNC-related shoulder dysfunction and rehabilitation. 
An overview of Classical Test Theory (CTT), item response theory (IRT), and Rasch analysis 
will then be provided, followed by an extensive review of shoulder-related PROs recommended 
for quantifying shoulder impairment in the HNC patient population. The chapter will conclude 
with a summary of what is currently known and unknown about the research topic and the 
anticipated contributions the study will make to the physical therapy and HNC fields. 
An Overview of Head and Neck Cancer 
Introduction to the Section 
 This section will first provide a definition for HNC, and a description of the risk factors, 
incidence, prevalence, and survival rates of the diagnosis. Common medical management 
strategies, with a focus on surgical management, will then be discussed.  
Definition, Risk Factors, Incidence & Prevalence 
HNC is characterized by tumors arising in the upper aerodigestive tract, including the 
oral cavity, pharynx (nasopharynx, oropharynx, and hypopharynx), larynx, paranasal sinuses and 
nasal cavity, and the salivary glands. Tumors are most frequently characterized as squamous cell 
carcinomas (SCCA).23 Although the presentation and management are often similar to HNC, 
cancers of the brain, eye, esophagus, thyroid gland, scalp, skin, and muscles and bones of the 
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head and neck, are not characterized as HNC.23 Risk factors for HNC predominately include 
alcohol and tobacco use, and human papillomavirus (HPV) infection related to high-risk sexual 
behavior.23 Other risk factors include the use of Paan (betel quid), Maté, poor oral hygiene, 
occupational exposure, radiation exposure, Epstein-Barr virus infection, and Asian ancestry.23 
In 2014, HNCs will make up approximately 4% of all cancers diagnosed (42,440 cases) 
in the United States, while 8,390 people are expected to die from the disease.24 The current one-
year survival rate for HNC is 83%, and the 5-year and 10-year survival rates are 62% and 51%, 
respectively.24 Chaturvedi and colleagues suggest that the overall increase in HNC incidence in 
the United States (56.4% from the 1980s -2000s) is a result of an increasing prevalence of HPV-
positive oropharyngeal cancers, and an overall decline in HPV-negative tumors related to alcohol 
or tobacco use.25 The increasing prevalence of HPV-positive oropharyngeal cancers is creating a 
“new” HNC patient that is younger, a nonsmoker, and a nondrinker.26 Although there is an HPV 
vaccine, its role for prevention of  HNC is yet to be determined.27 The incidence rate for HNC is 
twice as high in men than women, and in people over the age of 50.23,24 People with HPV-
positive tumors have an increased survival rate than those with HPV-negative tumors.25  
Medical Management Strategies 
Medical management of HNC varies based on the stage and location of the tumor, and 
the individual’s age and comorbidities; and typically includes a combination of surgery, radiation 
therapy, and/or systemic therapies.28,29 Surgical management of HNC may include surgical 
removal of the primary tumor, elective or therapeutic neck dissection, and reconstructive surgery 
to remediate structural deficits remaining from tumor removal. Tumors of the head and neck 
most commonly metastasize to the regional lymph nodes located in the neck. Lymph node status 
is an indicator of prognosis, and knowledge of this status directs treatment strategies.30 A 
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unilateral or bilateral neck dissection procedure is therefore utilized in the presence of known or 
suspected regional metastasis, and is intended to remove at-risk lymphatic and non-lymphatic 
structures.30  
The invasiveness of a neck dissection procedure is dependent on the extent of disease, 
and is classified based on the levels from which lymph nodes are excised.30 The American Head 
and Neck Society and the Committee for Head and Neck Surgery and Oncology of the American 
Academy of Otolaryngology-Head and Neck Surgery have endorsed a classification system for 
neck dissection procedures based on the anatomic level and (I-VI) and three sublevels (IA/IB, 
IIA/IIB, VA/VB) of the neck.31 A radical neck dissection (RND), first described by Crile in 
1906,32 includes removal of the lymph nodes in levels I to V of the neck, the sternocleidomastoid 
muscle (SCM), internal jugular vein (IJV), and the SAN. A modified radical, or functional, neck 
dissection (MRND) removes the lymph nodes in levels I through V, but spares a combination of 
the SCM, IJV, and SAN. A selective neck dissection (SND) is the least invasive and involves 
removal of the lymph nodes only in the areas of greatest risk, based on known patterns of 
metastasis.30 SNDs are named based on the cervical levels excised.30,31 An extended neck 
dissection is more invasive and includes removal of one or more additional lymph node groups 
or non-lymphatic structures in addition to what is typically removed in a RND.30 Improved 
diagnostics and surgical techniques have allowed for the evolution of the RND to MRND and 
SND, when medically indicated. The surgeons’ ability to limit post-operative complications, 
including shoulder dysfunction resulting from nerve sacrifice or intraoperative damage to the 
SAN, is one of many positive outcomes of less invasive surgeries.31,33-41 
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An Overview of Relevant Anatomy 
Introduction to the Section 
 This section will provide a review of the relevant anatomy to HNC, including the SAN, 
the cervical plexus and the trapezius muscle. Anatomical variations, and variations in motor and 
sensory input for each these structures will also be addressed.  
Spinal Accessory Nerve 
Cranial nerve XI has two parts, the cranial nerve and the spinal nerve. The cranial nerve, 
also known as the accessory nerve, originates internally from the nucleus ambiguous and joins 
with the vagus nerve to innervate the palatal, pharyngeal, and laryngeal muscles. The spinal 
nerve, or the SAN, originates in the ventral medulla and externally from the upper five cervical 
segments. The cranial and spinal fibers ascend through the foramen magnum and then exit the 
skull base through the jugular foramen with the glossopharyngeal nerve and the vagus nerve. The 
SAN enters the neck in close proximity to the internal carotid artery and IJV, bisecting the 
anterior triangle of the neck at level II. The nerve passes deep to the SCM where it pierces the 
muscle, emerging distally to cross the posterior triangle (level V) and enter the anterior border of 
the trapezius muscle.30,42-45 Research via intraoperative electromyography (EMG) suggests that 
the cranial branch of the SAN also descends to the trapezius muscle, providing innervation to the 
descending (superior) portion of the muscle.35  
Anatomical variations to the accepted anatomy and anatomical course of the SAN are 
reported in the literature. These anatomical variations in cervical anatomy from patient to patient 
and from side to side can result in unintentional intraoperative injury to the SAN.33,46 For 
example, a case report published by Bater and colleagues demonstrates a rare anatomical 
variation in which the SAN divides into two branches proximal to the SCM.47 In another study, 
14 
 
Lee summarizes variations of the SAN innervation of the SCM, in which the SAN penetrates the 
SCM in only 54.1% of the cases, sending a branch to innervate the muscle in other cases.44 
Another commonly cited anatomical variation exists in the course the SAN takes in relation to 
the IJV within the anterior triangle (level II) of the neck. A cadaveric study of 84 necks 
performed by Saman and colleagues found that the SAN passed anterior to the IJV in 80%, 
posterior in 19%, and in one case the nerve bifurcated the IJV.48 Lee and colleagues’ findings 
differed in that they found 39.8% of SANs crossing anterior to the IJV, 57.4% passing posterior, 
and 2.8% passing through the vessel.44  
Cervical Plexus 
The cervical plexus is comprised of the anterior portions of the first four cervical nerves, 
which form a series of anastomoses and generate five superficial or cutaneous branches and 10 
deep or muscular branches.49 Although variations in the anatomical organization of the cervical 
plexus exist, branches of the cervical plexus are thought to innervate the trapezius muscle. 
According to Pu and colleagues, “C2, C3 and C4 innervation does provide motor input to the 
trapezius muscle, but the innervation is not consistently present and, when present, does not 
consistently innervate all three parts of the trapezius muscle.”50(p571) Lee and colleagues report 
contributions to the SAN by the cranial nerves at C2 in 53.1% of the cases, C2 and C3 in 38.1% 
of the cases, and C3 in 8.8% of the cases.44 In some cases the second and third cervical nerves 
join with the SAN deep to the SCM prior to entering the trapezius muscle,42,51 and in other cases, 
the fibers originating from C3 and C4 cross the posterior triangle independently entering and 
innervating the middle and lower portions of the muscle.42,51,52 If the cervical plexus does 
innervate the trapezius muscle, sacrifice of the cervical root branches of the plexus can result in 
shoulder pain. Garzaro and colleagues compared individuals with neck dissection with 
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preservation of the cervical plexus and neck dissection with sacrifice of the cervical plexus and 
found greater shoulder morbidity in individuals in which the plexus was sacrificed.53 
Trapezius Muscle  
The trapezius is a large muscle that is made up of three parts, the superior/descending 
portion, the middle/transverse portion, and the inferior/ascending portion. Independently, the 
superior fibers elevate the scapula, the middle fibers retract the scapula, and the inferior fibers 
depress the scapula.54 When working in synergy the three portions stabilize the scapula against 
the thorax and upwardly rotate the scapula allowing for elevation of the arm, a movement 
defined as scapulohumeral rhythm.50,55 The trapezius muscle is most active between 35 and 140° 
of shoulder abduction, with the greatest force occurring at 90°.56 At rest, the trapezius muscle 
provides passive support to the shoulder.56  
Anatomical variations related to the innervation of the trapezius muscle exist across 
individuals. It is accepted that the trapezius muscle receives motor innervation from the SAN50,57 
and, in many cases, branches of the cervical plexus.33,42,51,53 A study of 30 cadaveric necks 
revealed motor innervation of the trapezius in all specimens by both the SAN and cranial 
nerves.51 Some anatomists suggest that the SAN and cervical nerves can also offer sensory (pain 
and proprioceptive) innervation to the muscle,50,58-60 although the source of innervation varies 
based on the study.50,58 A study performed by Dilber and colleagues, however, claims that while 
the cervical plexus offers sensory innervation to the neck, it does not offer sensory innervation to 
the trapezius muscle.61 
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Neurological Implications of the Medical Management for Head and Neck Cancer 
Introduction to the Section 
This section will discuss the factors that result in peripheral nerve injury to the SAN and 
cervical plexus ultimately resulting in trapezius muscle atrophy and shoulder dysfunction. 
Specifically, implications related to surgery, radiation and/or chemotherapy are discussed. 
Surgical Implications and Peripheral Nerve Injury 
Shoulder pain and weakness secondary to trapezius muscle atrophy may result from 
intraoperative sacrifice of the SAN in a RND or, in the case of nerve-sparing surgeries in which 
trauma to the SAN occurs.1,30,62 EMG studies comparing outcomes for people receiving SND, 
with little or no trauma to the SAN, shows that those receiving surgical excision of the cervical 
plexus experienced greater dysfunction of the upper trapezius muscle than those who do not.53,63 
The trapezius innervation from the cranial nerves supports the surgical and clinical experience in 
which some people maintain shoulder function despite known injury to or sacrifice of the 
SAN.34,51,64 Saunders and colleagues therefore recommend that the cervical plexus is also spared, 
when possible, to minimize shoulder dysfunction.36 
Intraoperative neurologic injury to the structures innervating the trapezius can occur from 
traction, compression, skeletonization, thermal injury, and de-vascularization, and are most 
common at the SAN with dissection or biopsy at levels IIB and V.30,34,57,63,65,66 The degree of 
injury and the time to recovery are dependent on the type of nerve injury sustained.55 There are 
three classifications of nerve injury - neuropraxia, axonotmesis, and neurotmesis.67,68 
Neuropraxia results from a transient block of the nerve, and will resolve spontaneously within 
three months. Axonotmesis results from a disruption of the axon and myelin sheath, triggering 
Wallerian Degeneration and nerve regeneration.69 Complete denervation, characterized as 
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neurotmesis, results from complete sacrifice of the nerve, as with a RND. In this case, 
spontaneous nerve regeneration will not occur.67,68  
Nerve regeneration occurs at a rate of one inch per month.67,68 The SAN is 4-5 
centimeters in length (cm) when it is lax and 9-10 cm at full length (approximately four 
inches).59 In HNC survivors’ nerve regeneration and re-innervation of the trapezius muscle can 
take 6-12 or 15 months or longer to occur.52,70 Orhan and colleagues studied motor conduction of 
the SAN in 42 necks using needle EMG studies of the trapezius muscle pre-operatively and post-
operatively at three weeks, three months and nine months. The study demonstrates “sufficient re-
innervation” at three and nine months when mild partial denervation of the SAN occurred, 
“moderate re-innervation” for moderate partial denervation, and “mild re-innervation” with 
severe partial denervation. Full recovery to pre-operative levels did not occur for any subject by 
nine months, however. Subjects with complete denervation experienced no re-innervation at 
three or nine months.71  
Although not related to peripheral nerve injury, surgical reconstruction, such as pectoral 
cutaneous flap or radial cutaneous flap, may also be a risk factor for increased shoulder 
dysfunction. Post-operatively patients undergoing surgical reconstruction were found to have a 
25° deficit in forward flexion range of motion (ROM) compared to patients not receiving 
reconstructive surgeries.72 Similarly, those receiving flap surgery report decreased overall quality 
of life (QOL) than those not requiring reconstructive surgery.73 Merve and colleagues did not 
find a significant difference in shoulder function between patients receiving neck dissection with 
pectoralis major flap reconstruction and patients receiving neck dissection only 1-1½ years 
following surgery, however.74 
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Implications Related to Radiotherapy and Chemotherapy 
The overall QOL for HNC survivors receiving radiotherapy is worse than those who do 
not.73,75 The impact of radiation and chemotherapy on aspects related to QOL, including shoulder 
pain and function, remains unclear. For example, Short and colleagues found that radiation alone 
did not cause shoulder pain in 75% of their sample,76 a finding also supported by Chaplin’s 
research,77 whereas all patients reporting shoulder pain in Teymorrtash’s study had received 
radiation therapy.78 When considering shoulder function, in the absence of surgery, radiation 
and/or chemotherapy do not seem to have a significant effect on shoulder function.39,65,75,76,79-82 
Studies have come to similar conclusions in individuals who also received surgery. For example, 
Kuntz and Weymuller found no correlation between shoulder dysfunction and the presence or 
absence of adjuvant radiation therapy at baseline, six and 12 months following surgery.83 Similar 
findings are noted for shoulder ROM five years following the conclusion of cancer treatments 
and radiation.75 The provision of chemotherapy alone also does not seem to impact patient 
outcomes with respect to shoulder function.81  
Other studies suggest increased shoulder-related morbidity in the presence of radiation 
and/or chemotherapy interventions.84-86 In 1989, Nowak and colleagues reported radiation 
therapy combined with neck dissection surgery increased morbidity, including loss of cervical 
and shoulder ROM.85 Gane and colleagues report similar findings.87 In addition, Schuller and 
colleagues found when radiotherapy and surgery were provided, patients had increased reliance 
on others for daily activities and decreased participation in social activities.81 It is possible that 
the common side effect of radiation fibrosis contributes to these findings.87 Radiation fibrosis is 
characterized by progressive tissue fibrosis and sclerosis of all tissues in the radiated field, 
including skin, muscle, ligament, nerve, and bone. The onset of radiation fibrosis can be 
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immediate or delayed, occurring greater than three months following the conclusion of therapy. 
The compressive forces generated by radiation fibrosis, in addition to the ischemia resulting in 
altered blood supply, can result in neurologic injury leading to neuropathic pain, myelopathies, 
and plexopathies.84 Exposure to chemotherapeutic agents enhances the risk of radiation 
fibrosis.88  
Head and Neck Cancer and Shoulder Dysfunction 
Introduction to the Section 
A systematic literature review performed by Goldstein and colleagues provides a 
comprehensive assessment of shoulder impairments and disability, based on the World Health 
Organization International Classification of Functioning, Disability and Health (ICF),89 after 
neck dissection procedure.90 This section will define HNC-related shoulder dysfunction, and 
provide an overview of the risk factors, prevalence, and prognosis for recovery. Factors that 
contribute to shoulder dysfunction including ROM, strength and pain will be reviewed, followed 
by a discussion related to the impact of shoulder function on QOL.   
Shoulder Dysfunction: Definition, Risk Factors, Prevalence and Prognosis 
Shoulder dysfunction, first described by Ewing and Martin in 19521 and Nahum and 
colleagues in 1961,91 is most commonly caused by sacrifice of or intraoperative trauma to the 
SAN during a neck dissection procedure.1,30,62 Individuals with this “shoulder syndrome” 
typically present with the following postural and functional characteristics: drooping of the 
affected shoulder, increased prominence of the medial and superior angle of the scapula 
(scapular winging) both at rest and with movement, shoulder shrug weakness, limitations in 
active shoulder abduction and flexion with preservation of passive ROM, compensatory 
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hypertrophy of other muscles with action at the scapula, and pain across the superior border of 
the trapezius muscle resulting from fatigue of the levator scapula and rhomboids.1,59,92  
Risk factors for developing shoulder dysfunction following a neck dissection surgery 
include the location and stage of the tumor, levels dissected, number of nodes removed, and the 
degree of reconstruction required. The prevalence of shoulder dysfunction is highest in 
individuals who receive RND because of the intentional sacrifice of the SAN, and ranges from 
47-100%.1,37,40,41,52,72,81,92-96 Shoulder symptoms are less frequently reported in nerve-sparing 
surgeries. For example, shoulder symptoms are reported in 18-77% of MRND cases,36,41,50,81,92-
94,96 and 15-50% of cases in SND.50,65,66,78,92-94,96,97 In general, regardless the surgery, dissection 
occurring at level IIB and/or level V place the SAN at the greatest risk.73,79,97,98  
Research supports a typical progression of shoulder dysfunction and subsequent recovery 
based on type of neck dissection received and time from surgery. According to Dijkstra and 
colleagues, 70% of a sample of patients undergoing RND, MRND, or SND experienced shoulder 
symptoms prior to discharge from the hospital post-operatively.72 Subjects receiving a SND 
typically have returned to baseline shoulder function six months following surgery. Those 
receiving MRND have minor recovery of function at six months and near full recovery at 12-18 
months. Those receiving RND have significant shoulder dysfunction at six months, which does 
not recover at 12 or 18 months. However, no subject that received MRND or RND regained 
normal trapezius strength or innervation 12 months following surgery.39,40 This general 
progression is supported by multiple studies that specifically assess the impact of HNC 
treatments on QOL and strength, ROM, and pain at the shoulder joint. 
 Shoulder dysfunction can persist even five years following the completion of cancer 
treatments for both SAN-sparing and sacrificing procedures.75 Although the levator scapula, 
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rhomboids and serratus anterior can compensate for weakness of the trapezius muscle during arm 
elevation,56,99 loss of motor innervation to the trapezius muscle results in resting postural 
abnormalities associated with downward rotation of the scapula and “sagging” of the shoulder.56 
Long term postural deficits may also result in upper extremity symptoms related to traction of 
the brachial plexus.45,60 Other reported outcomes of SAN palsy include subacrominal 
impingement,55,60 hypertrophic sternoclavicular joint,99,100 and secondary adhesive 
capsulitis.38,70,99,101 Adhesive capsulitis is a late sign of SAN palsy in that it is often cited as the 
culprit for persistent joint stiffness and discomfort once the SAN has recovered 12-18 months 
following surgery.38  
Shoulder Dysfunction: Clinical Presentation Related to Range of Motion, Strength, Pain, 
and Quality of Life 
Range of Motion 
 Impaired ROM, specifically shoulder abduction, is a hallmark sign of SAN palsy, 
although shoulder flexion is also impacted. Impaired shoulder abduction results from the failure 
of the trapezius muscle to stabilize the scapula sufficiently during glenohumeral joint abduction, 
resulting in early activation of the deltoid.93 ROM deficits may be present immediately following 
surgery and persist for longer than five years.72,75 For example, post-operative ROM deficits, 
when compared to the opposite shoulder, have been reported at 47° for abduction and 21° for 
forward flexion.72 Individuals receiving nerve-sacrificing surgeries experience greater ROM 
deficits than those receiving nerve-sparing surgeries.72,78 Ewing and Martin describe the classic 
shoulder syndrome in patients undergoing RND as an inability to abduct the arm greater than 
90°.1 Some patients receiving a MRND or RND experience an immediate post-surgical deficit of 
55° in abduction compared to those receiving SND.72 Other authors have reported even greater 
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restrictions in a similar populations with an average shoulder abduction ROM of 58° (range 30-
90°) and average forward flexion ROM to 91° (range 75-120°).59  
The timeframe for recovery of shoulder ROM outside of the post-operative period varies 
based upon the reference. For instance, some authors suggest that ROM deficits continue to 
decline in the post-operative period, and then gradually improve to baseline or equal to controls 
six to18 months following surgery.38,39 Another study found that subjects undergoing ipsilateral 
MRND or bilateral neck dissections were found to have abduction ROM deficits of 50-60° six 
and 12 months following surgery.39 There is evidence to suggest that ROM deficits persist years 
following surgery. Five-year cancer survivors undergoing nerve-sacrificing surgery had flexion 
and abduction ROM ranging from 100 to 140°, and those receiving nerve-sparing surgeries had 
flexion and abduction of approximately 140°,75 however Teymoortash and colleagues report a 
statistically insignificant difference in shoulder abduction nearly three years following surgery.78 
In summary, SAN palsy results in limitation of shoulder ROM, most notable in shoulder 
abduction. ROM deficits are more pronounced in nerve-sacrificing procedures and can be 
present immediately following surgery. ROM improves with re-innervation of the trapezius 
muscle and can take 6-18 months to occur, although some studies demonstrate chronic shoulder 
ROM deficits even five years after surgery. 
Strength 
Muscle strength is a contributing factor to shoulder function, and can be a result of SAN-
palsy related denervation of the trapezius, and overall loss of lean muscle mass occurring during 
cancer treatments. This section will highlight published research related to shoulder strength 
following various neck dissection procedures, in addition to the available literature related to 
overall deconditioning and muscle atrophy as a mechanism for loss of strength.  
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Isokinetic shoulder muscle strength testing performed by Cheng and colleagues93 one and 
six months post-operatively highlights the variations in shoulder strength following RND, 
MRND, and SND. Patients receiving a RND demonstrate statistically significant and lasting 
strength deficits compared to pre-operative and contralateral measurements for shoulder flexion-
extension, abduction-adduction, and internal-external rotation at one and six months following 
surgery. Patients receiving MRND also experienced statistically significant strength deficits with 
the same movement patterns at one month however had some improvements at six months. In 
patients receiving SND flexion-extension and abduction-adduction movement patterns were 
significantly weaker at one month but had returned to pre-operative levels by six months. These 
findings were supported by EMG studies of the trapezius muscle at five weeks post-surgery, 
which demonstrated abnormal EMG findings and diffuse denervation on the operated side in 
RND. The EMG findings in the MRND group were significantly lower than the contralateral 
shoulder, and there were no abnormal findings in the MRND and SND groups.93 Remmler and 
colleagues report similar findings with manual muscle testing of the upper and middle trapezius. 
Upper and middle trapezius strength declined in the post-operative period for both nerve-sparing 
and nerve-sacrificing procedures. While strength returned at six and 12 months to near normal 
preoperative levels in the nerve-sparing group, strength remained significantly lower than normal 
in the nerve-sacrificing group.40 Saunders and colleagues report 67% of patients receiving RND 
and 47% of patients undergoing MRND continued to demonstrate signs of muscle atrophy of the 
trapezius at a mean follow-up time of six years post-surgery.36 Another study of 92 neck 
dissections (MRND/SND and RND) found greater ROM and strength (elevation, abduction) 
deficits at the glenohumeral joint in those receiving RND however both groups demonstrated 
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greater deficits than the control group six months after surgery suggesting some degree of SAN 
impairment in all cases.80  
Individuals undergoing any combination of treatment for HNC experience significant 
weight loss during treatments, 72% of which is attributed to loss of lean muscle.102,103 In 
individuals undergoing combined chemo radiotherapy, weight loss can begin as early as the first 
week of treatment.103 This significant loss of weight is a result of decreased caloric intake,102 and 
a decline in physical performance and increased functional dependence on caregivers.103 In 
general, patients with HNC fail to meet recommended daily exercise levels with the majority 
being completely sedentary.104 Commonly cited barriers for physical activity include dry mouth 
or throat, fatigue, drainage in the mouth or throat, difficulty eating, shortness of breath, and 
muscle weakness.105 Decline in lean muscle mass and function may contribute to the persistent 
strength deficits and disability of the upper quarter. For instance, a study performed by 
McGarvey and colleagues found the expected strength deficits of the upper and middle trapezius 
at the ipsilateral shoulder following neck dissection surgery, however also found that the 
contralateral shoulder has significant strength deficits compared to healthy controls.106 
Pain 
 
There are inconsistencies in the prevalence of shoulder pain in the setting of SAN palsy. 
Cheng and colleagues report 57% of patients undergoing any neck dissection report shoulder 
pain,93 whereas reports by Van Wilgen and Dijkstra cite 69-70% experience shoulder pain after 
neck dissection.62,72 Reported incidence rates are lower in a study performed by Chaplin and 
colleagues, in which 14% of patients reported shoulder pain at diagnosis, 37% at 12 months, and 
26% at 24 months. Of these patients, only 1-5% characterized their pain as severe during the 
two-year timeframe.77 The incidence of pain following RND is higher than with less invasive 
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neck dissection surgeries, with 42-100% of patients reporting pain.1,72,93,107 There is a 
significantly decreased incidence of reported shoulder pain in nerve-sparing procedures, with 
39% of those receiving MRND76 and 5.8% of those receiving SND reporting shoulder pain.78 
Chaplin, however, did not find a significant difference in prevalence or severity of shoulder pain 
based on neck dissection procedure.77  
Quality of Life 
Shoulder dysfunction is a well-documented side effect of neck dissection surgery and a 
significant prognostic indicator of QOL.75,77,98,108-110 Shoulder dysfunction in the setting of SAN 
palsy results in decreased ability to perform basic activities of daily living (ADLs), recreation 
and employment activities, all of which contribute to QOL. Specifically, individuals report 
difficulty with overhead activities, including putting on a shirt, turning on a light switch, or 
combing hair, heavy lifting, and cutting food, prolonged writing and driving a car.56,60,109 As 
such, QOL and function seem to be less when the neck dissection side matches hand 
dominance.111  
Descriptive studies assessing differences in QOL in patients receiving SND, MRND, and 
RND mirror objective findings of ROM and strength deficits. Subjects receiving SND report 
near normal function on the University of Washington Quality of Life Questionnaire (UW-QoL) 
at six months, while those receiving MRND and RND report persistent shoulder dysfunction and 
decreased QOL. By 12-18 months, those receiving MRND have recovered function similar to the 
SND however QOL scores remain lower than pretreatment levels. Those receiving RND 
continue to report increased shoulder dysfunction and decreased QOL at 12 months.73,83 
Reported QOL in HNC survivors five years following both nerve-sacrificing and sparing 
surgeries remains impacted by the presence of shoulder dysfunction.75 Interestingly, one study 
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found that people with HNC tend to demonstrate improvements in subjective reports of shoulder 
function and/or QOL over time despite persistent objective findings of persistent shoulder 
dysfunction.98 
Schuller and colleagues studied employment-related disability in a population of patients 
receiving MRND and RND procedures and found that only 51% of patients returned to their 
prior employment following cancer treatments for HNC. There was no significant difference in 
return to work between surgeries. However, there is a relationship between the degree of 
physical activity that is required in the job and the rate of return, with 38% returning to work at a 
job classified as “very strenuous” and 54% returning to a job deemed “not strenuous.”81 
In summary, shoulder dysfunction is a common side effect of neck dissection and SAN 
palsy and is most prevalent in neck dissections that sacrifice the SAN. Shoulder dysfunction is 
characterized in the literature as shoulder pain, and limitation of ROM and strength. These 
impairments result in decreased ability to perform daily functional, recreational and employment 
activities – all components of the construct of QOL. As such, patient-reported QOL is also lower 
in HNC survivors. Shoulder dysfunction and QOL tend to improve 6-18 months following 
surgery; however, can persist for five years or longer. 
Head and Neck Cancer & Shoulder Dysfunction: The Role of Physical Therapy 
Introduction to the Section 
 Physical therapy can play a valuable role in the recovery of a HNC survivor during and 
following cancer treatments. This section will provide an overview of physical utilization, 
available research related to physical therapy interventions and efficacy, physical activity trends 
in the HNC population, and a brief introduction to importance of patient-reported outcome 
measures (PRO) to quantify impairment and show value of physical therapy interventions 
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provided. A more thorough description of available shoulder-related PRO will be discussed in 
later sections. 
Trends in Physical Therapy Utilization 
 
It is postulated that exercise interventions can improve reported QOL of HNC survivors 
by improving both cervical and shoulder function,110 nonetheless, there is evidence to suggest 
that referral to physical therapy is underutilized in this population.75,112,113 Often, physical 
therapy referral does not occur until adhesive capsulitis and subsequent disability have 
occurred.113 In a sample of 105 HNC survivors, only 15% report receiving exercises for shoulder 
dysfunction from a physical or occupational therapist. Six percent received exercises from a 
physician or a nurse, and 6% received exercises from both a medical and therapy provider.75 
Despite low referral rates, authors frequently recommend referral to physical therapy for 
shoulder dysfunction following neck dissection surgery for restoration and/or maintenance of 
ROM and strength of the neck and shoulder, strengthening of the scapular stabilizers, teaching 
joint protection and compensatory strategies, and decreasing pain.99,109,113-116  
Shoulder Rehabilitation: A Review of the Literature 
Despite the frequent support of physical therapy in the literature, the effectiveness of 
physical therapy in the HNC patient population has yet to be definitively proven. This section 
will provide a detailed summary of the literature available related to physical therapy 
management of shoulder dysfunction in the setting of HNC. Finally, the physical therapy 
management of individuals who have received muscle or nerve grafting surgical procedures to 
optimize shoulder function is mentioned. 
According to Kuntz and Weymuller, outcomes with respect to shoulder function are 
dependent on the “degree of injury to the SAN intraoperatively, variations in innervation of the 
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trapezius muscle, and the amount of physical therapy received postoperatively.”83(p 1337) 
Interestingly, subjects enrolled in the study performed by Kuntz and Weymuller were not 
enrolled in physical therapy, and were instead instructed to pursue non-specific “strengthening 
and ROM exercises at home” with no formalized instruction provided.83 Watkins and colleagues 
suggest that instruction in a home exercise program that includes stretching exercises before 
discharge from the hospital is just as effective as physical therapy, however he cites limitations 
in his study design and suggests that referral to physical therapy postoperatively “will save both 
the patient and the doctor possible morbidity.”65(p 618)  
In 2010, McGarvey and colleagues published a literature review, which systematically 
reviewed and critically appraised research related to HNC-related shoulder dysfunction and 
physical therapy through 2009.117 The authors retrieved 20 articles from the literature, and 
excluded 11 based on low levels of evidence (Sackett’s level of evidence four and five).118 Nine 
articles remained for review, five of which were pre- and post- study designs (level of evidence: 
three).40,119-122 From their review, McGarvey and colleagues concluded that although there is 
some evidence to support an indirect effect of physical therapy in patients with a potential for 
nerve recovery, there is a lack of evidence to support the effectiveness of, and the timing and 
type of physical therapy needed to address shoulder dysfunction in the HNC patient 
population.117 The authors suggest several reasons for the lack of robust clinical trials assessing 
the effectiveness of physical therapy in the HNC patient population including the ethical issues 
associated with withholding physical therapy from patients and the tendency for patients to be 
receiving adjuvant cancer-related treatments which would compound study results and decrease 
enrollment rates.117  
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In 1987, Herring and colleagues published a description of a rehabilitation program for 
patients following a RND procedure. The exercise program progressed the patient through a 
series of passive, active assisted and active ROM exercises in gravity eliminated progressing to 
anti-gravity positions. The authors also included isokinetic strength training using a Cybex 
machine with progression to a home-based exercise program including ROM and isotonic 
shoulder strengthening for varying planes of shoulder elevation to 90°.56 Although this paper was 
not experimental in nature, it is valuable in that it provides a thorough description of exercise 
progression for this patient population. The five pre- and post-study design studies included in 
the McGarvey review highlight the variation and progression of physical therapy intervention 
over the past four decades.40,119-122 An early descriptive study published in 1978 detailing 
physical therapy-supervised home exercise program for shoulder dysfunction in the setting of 
SAN sacrifice utilized infrared luminous lamps, strengthening of the scapular stabilizers and 
elevators, ROM exercises, and stretching to the serratus anterior muscle. The authors claimed 
that the physical therapy treatment provided significant or total pain relief in all 16 patients and 
postural improvements in 15 patients.120 A similar physical therapy intervention was also utilized 
in a manuscript published by the same authors in 1975.99 In another study published in 1986, all 
participants received physical therapy aimed at maintaining ROM of the shoulder joint. The 
results of the study were not focused on the outcomes associated with physical therapy 
intervention, rather the variations in shoulder function based on surgery type.40 A 1988 study 
utilized physical therapy intervention which included “constant (electrical) current, exponential 
and progressive current for the trapezius, massage for the neck and shoulders, and therapeutic 
exercises to the affected shoulder.”121(p 144) While the type of therapeutic exercise was not 
described, the authors concluded that physical therapy was beneficial in improving the 
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stabilization of the scapula through strengthening of the serratus anterior, rhomboids, and levator 
scapula, decreasing pain, atrophy, stiffness and pathological changes at the shoulder.121  
Studies have also addressed the role of shoulder orthosis in management of shoulder 
dysfunction.119,122 Kizilay and colleagues performed a study in which 34 subjects wore the 
orthosis with effects tested at baseline, and one, three, six and 12 months postoperatively. The 
authors report positive outcomes with use of the orthosis,122 however the lack of a control group 
limits the ability to claim that the orthosis caused the outcome. 
The remaining four studies included in McGarvey’s literature review117 include a 
prospective study (evidence level three),123 a retrospective cohort study (level three),124 a pilot 
for a randomized controlled trial (RCT) (level two),114 and a RCT (evidence level one).115 The 
prospective study published by Salerno and colleagues in 2002 assessed the efficacy of 
rehabilitation on pain and dysfunction in a sample of 60 patients following a MRND and total 
laryngectomy. The study utilized a two-group prospective design. Subjects were selected to 
receive physical therapy if they lived in close proximity to the hospital, and were otherwise 
assigned to the control group. The authors utilized interventions aimed entirely at restoring 
passive ROM of the shoulder in the post-operative stage (range 30 – 180 days) under the premise 
that the achievement of full passive shoulder ROM will result in the spontaneous recovery of 
active mobility. The authors found that those who received physical therapy experienced 
decreased shoulder dysfunction and improved QOL compared to those who did not six months 
following surgery.123  
The retrospective study is a Japanese study published in 2007, which studied the role of 
occupational therapy on shoulder pain, ROM and QOL following RND. The authors compared 
an occupational therapy group of 35 shoulders to a no-therapy group of 10 shoulders. The 
31 
 
occupational therapy group initiated therapy on average 55 days (range, 11-263 days) from RND 
and received services five days a week throughout their hospital stay (average 74 days). The no 
therapy group was on average 131 days from RND (range, 70-2466 days). Occupational therapy 
included muscle relaxation techniques, massage, ROM (passive, active-assisted) exercises, and 
ADL training. The results of the study showed that occupational therapy did not have an impact 
on shoulder pain in the setting of SAN palsy, but did improve shoulder ROM and return to 
independence in ADLs and housekeeping activities.124 Similar findings were reported in a 10-
patient case series by the same group of authors in 2002.125 
In 2004, McNeely and colleagues published a pilot study for a RCT that compared 
standard care to a 12-week progressive resistance exercise training (PRET) program. The pilot 
study considered subject willingness to participate in a 12-week PRET program for shoulder 
dysfunction in the setting of SAN neuropraxia or neurectomy following RND, MRND or SND 
surgery, and the effects of physical therapy intervention on shoulder function, pain, disability and 
QOL. Subjects less than eight weeks from surgery, in some cases currently undergoing radiation 
therapy, and subjects greater than eight weeks from surgery were compared for study and 
exercise adherence. The PRET group performed a series of ROM and stretching exercises and 
progressive strengthening exercises for the rhomboids, levator scapula, biceps, triceps, rotator 
cuff, and deltoid; and the standard of care group performed a home based program of ROM, 
stretching, and strengthening exercises of the rhomboids and levator scapula. The PRET group 
demonstrated statistically significant improvement in shoulder external rotation active ROM and 
Shoulder Pain and Disability Index (SPADI) scores. No significant difference was found in 
flexion or abduction ROM or in reported QOL. The authors also demonstrated high study and 
exercise adherence rates.114 
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In a follow-up RCT published in 2008, McNeely and colleagues compared a PRET 
program to a standardized therapeutic exercise protocol in patients who had undergone a RND, 
MRND or SND procedure. Eligibility required that subjects had completed adjuvant treatments 
including radiotherapy at the time of enrollment. Both groups underwent 2-3 supervised exercise 
sessions per week for 12 weeks. The standardized exercise protocol included ROM and 
stretching exercises, postural exercise, and basic strengthening exercises with light weights and 
elastic bands for various muscle groups. The PRET group received the same ROM and stretching 
exercises, however the strengthening exercises were replaced with a standardized PRET 
program. Similar to the pilot study, the RCT showed superior outcomes in the PRET group for 
the SPADI, shoulder strength and muscular endurance, and active external rotation ROM. 
Passive abduction ROM was also improved. QOL changes showed a trend toward improvement, 
but were not statistically significant.115 In 2015, the McNeely group published a follow up study, 
which reported maintained patient-reported shoulder function at 12 months following surgery. In 
addition those individuals who continued resistance exercise training reported better neck 
dissection-related function on the NDII and shoulder-related QOL on the SPADI than those who 
did not.126 
A Cochrane review published in 2012 by Carvalho, Vital and Soares127 included only 
three studies that met the rigorous criteria for conclusion.114-116 The McNeely pilot114 and RCT115 
included in the McGarvey117 literature review were included, as was a newer paper published by 
Lauchlan116 in 2011. The Lauchlan study utilized a RCT design to compare routine postoperative 
physical therapy while the patient was hospitalized, including respiratory care and advice for 
active movement of the neck and shoulder, to an intervention group which received the same 
routine postoperative physical therapy in addition to outpatient physical therapy for the first three 
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months following surgery. Outpatient physical therapy intervention included individualized 
exercise prescription based on patient presentation, and included active ROM, stretching and 
strengthening of the shoulder, postural care, and neuromuscular re-education of the 
scapulothoracic postural muscles. The results did not show a significant difference between the 
intervention and control group with respect to shoulder function or QOL one year following 
surgery.116 This study has several design flaws and was classified by the Cochrane review as has 
having a high risk for bias. The McNeely pilot study was also classified as having a high risk for 
bias, while the RCT was classified as having a low risk for bias. Pooled data from the three 
studies (n = 104) suggests that PRET is more effective than standard physical therapy treatment 
for the management of shoulder dysfunction in the setting of HNC. Neither demonstrate a 
significant improvement in reported QOL, however.127 A limitation of the Cochrane review is 
the heterogeneity of samples included. The Lauchlan study enrolled subjects immediately 
following surgery, whereas the McNeely studies included subjects who were 2-180 months from 
surgery. This variation leads to bias in interpretation because of the change in shoulder function 
that occurs as trapezius muscle re-innervation or compensatory strengthening occurs. 
In 2015, McGarvey and colleagues published the results of a single-blind prospective 
RCT which compared a supervised physical therapy program to usual care at three medical 
facilities in Australia. Patients undergoing SND or MRND with SAN-related shoulder 
impairment were randomized to an intervention group, which received progressive scapular 
stabilization exercises among other interventions, or a control group which received general 
advice and a brochure of general shoulder and neck exercises. Outcomes, including shoulder 
flexion and abduction ROM, the Neck Disability Impairment Index (NDII) and the SPADI, were 
measured at baseline, three months, six months and 12 months. The authors found a statistically 
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significant difference in shoulder abduction between groups at three months, but no significant 
difference for shoulder pain, function, or QOL on the NDII or SPADI at any time point. The 
authors do cite several potential limitations in their study which could have impacted their 
outcomes, including a high attrition rate decreasing statistical power at the six and 12- month 
time points and the potential contamination bias of the control group through allowance of 
individuals (26% of sample) to obtain physical therapy if they desired.128  
Gallagher and colleagues also published a study in 2015, which showed positive effects 
of physical therapy as measured by the Constant’s Shoulder Score (CS) and NDII. Physical 
therapy intervention was not the primary outcome of this study, therefore authors did not collect 
data related to the physical therapy received, duration, frequency or intensity.129 
Recent studies have considered the effects of alternative therapies including 
acupuncture130 and Tai Chi Qigong.131 Six months of Qigong helped to maintain shoulder 
function but did not improve it.131 On the other hand, weekly acupuncture treatments were found 
to improve shoulder function, as measured by the CS, and shoulder-related QOL, as measured by 
the NDII, more than five weeks of standard physical therapy. The authors of this study 
recommend consideration of a combination of PRET-based physical therapy and acupuncture, 
rather than standard physical therapy alone.130 
Literature on surgical repair techniques for trapezius paralysis, such as the Eden-Lange 
dynamic muscle transfer technique, tends to report that conservative rehabilitation is 
ineffective.55,60 The Eden-Lange procedure involves the transfer of the levator scapula, rhomboid 
major and rhomboid minor muscles in a way that their new muscular insertions recreate the force 
vectors previously offered by the three parts of the trapezius muscle.55 Bigliani describes 
conservative management as “physical therapy, transcutaneous nerve stimulation, external 
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support, chiropractic consultation, management in pain clinic, and use of non-steroidal anti-
inflammatory medications as well as narcotic analgesics.”60(p 1535) It should be noted that the 
details of the physical therapy provided are not outlined. In addition, the publications used to 
substantiate the claim that conservative management is ineffective range in publication date from 
the 1950’s to the 1980’s, and appear to be based on clinician expertise rather than 
research.55,132,133  
Various surgical techniques aimed at restoring shoulder function through nerve grafting 
are also described in the literature. A study published by Clinton and colleagues describes a 
single patient case study detailing physical therapy intervention directed to a manual laborer 
following a MRND with sacrifice of the SAN and subsequent reconstruction using the greater 
auricular nerve. Physical therapy intervention began six months following surgery and included 
patient education, scapular taping, soft tissue mobilization, and PRET. Strengthening emphasized 
functional strength allowing the patient to return to work successfully, however trapezius muscle 
strength had not recovered 12 months following surgery.134 
Physical Activity & the Head and Neck Cancer Survivor 
Physical activity patterns in the HNC population are problematic. According to Rogers 
and colleagues, only 30.5% of individuals with HNC are meeting recommended exercise 
guidelines (150 minutes of physical activity per week and strength training twice a week) at the 
time of diagnosis. Physical activity declines further after diagnosis with only 8.5% of individuals 
meeting recommended exercise guidelines. Rogers and colleagues demonstrate a significant 
association between weekly physical activity, functional well-being, overall QOL and fatigue104; 
and Fong and colleagues report improved cervical and temporomandibular joint mobility, and 
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sleep quality in Cantonese patients with nasopharyngeal cancers who participated in a 6-month 
Tai Chi Qigong training program.131  
The already low physical activity levels in this population make adherence to exercise 
prescription following diagnosis difficult. Factors that may contribute to decreased engagement 
in physical activity include xerostomia, fatigue, swallowing difficulties, shortness of breath, pain, 
communication difficulties, and dissatisfaction with QOL.105 McNeely and colleagues suggest 
that more extensive, nerve-sacrificing surgeries and alcohol consumption are predictors for low 
exercise adherence rates.135 Rogers and colleagues offer additional factors to non-adherence 
including increased levels of fatigue during the sixth week of radiation therapy and lasting for 
several weeks following the conclusion of treatment, the patient’s desire to put the cancer 
diagnosis and treatment behind them once the cancer treatments have ended (including exercise 
prescribed during cancer treatments), depression and anxiety.136 
Quantifying Impairment and Demonstrating Value 
Physical therapy referral at diagnosis may be of benefit to the patient. Pre-operative 
assessment can uncover preexisting postural, ROM, and/or strength deficits, provide appropriate 
exercises to address these deficits in order to minimize post-surgical changes, and provide 
education on posture, joint protection and positioning. Establishment of baseline shoulder 
function and/or QOL through validated questionnaires would also be of benefit.137  
 The Centers for Medicare and Medicaid Services (CMS) have mandated the use of 
functional outcome reporting in the assessment and management of patients by physical, 
occupational, and speech therapists.22 A future shift to pay for performance reimbursement 
models will also require use of objective measures to quantify change related to interventions 
provided. PROs defined as “instruments that elicit the individual’s observation of his or her 
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experience,”138(p 193) are commonly used to satisfy CMS mandates, to demonstrate treatment 
effect in the clinical setting, and as a measured variable in research. PROs can be general 
assessments of health-related QOL (HRQOL), or specific to a disease or diagnosis.138 
Traditionally, there are numerous considerations when choosing an outcome measure, including: 
(1) the diagnosis, age and level of disability of the patient or population of interest; (2) whether 
short or long-term conditions are of concern; (3) the level of detail required by the assessment; 
(4) that the test measures what it is intended to measure; (5) the scoring is clear; (5) the measure 
is responsive to change; and (6) evidence exists for the reliability and validity of the measure.139 
Other considerations include the mode of administration, response option format, recall period, 
responder burden, translation or cultural adaptation availability, accessibility to the test, scoring 
and interpretation information, and the presence of floor and/or ceiling effects.138,140 
In summary, while physical therapy referral is often recommended in the literature, HNC 
survivors are not receiving physical therapy services at an optimal rate or time within their 
recovery. There are very few high-quality physical therapy-related research studies available for 
this patient population, leaving clinicians with very little evidence to base clinical decision-
making on. Physical therapy research for shoulder dysfunction in the setting of trapezius muscle 
weakness has demonstrated overall improvements in shoulder function and QOL when compared 
to those who do not receive physical therapy. In the clinic, physical therapists should use 
validated PROs to quantify impairment and demonstrate value.  
Psychometric Theory Models: Classical Test Theory, Item Response Theory, Rasch 
Analysis 
Introduction to the Section 
 
Psychometric theory, or test theory, is a “theoretically oriented field of study, which is of 
general relevance regardless of the particular test, scale or measuring instrument used in a given 
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situation.”141(p 9) It refers to the statistical and mathematical methods underlying the construction, 
development, and revision of measurement instruments and their application. Originating in the 
behavioral, social, and educational fields, the purpose of test development and administration is 
to quantify various constructs of interest.141 A construct is an indirectly observable or measurable 
trait or behavior that exists on a continuum within individuals. Constructs, often referred to as 
latent variables, are measured by a sampling of content indicators or proxies (test items) that 
represent various aspects of the construct. While impossible to include all characteristics that 
make up a construct, a test should provide a good representation of the latent variable and should 
demonstrate an accurate relationship with other similar, previously established constructs, a 
concept known as construct validity.141-143 Because the construct cannot be directly measured, it 
must be assumed that error exists within the test score.143 
Two theoretical approaches for creating and evaluating tests are CTT and IRT.142 The 
five scales addressed in this research study were developed and have been studied using CTT, 
which will be described here. IRT offers a contemporary method of psychometric testing which 
provides a more in-depth analysis of the construct validity and reliability of measures. This 
section will also provide a description of IRT, in addition to a detailed review of Rasch analysis 
– a theoretical framework derived from IRT. 
Classical Test Theory 
 
CTT is a theoretical framework that analyzes how successful proxy indicators are at 
quantifying latent variables of interest.143 CTT is based on the premise that an observed test score 
(X) is comprised of an individual’s true score (T) and measurement error (E), X = T + E.142-145 
CTT also assumes that the random error around the true score is normally distributed and, over 
an infinite number of trials, would equal zero. It is also assumed that random error is 
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uncorrelated with other random error and with the true score.146 There are two sources of 
measurement error, systematic and random. Systematic error occurs in a consistent and 
repeatable manner and is unrelated to the construct being measured.147 Random error “represents 
the combined effect of particular, transient, unrepeatable, and nonsystematic factors…that are 
unrelated to the attribute of concern.”147(p 116) Random error may be a result of external and 
internal factors such as mood or current physiologic state or a factor of uninformed guessing. 
Both random and systematic errors are impossible to separate from the true score because the 
true score is a latent construct that cannot be directly measured. As mentioned previously, CTT 
assumes that random error across multiple trials is zero. The same assumption does not exist for 
systematic error because it is consistent and repeatable across trials. Systematic error is absorbed 
into the true score and therefore poses a significant threat to validity of the test.147 If the test is 
perfectly measuring the construct of interest, there would be no error and the observed test score 
and the true score would be equal. Reliability coefficients, expressed as a ratio of true test score 
variance to observed test score variance, provide an estimate of the accuracy of measurement and 
the degree of consistency between the observed test score and true score.142,148 Error in a sample 
decreases the reliability, or precision, of a measurement. Therefore, the greater the error variance 
the more unlikely the test will be able to capture change in ability level.149 
Reliability 
Commonly utilized scale characteristics under the CTT framework for reliability are 
based upon several assumptions for parallel forms described by DeVellis143 and include temporal 
stability (test-retest reliability), interrater reliability, internal consistency reliability (Cronbach’s 
alpha), and standard error of the measure (SEM).138,142,143,150 These characteristics are established 
for sample-based data, and are therefore influenced by group characteristics. Clinicians and 
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researchers should therefore choose measures that have been tested in populations similar to the 
population of interest before generalizing findings.150,151 Increasing the number of test items is a 
way to improve reliability; in fact Cronbach’s alpha is based upon the correlation between the 
test items and the number of items within the measure.143 SEM, an index of the quality of a 
measurement, is defined as the “average, across persons, standard deviations of the individual 
propensity distributions on a measure under consideration.”148(p 144) The SEM is commonly used 
to construct confidence intervals (CI) around scores.151 Approximately two-thirds of subjects’ 
observed scores will fall within ±1 SEM of their true score and approximately 95% will fall 
within ±2 SEM. This is based on the assumption of normal distribution and identical standard 
deviations (SD) of the individual propensity distributions (true test scores).148 A problem with 
SEM is that it incorrectly assumes that test item precision is equal for mid-range and extreme 
scores.151 
Validity 
Measurement validity, the idea that the test is measuring what it is intended to measure, is 
also included within the CTT framework. The question whether a measure is valid can never be 
affirmatively answered, because there are varying degrees of validity. The goal is to establish a 
strong case for validity through accumulating evidence to more than one of the following 
primary types of validity: criterion-related, content and construct validity. Criterion-related 
validity refers to the ability to predict an individual’s test score on one measure based on his or 
her performance on another measure. There are two kinds of criterion validity: predictive and 
concurrent validity. Content validity refers to the degree that the test items within a measure 
represent the domain assessed and is therefore also dependent on the operational definition 
provided for the construct. Content validation often occurs through expert review of items from 
41 
 
content experts not involved in the development of the measure. Construct validity is an all-
encompassing form of validity, which also includes criterion-related and content validity, that 
supports that a test adequately measures the construct of interest.152 Baghaei defines construct 
validity as the “trustworthiness of score meaning and its interpretation.”153 Under CTT, construct 
validity may be established through correlational analysis, differentiation between groups, factor 
analysis and latent variable modeling, and multi-trait, multi-method procedures supporting 
convergent and discriminant validity of the measure.152  
Strengths and Limitations of CTT 
CTT is based upon assumptions that are easily met by most data sets.145,154 It has 
therefore been widely utilized across various fields of study, including physical therapy, for test 
development and score analysis.154 CTT has remained popular over the years for the following 
reasons: (1) widespread familiarity with CTT terminology and methodology across fields of 
study; (2) most currently available measurement tools are based on CTT; and (3) easy 
accessibility to statistical packages that run CTT-based analyses. In addition, CTT parameters 
often strongly correlate with other modern measurement theory parameters, suggesting that the 
models are comparable.143  
Despite its frequent use, CTT has several reported weaknesses related to sample 
dependency, assumption of test item equivalence, and assumption that SEM is equal across 
difficulty levels despite ability level. CTT assumes item equivalence, or that each test item 
contributes equally to the test score, irrespective of the item difficulty level or person ability 
level. This assumption leads to incorrect test score interpretation when one assumes that a raw 
score of 50 indicates twice as much disability as a raw score of 25 for example. Similarly, one 
cannot assume that the difference between a response option of ‘agree’ and ‘strongly agree’ is 
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equal to the difference between ‘disagree’ and ‘strongly disagree.’ The SEM is also assumed to 
be equal at each point along the scale or for every individual. This assumption is incorrect 
because, by definition, in a normally distributed sample the SEM increases further away from the 
mean, and is not equal at each point along the scale.141,142,144(p 299-301) Other reported weaknesses 
include: (1) failure to capture individuals with low and high ability levels; (2) inability to equate 
ability levels across two or more tests; (3) reliance on the idea of parallel forms (respondents 
remain the same over test trials) for reliability testing; (4) interpretability is based on overall test 
score and does not take into account performance on individual test items; (5) failure to provide 
solutions to common testing problems related to designing tests and identifying biased test items; 
(6) the use of nominal or ordinal level data in mathematical functions and comparisons; and (7) 
inability to estimate item difficulty and person ability separately.154-157  
Item Response Theory  
 
IRT, also described as “item response theory,” “item characteristic curve theory,” or 
“modern test theory,” dates back to 1916 when Binet and Simon plotted performance levels 
against another variable for test development. However, the “birth” of IRT is attributed to the 
work of Frederic Lord in the 1960s. The development of IRT is described in detail by Hambleton 
and Swaminathan.154 IRT assumes that an individual’s performance on a test can be predicted 
based on the identification of latent traits or abilities, estimating ability scores, and subsequently 
using those scores to predict performance.154,158 IRT models assume that the more able a person, 
the more likely he or she will be to answer higher difficulty items correctly.142,156 Ability level 
does not change based upon the test taken, however a person’s test score may change based on a 
test that contains easy or more difficult items.145  
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Strengths and Limitations of IRT 
IRT provides a solution for many of the weaknesses reported in CTT. Unlike CTT, IRT 
allows for score estimation independent of the sample from which the score was obtained, and 
the ability to equate one measure to another based on the completion of a set of common items or 
test items. In addition, the scores are transformed from nominal or ordinal level data to interval 
level data (expressed on a linear scale as a log odds unit, or logit) allowing for the performance 
of mathematical functions and comparisons (conjoint additivity).151,159 Data transformation to 
interval level data solves a problem inherent in CTT related to processes for handling missing 
data. For example, one method for handling missing items in CTT is to calculate the mean of the 
sum of answered items, inputting the value in the data set for the missing test item. In doing so, 
the researcher makes a critical error in using numerical labels from an ordinal scale to perform 
mathematical functions that require continuous level data. This value is then utilized for data 
analysis and increases the risk of making a Type I error. This method violates the principle of 
conjoint additivity. Of note, IRT does not require that each item is answered for analysis to 
occur.159 
IRT provides information related to how single test items and persons function within the 
entire measure or population (item or person fit), dimensionality, floor and ceiling effects, and 
gaps and redundancies in test item content.144(p 324) Information related to gaps and redundancies 
in a measure allows for modification or development of measures that are shorter in length and 
more precise. Because each person and item are estimated (referred to as “measures”), IRT 
models provide an ability to assess the measurement precision for items along the latent 
construct.  Each person and item measure is accompanied with its associated error, called 
“standard error” (SE). SE is analogous to the SEM in CTT however more accurate than the SEM 
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because it is based on each person or item measure rather than the entire test score.142,151 The SE 
for each individual item can be summed to produce an average error for the scale. This method is 
more accurate than reporting an error variance for the average person sampled.151 Another 
benefit of IRT models is that specific item contribution to the precision of the overall test can be 
determined. In test development, this information can be utilized to add or remove test items that 
are found to be imprecise across ability levels.160  
Assumptions of IRT 
IRT is a framework of numerous mathematical models, which are each based on specific 
assumptions about the data set including unidimensionality or multidimensionality, linear or non-
linear models, and dichotomous or multichotomous response options.154 Multidimensional 
models however are not fully developed and therefore are infrequently utilized.146 IRT replaces 
the “soft assumptions” of CTT with two “hard assumptions” - local independence and 
unidimensionality.142,144(p 301-2) Local independence refers to the idea that individual test items are 
independent of each other and unrelated to any other item on the test.142,144(p 301-2) The lack of 
local independence is considered statistical dependence.161 Unidimensionality refers to the idea 
that “one trait can be used to explain the lack of statistical dependence among” test items.155(p 274) 
The presence of unidimensionality under IRT allows for test results to be equated to another due 
to the assumption that the test is measuring only one trait, not several.154 As such, one source 
suggested a third assumption of IRT - that tests are not administered under timed conditions. A 
timed test would be a violation of unidimensionality because one would be unable to determine 
whether a test item was answered incorrectly due to ability level, or because they failed to reach 
the test item or rushed to answer it.146  
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Hambelton and Jones suggest that IRT models are robust to deviations from these 
assumptions.145 Wright and Linacre suggest that it is impossible to remove all latent variables 
from a construct, leaving an entirely unidimensional scale; however “the pursuit of approximate 
unidimensionality” is an important endeavor to pursue in order to have accurate interpretation of 
a total score.156 If these assumptions are met, one can begin to predict the probability of a correct 
response on a test item based on the relationship between a test item’s difficulty and the person’s 
ability level, which can be graphically depicted in an item characteristics curve.144(p 301-2) Ability 
level across the latent construct is displayed on the horizontal axis, expressed in standard 
deviations from the a mean ability level of zero, and the probability of answering the item 
correctly (0-1.0) is on the vertical axis.162,163 
Models of IRT 
The three commonly used models of IRT, the one-, two-, and three-parameter models, 
vary based on the parameters considered in the model.164 The three parameters considered in IRT 
include item difficulty, item discrimination, and guessing. The item difficulty parameter assumes 
that when all else is equal, a more difficult item will have a greater probability of being answered 
incorrectly. The item discrimination parameter represents the ability of a test item to discriminate 
between ability levels. More difficult items are better at discriminating between ability levels 
than easy items, and are therefore more desirable. The guessing parameter takes the likelihood 
that test-takers will guess on test items into account, and indicates the probability that an 
individual of low ability will answer an item correctly based on their ability to guess correctly.162 
This section will provide an overview of each of these models. 
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One-parameter Model 
 The one-parameter model, sometimes referred to as the Rasch model, is the simplest of 
the three models. It assumes that all test items discriminate person ability equally and that no 
guessing occurs. The only factor considered is item difficulty. Therefore, the item characteristic 
curves each have the same slope, but are placed at different levels of difficulty along the 
construct continuum. The one-parameter model also assumes that at the lowest ability level of a 
trait, the responder has a zero percent likelihood of answering the easiest test item correctly. 
Therefore, the construct continuum begins at zero (the x-axis on the item characteristic curve.144 
Two-parameter Model 
The two-parameter model allows the item characteristic curves for each test item to vary 
on two parameters, item difficulty and item discrimination; therefore the item characteristic 
curves vary both on slope and spacing along the construct continuum.144 The addition of the item 
discrimination parameter provides a better understanding of how two test items separate 
individuals based upon their ability levels.162 The varying slopes of the item characteristic curves 
offer a possibility that at some point the curves may cross, suggesting the chance that a low 
difficulty test item may be answered incorrectly, while a more difficult test item is answered 
correctly. Like the one-parameter model, the two-parameter model also assumes that an 
individual with the lowest ability level of a trait will have a zero percent likelihood of answering 
an item correctly, and the curve therefore starts at zero (x-axis).144  
Three-parameter Model 
 
 The three-parameter model varies from on the one- and two-parameter models because, 
while it also considers item difficulty and item discrimination, it also accounts for guessing on 
test items. The one- and two-parameter models do not account for the possibility that individuals 
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are answering test items without error related to distractions or guessing. The item characteristic 
curve varies from the two-parameter model in that it allows the curve to begin somewhere 
greater than zero probability of answering the item correctly and vary based on test item. Three-
parameter models are most frequently utilized in the education field.144 
Partial Credit and Graded Response Models 
 The one-, two-, and three-parameter IRT models assume binomial response options for 
test items. More recent models have been developed which support polytomous response 
options, including the partial credit model and the graded-response model. Although these 
models can accommodate for alternate response options, they rely on the same parameters as the 
one- and two-parameter models.163 The graded-response model is an extension of the two-
parameter IRT model, it accounts for multiple response options by generating a characteristic 
curve for each between response option category threshold. This threshold represents the ability 
level needed to respond beyond a threshold of 0.50. The partial credit model is an extension of 
the one-parameter and Rasch model for polytomous response options. In this model, intersection 
parameters are utilized to represent the ability level at which an individual is more likely to 
respond to one response option category than another.157 The partial credit model assumes equal 
distance between response options, while the graded-response model does not.144,157 
Rasch Analysis 
Overview of the Model 
The one-parameter logistic model is sometimes referred to as the Rasch model. However, 
Boone and colleagues suggest that the Rasch model should not be considered an IRT model 
because of the many differences between the two. The fundamental difference, according to the 
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authors, is that IRT models add parameters to fit the data whereas in Rasch measurement the 
model is not altered to fit the data.165 Using Rasch analysis, an outcome measure is tested against 
the mathematical measurement model to determine the fit of the data to the model, whereas in 
other IRT models the model is fit to the data.166 Despite the apparent similarities between the 
one-parameter IRT model and the Rasch model, it is incorrect to assume they are the same.165 
Assumptions specific to the one-parameter IRT and “Rasch model” include all items have 
equal discriminating power and the responder does not guess when answering test items. It is 
known that these assumptions are unrealistic, and Hambleton and Swaminathan suggest that the 
model may be robust to violations in these assumptions.164 The Rasch model requires a smaller 
sample size (50-200 subjects depending on specific needs) than the two and three-parameter 
models, making it easier to use in clinical resarch.142,167  
Selection of Model for the Study 
This research study will utilize the partial credit Rasch analysis model. Rasch analysis is 
the simplest of the three models, but is also the most frequently used in health care. It is quickly 
gaining popularity in physical therapy research.6-9,12,168 Rasch analysis allows for estimation of 
ability level based on item difficulty. While it does not account for item discrimination, 
observation of Rasch output does allow one to gain an understanding of the test’s ability to 
separate individuals based on ability level through other methods described later. In addition, the 
outcome measures utilized in physical therapy-related research, and specific to this study, are 
based upon an individual’s personal experience and should therefore not be arrived at through 
guessing. These factors rule out the need for the two and three-parameter IRT models. The 
partial credit model is necessary because the measures utilized in this study utilize polytomous 
response options.  
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Data Provided by the Model 
There are several software packages that perform Rasch analysis, and the output of each 
varies slightly across programs. Winsteps (Winsteps® Rasch measurement computer program, 
Beaverton, USA),169 RUMM2030 (RUMM Laboratory, Australia),170 and ConQuest (Australian 
Council for Education Research, Camberwell, Australia)171 are three of the most frequently 
utilized.166 Output from Winsteps will be used in this study and described here. This section will 
provide a detailed summary of the data provided by Winsteps and Rasch analysis, including 
information related to scale dimensionality, person and item fit, differential item functioning 
(DIF), response scale structure and person and item reliability and separation indices.  
Scale Dimensionality 
As mentioned previously, an assumption of IRT and Rasch analysis is unidimensionality. 
The presence of unidimensionality allows for greater confidence that the scale is measuring what 
it is intended to measure (construct validity). Principle component analysis (PCA), person and 
item fit, DIF each contribute to the understanding of a scale’s dimensionality, and therefore 
construct validity.  
PCA in Rasch analysis looks for unexpected patterns in a group of test items. The 
presence of a group of test items that behaves unexpectedly when compared to the model could 
indicate the presence of an additional construct in the PRO.172 The data are deemed to fit the 
model well when greater than 50% of the observed raw score variance is accounted for by the 
model.173 An unexplained variance by the first factor eigenvalue of 1.4 to 3.0 or less suggests 
random correlation between remaining variables.6,14,173 An eigenvalue is similar in concept to 
explained variance. A large eigenvalue, defined as a value greater than one, represents a strong 
source of variance or variability in a set of observed variables. Raykov and Marcoulides suggest 
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that the number of factors in a measure corresponds with the number of eigenvalues higher than 
one.174 It is likely that internal and external factors, such as cultural difference, test anxiety or 
reading comprehension, introduce additional constructs to the measure, therefore changing the 
dimensionality. In general, there must be a dominant factor related to the ability measured within 
the test.146  
In the case that PCA suggests the presence of more than one dimension in a measure, 
individual item loading coefficients (≥ 0.40) are considered. Groupings of test items in the 
positive or negative direction may suggest the presence of additional constructs in the measure, 
which could be analyzed as separate subscales in further PCA.172 
Person and Item Fit 
In Rasch analysis, logits are used to express both person and item measures. Person 
measure refers to how an individual performs on a specific test item and is interpreted as ability 
level. Item measure refers to item difficulty.175 Wright Maps, also referred to as person-item 
maps, are used to display person and item measures, expressed in logits, on a single linear scale 
for a single variable using a scale hierarchy for test items. A Wright Map allows a researcher to 
visualize how the latent construct is defined through the range of ability levels addressed by the 
test. It also provides information regarding floor and ceiling effects, and the presence of 
redundant test items addressing the same ability level or the lack of test items (gaps) to capture 
an ability level.176 Gaps in the item hierarchy suggest imprecision of the measure.9 Valid 
measurement requires consistency in test item difficulty or person ability level despite who is 
responding to the item or which test items are being answered.156 A variation of the Wright Map, 
the Rasch half-point threshold map, is available, which provides a more accurate representation 
of the polytomous representation of test items across ability levels. 
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The term “fit” in Rasch analysis refers to goodness of fit, or how well a data set conforms 
to the Rasch model. The Rasch model can predict, based on item difficulty level and person 
ability level, how a responder will answer a specific test item. Deviation from this predictable 
model would suggest misfit. Misfit on the person level occurs when an individual deviates from 
an expected pattern of test item response based on their ability level.177 Person misfit could be a 
result of “aberrant response patterns” such as unrecorded comorbidity, including cognitive 
deficits.166 For example, misfit occurs when responders with high ability level incorrectly answer 
a test item with low difficulty level, or vice versa. Misfit of persons and/or items degrades the 
quality of measurement. Person and item fit are further defined by infit and outfit statistics. 
Outfit statistics are more sensitive to outliers and may be a result of coding error. Infit statistics 
are sensitive to violations close to the ability level and pose a challenge to interpretation, and 
therefore a greater threat to validity.177 According to Chiu and colleagues, outfit statistics are 
unweighted and occur far from the person or item, for example a person of low ability 
unexpectedly answers a difficult item correctly. Infit statistics are weighted and are affected by 
incorrect responses close to the person, item, or measure. For example, a person with low ability 
answers an easy or less difficult item incorrectly suggesting even lower ability.7  
The presence of person or item misfit is determined by analysis of Person Infit MNSQ 
(mean-square) and ZSTD (z-standardized), Person Outfit MNSQ and ZSTD, Item Infit MNSQ 
and ZSTD, and Item Outfit MNSQ and ZSTD. MNSQ is a chi-square calculation in which the 
distribution of observed frequencies is compared to the expected frequencies of the Rasch model. 
If the observed and expected frequencies are the same, the chi-square statistic will be equal to 
zero.178 A MNSQ value of 1.0 logit is expected.177 Values greater than 1.0 suggest underfit and 
suggests unexpectedly high variability (variance or noise) in the response pattern, while values 
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lower than 1.0 suggest overfit. Overfit indicates that the pattern that is too predictable or 
redundant, and an item that fails to differentiate individuals.15,177 Most surveys or performance 
scales have inherent error, therefore when considering person and item fit in Rasch analysis, a 
range of 0.5 to 1.5 logits is defined as a reasonable fit of the data to the model.177 When the 
MNSQ values fall outside of this range, the ZSTD statistic is analyzed. The ZSTD provides a t-
test statistic that measures the probability that the MNSQ calculation occurred by chance. A 
ZSTD of > ±2 would suggest person or item misfit.177 In scale development or revision, one may 
choose to eliminate misfitting items from a scale, however this could result in a change in the 
validity of the measure and interpretability and should therefore be done with caution.179  
Differential Item Functioning 
 DIF refers to the “relative difficulty of individual test items for groups with dissimilar 
cultural or experimental backgrounds,” but equal ability levels, that results in unequal probability 
of success.158(p 196-7) In many cases, authors attribute the presence of DIF to item bias.12,166 
According to Boone, however, DIF does not seek to identify whether test items are unfair or 
biased between groups, rather whether test items “operate in the same way for different groups of 
respondents.”180(p 274) Different groups within a sample may answer test items differently based 
on their gender, age, race or language, for example, and if present could suggest the presence of 
additional constructs or dimensions tested within the scale.180 DIF is assessed by comparing the 
item characteristic curve for the same item across two different groups.158 A measurement 
instrument with high construct validity should not have test items that shift in order or spacing 
along the item hierarchy based on the group of people answering. Individual test items which are 
less than a probability of 0.05 and have an effect size of greater than 0.64 must be qualitatively 
considered for DIF.180 In the event that DIF is present, resolution requires consideration of the 
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following: (1) ignoring it as inherent in the measuring system; (2) remove or rewrite the item; (3) 
treat data for one DIF group as missing data for further analysis; or (4) split the item making two 
test items, one item with active data for one DIF group and missing data for the other.181 
Response Scale Structure 
The structural integrity and scale functionality of a rating scale can be assessed in Rasch 
analysis by looking at response category utilization, uniform distribution of use of response 
options, scale calibration, and absence of misordered category steps.8 Specifically, Linacre 
proposes five necessary characteristics of an optimal rating scale: (1) test items are oriented with 
the latent variable and are of the same scoring structure; (2) there are a minimum of 10 responses 
per response option for each test item; (3) there is uniform distribution of category utilization; (4) 
average measures per category and step calibrations increase monotonically; and (5) the response 
category outfit MNSQ does not exceed 2.0.182 At least 10 observations per response category are 
needed to determine measure stability. Fewer observations per response option can result in 
imprecise step calibration and make the scale unstable.182,183 Step calibration provides 
information related to ordered response options. Step calibration should sequentially increase or 
decrease with item difficulty. The average measure values should also increase or decrease with 
item difficulty for each response option. Failure of average measures to increase up the rating 
scale limits the ability to interpret the measure for the data set. Mean-square statistics calculated 
for each response category provides an estimation of the degree of error within a category An 
outfit value of greater than 2.0 suggests that there is more unexplained variance than explained 
variance in a category, and therefore limits the accuracy, stability and interpretability of the 
measure.182 Scale structure can also be assessed through consideration the Rasch half-point 
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threshold map and the presence of gaps or redundancies in the rating scale and the presence of 
floor or ceiling effects. 
General Scale Indices 
Rasch analysis provides evidence for test reliability through assessment of dimensionality 
and the provision of an unbiased reliability estimate. Rasch analysis through Winsteps provides 
output for person and item reliability, and person and item separation, both of which are reported 
in logits. A logit is a “log-odds unit” derived from the log odds ratio of the probability of success 
divided by the probability of failure on a test item. Logits may range in value from zero to 
infinity, and are interval level data that have been transformed from ordinal level data.184 Person 
reliability is related to the ability of the test to discriminate into ability levels. Person reliability 
in Rasch analysis is similar to internal consistency (Cronbach’s alpha, α) in CTT where a value 
closer to one indicates greater internal consistency.185 Smith151 suggests differences between 
these values, however. In CTT, internal consistency is developed from data that is non-linear and 
includes extreme scores (perfect and zero scores). Inclusion of extreme scores (perfect and zero 
scores) in reliability calculation decreases the average error and inflates reliability reporting. 
Therefore, in Rasch analysis, extreme scores are often eliminated from analysis.151 Elimination 
of extreme scores is necessary because the error of the person measure is “infinite.” There is no 
way of knowing how far beyond the item score a person’s ability level continues. Inclusion of 
these individuals does not provide any useful information about how accurately the test is 
functioning. 185 In Winsteps, the ‘REAL’ estimate provides the person reliability coefficient with 
extreme scores removed. The ‘MODEL’ estimate does not remove extreme scores. Boone and 
colleagues suggest using the REAL estimate when reporting.185 A minimum value of 0.7 is 
preferred for group level analysis, and a value of 0.85 is suggested for the individual level.166  
55 
 
Item reliability is also reported from zero to one. Higher item reliability suggests the 
presence of a large range of item difficulty within the measure. Therefore, low item reliability 
may suggest an inadequate sample size to establish item difficulty hierarchy. Item reliability is 
independent of test length and uninfluenced by model fit.  A reliability index of greater than 0.9 
is desired to verify item hierarchy.186 
Rasch output also provides a person and an item separation index.185 The separation 
index is the square root value of the ratio between the true person variance and the error variance 
in the data.173,185 The separation index can range from zero to infinity, with a higher score being 
more desirable. Boone and colleagues reference a discussion with Mike Linacre in 2012 in which 
Linacre explained that person separation is used to classify people into ability levels. A low 
person separation index may suggest that the measure is not sensitive enough to distinguish 
between ability levels. The item separation index verifies item hierarchy.185 A person separation 
index of 1.50 is acceptable, a value of 2.0 indicates a good level of separation, and a value of 3.0 
is excellent. For item separation, a value of 1.5 is required for analysis at the individual level and 
a value of 2.5 is required for group level analysis.185 
Reliability and Validity – Establishing the Theoretical Framework for this Study 
The increasing popularity of IRT and Rasch analysis offer additional methodologies to 
study the functionality and appropriateness of test score interpretation of a PRO. In general, CTT 
is “test based,” whereas IRT and Rasch models are “item based.” Item based models allow for a 
broader range of interpretations based on individual test performance.145 Pusic and colleagues 
therefore suggest that CTT be used for group-based research, while IRT and Rasch analysis be 
used for interpretation on the individual level.5 According to Tennant and Conaghan, Rasch 
analysis should be used in the following circumstances: when a set of ordinal-level test item 
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scores are intended to be combined into a composite score; in the development of a new scale; 
when reviewing the psychometric properties of existing scales; in the assessment of the 
dimensionality of tests; when constructing test item banks for computerized adaptive testing 
(CAT); and when change scores need to be calculated from ordinal scales.166  
IRT and Rasch analysis are useful in supporting the reliability and validity of a PRO.151 
The section will provide an overview of the information gleaned from Rasch analysis regarding 
reliability. It will also introduce the theoretical framework for this research study related to 
construct validity and the ability of Rasch analysis to contribute to the validity of a measure’s 
test score interpretation.  
In Rasch analysis, the standard error estimate of a person’s ability level and item 
difficulty level provide information related to reliability on an item level. In addition, the person 
reliability estimate provides information related to internal consistency and is analogous to 
Cronbach’s alpha in CTT.151 Item reliability is unique to IRT and Rasch analysis in that it offers 
a reliability estimate for the items185 The reliability of a measure contributes to the validity of a 
measure. In other words, a measure must be reliable to be valid, however the measure does not 
need to be reliable to be considered valid.187 
Although there are many forms of validity reported in psychometric models,187 Messick 
suggests that validity is a unified concept in which the multiple facets of validity (content, 
substantive, structural, generalizability, external, and consequential) each contribute to the 
overall construct validity of the measure.188,189 Construct validity is defined as “any evidence that 
bears on the interpretation or meaning of the test scores.”189(p 7) The accuracy or appropriateness 
of test score interpretation is never definitively defined, rather the available evidence to support 
construct validity is considered to establish the “degree” to which a test score interpretation can 
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be trusted.189 Various approaches must therefore be utilized to contribute to the evidence for 
validity.151  
Rasch analysis has three components that address the six facets of construct validity 
proposed by Messick (and listed previously)188,189 and two additional facets (responsiveness and 
interpretability) proposed by the Medical Outcomes Trust151: (1) model requirements and 
measurement properties if the data fit the model; (2) linear hierarchical scale and standard error; 
and (3) item and person fit.151 The eight facets of validity and how they are assessed using Rasch 
analysis are as follows151,188,189: 
• The content facet of reliability refers to the relevance, representativeness, and technical 
quality of a measure. The relevance and representativeness are substantiated by analysis 
of the item hierarchy and item calibration. Failure of a scale to cover a full range of 
ability levels related to a construct suggests poor interpretability and utility.  Technical 
quality is addressed through analysis of fit statistics, and the degree that each test item 
contributes to measuring the latent variable.  
• The substantive component is confirmed through analysis of the item hierarchy and 
whether the hypothesized and empirical item difficulties are similar. Person fit also 
contributes to this facet.  
• The structural facet refers to the credibility and interpretability of the scoring system. It is 
supported by item and person parameters.  
• The generalizability aspect of construct validity addresses the invariance of person 
measures and item calibration across different groups, times or contexts. It can be 
addressed through comparison of means for different samples. Generalizability will not 
be assessed in this research study.  
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• The external facet is concerned with convergent and discriminant evidence. 
Discriminative evidence can be addressed through assessment of variance between 
known groups, such as with DIF. Convergent evidence can be assessed through 
calibration and comparison of person measures with another measure.  
• Consequential evidence considers the value and consequences of score interpretation and 
test use. It also considers test fairness, which can be assessed using DIF.  
• Responsiveness is related to the measure’s ability to detect change. In Rasch analysis 
scale responsiveness can be addressed by assessing the ability of the measure to 
distinguish between two ability levels using person reliability and separation index. 
• Interpretability refers to the ability of a quantitative meaning to be assigned to a 
qualitative measure. In Rasch analysis, this is determined through analysis of the person-
item map because it places item difficulty and person ability on the same scale. This 
allows for prediction of how an individual will answer an item of specified difficulty 
level based upon their ability level.  
According to Messick, validity refers to the “relevance and utility of the test scores for 
particular applied purposes and of the social consequences of their use.”189(p 5) Two sources of 
construct invalidity include construct underrepresentation and construct-irrelevant variance. 
Construct underrepresentation occurs when the measure fails to include all relevant aspects of a 
construct; and construct-irrelevant variance occurs when the measure is too broad and includes 
variance related to other dimensions or constructs.188,189  
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Patient-Reported Outcome Measures to Objectify HNC-Related Shoulder Dysfunction 
Introduction to the Section 
 As stated previously, physical therapists should utilize validated PROs to quantify 
shoulder-related impairment and to demonstrate value of interventions provided. There are 
numerous shoulder-related PROs available to the clinician, only a few of which have been 
utilized in HNC research. Even fewer were developed specifically for the HNC patient 
population. This section will summarize the systematic reviews available in the literature that 
have attempted to offer clinicians treating this population with guidance as to which PROs are 
most appropriate. An in-depth analysis of the literature related to seven shoulder-related PROs 
will then be provided.  
Recommended PROs for HNC-related Shoulder Dysfunction   
When considering shoulder dysfunction in the HNC population, there are very few PROs 
that have been developed for and validated in populations of individuals presenting with 
shoulder dysfunction following neck dissection surgery. In addition, the psychometric research 
that has been done is grounded in CTT, thus is susceptible to the limitations previously outlined. 
Researchers have attempted to provide medical professionals treating patients with HNC with 
recommendations of the most appropriate shoulder-related PROs for the population.2,3,190 
Through a review of HNC literature published between 1980 and 2011, Goldstein and colleagues 
identified seven PROs that have been utilized in research to quantify HNC-related shoulder 
dysfunction, including: modified American Shoulder and Elbow Surgeons standardized form 
(ASES), CS, Disability of the Arm, Shoulder and Hand (DASH), NDII, Shoulder Disability 
Questionnaire (SDQ), SPADI, and the Simple Shoulder Test (SST). Of these measures, the NDII 
is the only measure identified that was specifically designed and validated in the HNC 
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population, however the measure’s psychometric properties have not been thoroughly 
researched. The authors highlight the DASH as the most extensively developed measure across 
diagnoses, however also point out that the psychometric properties of the measure have not been 
established in the HNC population.3  
The Previously Untreated, Locally Advanced (PULA) Task Force of the Head and Neck 
Steering Committee of the Coordinating Centre for Clinical Trials at the National Cancer 
Institute has provided recommendations for PROs use in clinical trials for HNC.190 Similar to the 
Goldstein article,3 the Task Force also recommended the DASH and NDII as subjective 
measures of shoulder and tissue fibrosis. The authors also named the CS as a measure of 
shoulder and tissue fibrosis, however do not include it as one of the recommended measures. 
Their rationale for this is not stated.190  
The Academy of Oncologic Physical Therapy of  the American Physical Therapy 
Association’s (APTA) Evaluation Database to Guide Effectiveness (EDGE) Task Force191 for 
HNC has also issued recommendations for physical therapists treating patients with HNC-related 
shoulder impairment based upon an extensive literature review of outcome measures utilized 
across patient populations and diagnoses to quantify shoulder impairment. Nearly 50 PROs 
related to the shoulder were found, and 16 met the inclusion criteria for analysis by the Task 
Force. The Task Force recommendations are based upon a review of the psychometric 
properties, based on CTT, of the tools, the population and condition the tool was developed in, 
and whether the tool has been used in HNC-related research. Table 2 provides a description of 
the recommendation system. The Task Force highly recommends (score of 4) the DASH, the 
SPADI, NDII, and the UW-QoL (shoulder subscale) for use by physical therapists when 
quantifying shoulder dysfunction following neck dissection surgery, and recommends (score of 
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3) the QuickDASH. The Task Force chose to recommend the UW-QoL (shoulder subscale) and 
the NDII because they were developed specifically for the HNC population and have shown 
promising reliability and validity. The DASH, QuickDASH, and the SPADI, on the other hand, 
were not developed in the HNC population, but have been utilized and tested extensively across 
multiple patient populations and diagnoses.2 The DASH and the SPADI have both been used in 
HNC research,21,66,79,86,109,114,115,128,192-199 but have not been sufficiently tested to demonstrate 
adequate psychometric properties.  
Table 1. Head and Neck Cancer Rating Scale 
4 Highly 
Recommended 
Highly recommended; the outcome has good psychometric properties 
and good clinical utility; the measure has been used in research on 
individuals with or post head and neck cancer. 
3 Recommended Recommended; the outcome measure has good psychometric 
properties and good clinical utility; no published evidence that the 
measure has been applied to research on individuals with or post head 
and neck cancer. 
2A Unable to 
Recommend 
at This Time 
Unable to recommend at this time; there is insufficient information to 
support a recommendation of this outcome measure; the measure has 
been applied to research on individuals with or post head and neck 
cancer. 
2B Unable to 
Recommend 
at This Time 
Unable to recommend at this time; there is insufficient information to 
support a recommendation of this outcome measure; no published 
evidence that the measure has been applied to research on individuals 
with or post head and neck cancer. 
1 Do not 
Recommend 
Poor psychometric and/or poor clinical utility (time, equipment, cost, 
etc.) 
A Review of the Psychometric Properties of Shoulder-Related PROs 
American Shoulder and Elbow Surgeons Standardized Form 
 
The ASES, first published in 1994, was developed by a research committee of the 
American Shoulder and Elbow Surgeons in an effort to facilitate communication between 
researchers and encourage multicenter trials. The test was developed through assessment of all 
published outcome measures at that time and expert opinion from the members of the 
organization.200,201 The ASES has 2 sections – a clinician assessment (cASES) of ROM, strength 
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and instability, which is not included in the total test score, and a patient self-evaluation 
(pASES). In most cases, the pASES is the only section reported in research. The pASES consists 
of 11 items, which are divided into two areas, pain [one item scored on a 10-cm visual analog 
scale (VAS) with 10-cm indicating worst pain ever] and function (10 items). The function items 
are specific to ADLs, usual work and recreational activities, and are unique in that they ask the 
responder to rate the difficulty separately for the left and right upper extremity. The recall period 
for the pASES is one week. Test items are based on a 4-point Likert scale (0 = unable to do so, 3 
= not difficult). The pain scale response is multiplied by five to get a score out of a maximum 
score of 50, and the function subscale is multiplied by 5/3, to also provide a score out of a 
maximum score of 50. An overall score of 0-100 points is possible, where a score of 100 
indicates normal shoulder function. The pASES has low responder and tester burden, taking 
approximately 3-5 minutes to complete and two minutes to score.149,202,203 Bot and colleagues 
have classified the ASES as difficult to score, however.204 A modified version of the ASES 
added five additional questions related to pain, including the use of pain medication and shoulder 
instability. The newer test items are not included in the test score, however.205 The ASES is 
available in German,206 Italian,207 Turkish,202 Arabic,208 Finnish,209 Spanish,210 and 
Portuguese.211,212 
The ASES was developed to provide a measure of shoulder function irrespective of 
diagnosis.201,203 It has also been utilized in studies addressing shoulder pain and 
dysfunction,202,203,212 subacromial impingement,210,213 rotator cuff dysfunction210,214 
instability,207,214 and rheumatoid arthritis (RA), osteoarthritis (OA), total joint arthroplasty,206,214-
217 and clavicle fracture.218 Normative values range from 92-99 points.219,220 
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 Reported test re-test reliability and internal consistency in the literature ranges from 
Intraclass Correlation Coefficient (ICC) = 0.75-0.96,202,203,206,207,209,212,214,217,219,221,222 and 
Cronbach’s α = 0.61-0.96,202,203,206,207,210,212,214,222 respectively. Person reliability, which is 
analogous to internal consistency in Rasch analysis, is reported as 0.89 – 0.90.20,210 An SEM of 
2.51,202 10.55,212 11.0,203 is reported. The Minimal Detectable Change95% (MDC) can therefore 
be calculated as 6.96,202 29.24,212 and 18.74.203 Minimal Clinical Important Difference (MCID) 
values range from 6.4-16.9 in the literature.203,223 The Turkish and Spanish versions were found 
to have minimal to no floor and ceiling effects.202,210 However, significant ceiling effects are 
present in the pain and instability sections of the measure for patients who have received total 
shoulder arthroplasty.216 
 Convergent validity is reported using the Spearman’s correlation coefficient (r) for 
parametric data or the Pearson’s correlation coefficient (rs) for nonparametric data. For simplicity 
both Spearman’s and Pearson’s correlation coefficient will be presented as ‘r’ in this document. 
The convergent validity of the ASES has been established with comparison with other shoulder-
related outcome measures as follows: SPADI total score (r = -0.81 to -0.92),202,216 DASH (r = -
0.47 to -0.92),206,207,212,216,217,224 QuickDASH (r = -0.55 to -0.85),224 SST (r = 0.536-0.73),209,225 
the physical functioning, role limitation, and bodily pain domains of the Medical Outcomes 
Short Form 36 (SF-36, r = 0.33-0.74),203,209,210,212,216 CS (r = 0.71-0.87),216,226 Turkish version of 
the CS (r = 0.48),202 Spanish version of the CS (r = 0.62)210 Barthel Index (r = 0.31),210 and the 
Penn Shoulder Score (r = 0.78-0.87).203,227 Discriminant and divergent validity have also been 
supported.203 Responsiveness of the ASES has been reported with a standardized response mean 
(SRM) of 1.6 and an effect size (ES) of 1.4.203 Partial credit Rasch analysis of a modified version 
of the pASES performed in 2001 found misfit of two test items, Item 1: sleep on shoulder and 
64 
 
Item 10: reach behind back to fasten brassiere. The analysis suggests that the pASES does not 
have equal interval measures, indicting a limitation in responsiveness to change over time. In 
addition, the measure is imprecise at measuring those with lower and higher shoulder 
functioning.20  
 Rasch analysis was utilized to validate the Spanish version of the ASES. Due to the 
concern of multidimensionality, the authors utilized factor analysis and Rasch analysis on two 
models: (1) all 11 items and (2) the 10 function-based items (eliminating the pain analog scale). 
Analysis supported unidimensionality of the full 11-item scale.  Person and item reliability (0.90 
and 0.98) and person and item separation indices (2.93 and 7.53) were deemed acceptable. Item 
10:  do usual sports had the highest frequency of missing data and poorest fit to the model. Item 
7: lift 10 pounds over shoulder and Item 8: throw a ball overhand were the most difficult to 
endorse and Item 4: manage toileting was the easiest to endorse.210 Beckmann and colleagues 
utilized Rasch analysis to study the 11-item scale and report limitation related to 
multidimensionality and poor person reliability (0.48). Strengths included excellent item 
reliability (0.98) and no floor or ceiling effects.225 
Wright and Baumgarten suggest that the ASES is the most appropriate measure to be 
used for research purposes as a general shoulder measure.228 Schmidt and colleagues performed a 
comprehensive review of PROs addressing shoulder dysfunction in a broad range of diagnoses, 
and also supported the ASES as the best overall shoulder-specific PRO.229 The ASES has been 
used in HNC literature,116 however psychometric properties specific to the population are not 
reported.  
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Constant’s Shoulder Score 
 
The CS, also known as the Constant’s Score and the Constant-Murley Score, is one of the 
original shoulder-specific PROs first published in 1986 and 1987. It was proposed by orthopedic 
surgeons in the European Society for Surgery of the Shoulder and Elbow as a shoulder-specific 
measure to compare shoulder function before and after treatment,228 and according to the 
developers is “applicable irrespective of the details of the diagnostic or radiologic abnormalities 
caused by disease or injury.”230(p 160) The methodology for development of the CS, including item 
selection, item reduction and item weighting, has not been published.200 The measure was further 
reviewed and modified in 2008,231 and a standardized testing protocol was published in English 
and Danish in 2013.232 
The CS consists of a patient-reported section, which accounts for 35% of the total test 
score, and a clinician measure that accounts for the remaining 65% of the test score. The patient-
reported section includes five items that address pain and ADLs. The first item addresses the 
most severe pain experienced during ordinary activities within the past 24-hour period, using a 
VAS with anchors of ‘no pain’ and ‘intolerable pain.’  Pain is scored on a 0-15 point scale, 
where a pain level of zero is awarded 15 points. The ADL section has 20 available points 
distributed over four test items related to sleep (0-2 points, 2 points awarded for undisturbed 
sleep), work disturbance (0-4 points, 4 points awarded for no limitation), recreational activities 
(0-4 points, 4 points awarded for no limitation), and the ability to lift the arm (0-10 points, 10 
points awarded for lifting above the head, 8 points to head, 6 points to neck, 4 points to sternum, 
2 points to waist, and no points for below the waist). The remaining 65 points are scored based 
on the clinician’s assessment of shoulder ROM (40 points) into forward flexion, abduction, 
internal and external rotation measured with a goniometer and strength (25 points) measured at 
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90° of abduction in the scapular plane using an Isobex isometric dynamometer or myometer. The 
average of three trials performed with one-minute rest between trials is scored. A subject who 
cannot achieve 90° of abduction receives a score of zero. A score of 100 indicates no 
limitation.231 Individuals are asked to recall their symptoms over the past week when completing 
this questionnaire.205 The CS takes 10-15 minutes to complete and two minutes to score.149,228 
According to Angst and colleagues, the CS is used in most languages without official 
translation,205 but has been validated in the Turkish language.202 Performance of the test on both 
extremities allows for comparison between sides.233 
The psychometric properties of the CS have been reported in various patient populations 
with musculoskeletal disorders and shoulder instability. Normal CS values for male and female 
subjects, aged 21-100 years old, are reported in the literature.231 The test-retest reliability is ICC 
= 0.80-0.96.3,149,202 Internal consistency (α) ranges from 0.37-0.60.205 The strength domain 
provides a high risk of error in measurement resulting in low intertester reliability.205 MDC, 
MCID, and SEM are not reported.3,205 Effect Size (ES) and SRM for patients with OA and RA 
undergoing shoulder arthroplasty, shoulder impingement with surgical decompression, rotator 
cuff repair, and physical therapy for instability are reported.205 
The convergent validity of the CS is supported through the correlation (r) with several 
PROs including, the ASES (0.48-0.87), Oxford Shoulder Score (0.65-0.87), DASH (-0.50 to -
0.82), SPADI (-0.53 to -0.82), and the SST (0.49).202,205,216,234 A review of PROs cites no floor or 
ceiling effects for the CS total score,202,205 however, significant ceiling effects were found for the 
pain and ADL components of the CS in a population of patients receiving total shoulder 
arthroplasty.216 A floor effect as high as 52% has been reported for the strength subscale because 
subjects were unable to achieve the required 90° abduction, and therefore were awarded a score 
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of zero.235 This is a significant finding and a consideration for the HNC population given the 
tendency for abduction ROM to be significantly impaired. Content and divergent validity 
however are described.3 
The CS has been used in research related to SAN injury,236 and in HNC-related 
studies.65,74,116,123,129,130,237-241 According to Goldstein,3 normative data are not available, 
however, the validation study of the NDII reports a mean (SD, range) score in a population of 
patients with HNC as 70.7 (17.4, 38-100).4 Similar findings are reported by Chepeha and 
colleagues in a population of patients 11 months following SND and MRND surgery for HNC 
(71.0 ± 18.8, 22-100).238 Watkins and colleagues utilized cut off scores to classify subjects as 
having mild, moderate, and severe shoulder dysfunction by comparing the involved extremity to 
the uninvolved extremity. Subjects with 1-2 SD variation between sides were classified as having 
mild dysfunction, and subjects with 2-3 SD and greater than 3 SD were classified as moderate 
and severe dysfunction respectively.65 Convergent validity in HNC populations has been 
established with correlation of the CS with the NDII (r = 0.854 and 0.64129). The subjective and 
objective measurements of the CS are also significantly correlated (r = 0.65) in a population of 
patients with HNC.238 Merve and colleagues support the discriminative validity of the CS based 
on neck dissection type.74 Psychometric properties related to reproducibility and responsiveness 
to change has not been reported for the HNC population. 
A limitation of the CS is the required equipment for testing strength, which may not be 
readily available in the clinic. According to Constant and colleagues, manual muscle testing is 
“condemned.”231 Other limitations include variations in CS administrative practices, limited 
evidence to support reliability and validity across patient populations, lack of normative values 
for various patient populations, and lack of MDC and MCID values.205 Several authors suggest 
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the CS scoring system may be inappropriate due to the multidimensionality of the clinician- and 
patient-rated domains, and should therefore not be included in the same test score. There is also 
criticism based on the weighting of the various items within the scale. ROM accounts for 40% of 
the scale, while strength accounts for 25%, pain 15% and function 20%. In addition, the risk of 
bias based on variations in the clinician assessment has also been suggested as a weakness of the 
scale.200,228 It does not appear that the psychometric properties of the CS have been assessed 
using Rasch methodologies at this time.   
Disabilities of the Arm, Shoulder and Hand, QuickDASH 
DASH 
 
The DASH was originally developed in 1996 by the American Academy of Orthopedic 
Surgeons and the Institute for Work and Health as a “tool to be used for patients with any 
condition of any joint of the upper extremity.”200(p 1113) Test items were generated through a 
review of the literature to establish an item pool of 821 items that were reduced through expert 
opinion, pilot testing in a sample of 20 patients, and field-testing in a sample of over 400 subjects 
across various upper extremity diagnoses and regions.3,200,242 Information about the DASH, 
including test development, populations tested, and psychometric properties, is available in 
published manuals. The most recent was published in 2011.243 The DASH has been translated 
into 52 versions, with 20 additional versions currently in progress.244 Two shortened versions of 
the DASH, the QuickDASH and the QuickDASH-9, are also available.245,246 The QuickDASH is 
widely used in clinic and research settings, whereas the QuickDASH-9 is rarely used and is not 
supported by the developers of the DASH and QuickDASH.205 MacDermid and colleagues 
suggest the QuickDASH adequately covers the range of difficulty of DASH items and therefore 
may be an appropriate “surrogate” for the DASH.224 In 2017, Kennedy and Beaton published the 
69 
 
results of a survey of DASH and QuickDASH users. The purpose of the survey was to: (1) 
determine how the measures are being utilized in clinical and research settings, and (2) to 
understand which items users found most useful and most problematic to better inform further 
iterations or versions of the measure. The authors concluded that the DASH and QuickDASH are 
being utilized as intended: in more than 29 countries; in various practice settings; in patient care 
and research; across all diagnoses affecting the upper extremity; and populations of all ages.247 
The DASH is a 30-item PRO designed to quantify disability related to the entire upper 
extremity.244 It includes five items which address body function and structure, 21 items which 
address activity limitation, and four items which address participation restriction.248 
Franchignoni and colleagues suggest an alternative division of test items (constructs) as follows: 
manual functioning (items 1-5, 7-11, 16-18, 20, 21), disability because of limitation in shoulder 
ROM (items 6, 12-15, 19), and symptoms and effects of the patient’s problem (items 22-30).14 
The DASH also includes two optional 4-item modules for work and sports/performing arts that 
are scored separately.244 The recall period is one week. Each item is scored on a Likert scale of 
1-5. A score of one represents ‘no difficulty’ and ‘not limited at all’ and a score of 5 represents 
responses of ‘unable’ or extreme difficulty. Scoring requires summing the 30-item responses, 
subtracting 30 from the total, and dividing by 1.2. Missing items are replaced by the mean value 
of the other responses before summing. The score cannot be calculated if more than three items 
are missing.228 An alternative, more frequently used scoring system is also available [(raw 
score/number of items measured) – 1] x 25.244 A total test score of 0-100% is possible, where a 
higher score indicates greater dysfunction. The DASH takes 5-7 minutes to complete and three 
minutes to score.149,228  
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Carr and colleagues published a classification system for the DASH in which a score of 
1-33% is characterized as mild disability, a score of 34-67% is characterized as moderate 
disability, and a score of 68-100% is suggestive of severe disability.66 This classification system 
is not widely utilized, nor is it acknowledged on the DASH website.244 Kennedy and colleagues 
published a different set of cut-off scores, in which a score of less than 15 is interpreted as ‘no 
problem,’ a score of 16-40 represents ‘problem, but working,’ and a score of greater than 40 
suggests ‘unable to work.’243 Normative values (population mean ± SD) from a sample of 1706 
individuals in the United States have been reported as 10.1±14.68.249 Aasheim and Finsen 
reported similar findings in Norway with a mean population DASH score of 13. The authors 
found increasing scores with age, and higher scores in women (15±3) than men (11±2). Age and 
gender based normative values are available in the literature.111 Normative values in a population 
of young, active adults with a mean age 28.8 years has, however, been reported to be lower than 
the population mean (1.85±5.99).220 
The original version of the DASH was developed in a population of 420 patients, age 18-
65 years, presenting to 23 outpatient clinics across Canada, Australia and the United States with 
disorders of the upper extremity. Upper extremity diagnoses included Colles’ fracture, carpal 
tunnel syndrome, symptomatic OA, RA, painful arc of the shoulder, lateral elbow pain, and 
nonspecific soft tissue pain.242 The DASH has since been utilized in the literature for numerous 
populations, including: RA,250-252 psoriatic arthritis and inflammatory disease,253 post-operative 
upper extremity surgery,250 intercollegiate athletes,248 non-traumatic neck complaints (new onset 
or recurrence) with upper extremity symptoms,254,255 multiple sclerosis (MS),11 shoulder 
impingement,256 subacromial pain syndrome,257 adhesive capsulitis,258 proximal humeral 
fractures,259 “any upper extremity problem (excluding the shoulder),”16 and stroke.18 The DASH 
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has also been utilized in research related to traumatic brachial plexus nerve injuries,260 and breast 
cancer.261,262 The psychometric properties of the DASH have been found to have excellent 
reproducibility, with internal consistency/cross-sectional reliability ranging from Cronbach’s α = 
0.87-0.9811,18,149,205,249,252,261 and test-retest reliability ranging from ICC = 0.91-0.99.149,205,250-
252,256,257,259,263,264 Responsiveness to change of the DASH has also been reported in various 
populations. In a general musculoskeletal population a SEM = 4.3-7.6 and MDC90% = 10.81-12.8 
have been reported.149,256,257,264 A MDC90% of 10.7 and a MDC95% of 7.9 – 14.8 have also been 
reported.217,256,263,265 An MCID of 10.83 points is reported in a population of patients with upper-
limb musculoskeletal disorders.264 Area under the receiver operating characteristic curve (ROC- 
curve) is reported as 0.67266 and 0.77 (95% CI: 0.63, 0.92).257 ES and SRM are reported in the 
literature for various musculoskeletal diagnoses.205 
Convergent validity of the DASH is supported by multiple comparisons with other 
shoulder-related and generic HRQOL PROs: SPADI (r = 0.55 - 0.93),216,217,258,267,268 pASES (r = 
-0.63 to - 0.79),216,217 CS (r = -0.82),216 VAS (0.31),258 Upper Limb Functional Index (ULFI) 
(0.90),266 QuickDASH (0.94-0.99),224 and SF-36 physical function scale (r = 0.67).216 Beaton and 
colleagues support the discriminative validity of the DASH in a sample of adults with upper 
extremity complaints. Participants who were working with their upper limb condition and were 
able to continue to work had a significantly lower disability than those unable to work (26.8 vs. 
50.7, t=-7.51, p<0.0001). Similarly, the DASH was able to discriminate between those who 
could do everything they wanted to compared to those who were not (23.6 vs. 47.1, t=-5.81, 
p<0.0001).263 Low to no floor or ceiling effects are reported in populations of patients with RA, 
proximal humeral fracture, total shoulder arthroplasty, adults with subacromial pain, and adults 
with musculoskeletal upper extremity complaints,216,252,257,259,263 however, a significant ceiling 
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effect was found in a population of intercollegiate athletes in which 65% scored a zero (‘no 
disability’).248 In a population of individuals with upper extremity impairment (excluding the 
shoulder) a 4% ceiling effect (score of 0) and a 1% (score of 100%) floor effect is reported.16 
Through Rasch analysis, discussed in more depth later, researchers have questioned the construct 
validity of the DASH.11,14,205 
Kennedy and Beaton surveyed 157 DASH and QuickDASH users. Users selected the 
following five items as most informative:  Item 1: open a tight jar; Item 16: use a knife to cut 
food; Item 23: limited work or daily activities due to upper extremity problem; Item 29: difficulty 
sleeping; and Item 6: place and object on a shelf above your head. The following five items were 
selected as most problematic: Item 21: sexual activities (most problematic); Item 18: 
recreational activities with some force; Item 20: manage transportation needs; Item 1: open a 
tight jar; and Item 7: do heavy household chores. Of note, Items 21, 18 and 20 have been flagged 
by the authors as items needing further consideration in future iterations of the DASH.247 Item 
21:  sexual activities on the DASH has previously been reported in the literature as being a 
problematic item.111,205  
MacDermid and colleagues provide QuickDASH and DASH item ranking by difficulty 
for individuals prior to surgery and three and six months following total shoulder arthroplasty or 
rotator cuff repair.  For both surgical procedures Item 19: recreational activities in which you 
move your arm freely and Item 18: recreational activities in which you take some impact are 
deemed the most difficult whereas Items 2: write and Item 3: turn a key are the easiest.224  
The DASH has been used to assess shoulder disability and function in individuals with 
HNC,66,86,192,193,196-198 and has been used in studies to assess shoulder function with other 
diagnoses of cancer affecting the upper extremity,193,261,262,269 including individuals with thyroid 
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cancer following ND surgery.270 It has also been used to study upper extremity disability in 
individuals undergoing radial forearm flap harvest for HNC.271 Reliability and validity of the 
DASH in a population of patients undergoing unilateral neck dissection found a test-retest 
reliability of ICC = 0.91 (95% CI, 0.90-0.98) and convergent validity based on a strong 
relationship with the NDII of -0.86.196 
The DASH was used to quantify shoulder dysfunction in a population of 65 patients 
(mean age 62 years, 77% male) 1.6 years (range, 0.5-4 years) following various SND surgeries. 
The authors provide normative values for the study population of mean DASH score of 21.1 ± 
23.3 (range, 0-97.5). Despite the variability in the sample, the authors suggest that the DASH has 
high sensitivity in this patient population and recommend that the DASH be utilized to establish 
baseline shoulder function for post-operative comparisons and rehabilitation planning. The 
authors however do not provide psychometric data related to reliability, validity or 
responsiveness to change in this study.66 Another study utilized the DASH to quantify shoulder 
dysfunction in a population of individuals with nasopharyngeal cancers after undergoing SND 
procedures, including dissection of level IIB. In this group, individuals scored mean 4.2 (SD, 
1.8) prior to surgery, 44.2 (10.1; range, 28.0-66.5) one year after surgery and 46.4 (12.4; range 
22.3-70.5) two years after surgery. The authors report the most frequently affected movements in 
this population (test items answered as being most difficult) as Item 6: place an object on a shelf 
over the head, Item 13: wash and blow dry your hair, and Item 15: put on a pullover sweater.86  
QuickDASH 
The QuickDASH, developed in 2005, is a modified version of the DASH developed to 
decrease responder and tester burden. The QuickDASH was developed using three modern 
questionnaire development strategies for item reduction: concept-retention, equidiscriminative 
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item-total correlation approach, and Rasch analysis.205,245 The three questionnaire variations 
derived from these strategies were compared and ultimately the concept-retention version was 
maintained as the new QuickDASH. Based on the concept-retention strategy, DASH items were 
ranked according to the importance and difficulty of each item based on field-testing, and the 
item correlation with the overall test score. Domains related to weakness, stiffness, family care, 
sexual activities, and self-image were ellimiated.245 
Like the DASH, the QuickDASH is a region-specific PRO. It consists of 11 items taken 
directly from the DASH (two related to symptoms, eight related to function) and the two optional 
modules also included in the DASH. The recall period is one week. Ten of the 11 items must be 
completed to score. The QuickDASH is scored using the same methodology as the DASH, 
yielding a final score of 0-100% disability related to the upper extremity.244 It has been translated 
into 48 different languages,244 and is gaining popularity in the musculoskeletal patient 
populations.245,246,255,272-283 It also been validated in a population of breast cancer survivors.284 
Population based (Norway) normative data based on age and gender have been published, 
and are similar to the DASH data.111 Psychometric properties of the QuickDASH, including 
reliability and validity, have also been shown to be similar to the DASH.245,285 QuickDASH 
internal consistency ranges from α = 0.91 to 0.95 and test-retest reliability (ICC) ranges from 
0.90 to 0.94.205,264,284,286 Test-retest reliability in the breast cancer population is somewhat lower, 
with a reported ICC of 0.78.284 Convergent validity of the QuickDASH is supported through high 
correlations with other shoulder specific PROs, including the SPADI (0.84),205 DASH (0.93-
0.99),111,224,245,287 ASES (-0.55- -0.85),224 ULFI (0.86),272 VAS for function (0.80), VAS for pain 
(0.64-0.73),286 and global HRQOL measures including the SF-36 physical functioning scale 
(0.68).205 Ability to detect change for the QuickDASH is reported as MDC90% = 11.0-17.2264,286 
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and MDC95% = 12.63-24.7 based on population.276,284,286 The MCID in a population of patients 
with upper-limb musculoskeletal disorders is 15.91 points.264 ES and SRM for musculoskeletal 
populations are reported,205 and indicate that the QuickDASH is sensitive to varying amounts of 
change. However, poor correlations with estimates of change suggest low responsiveness of the 
measure.286 Chester and colleagues suggest that the QuickDASH is able to discriminate between 
physical therapy responders and non-responders in a population of individuals with shoulder 
pain, reporting an area under the curve (AUC, 95% CI) of 0.78 (0.75, 0.81) at 6 weeks following 
initiation of physical therapy and 0.85 (0.81, 0.88) at the six-month time point.288 The sensitivity 
and specificity of the shortened tool have been questioned.205 The QuickDASH may 
underestimate symptoms and overestimate function when compared to the DASH.285 
QuickDASH Item 6: recreational activities in which you take some impact is the most difficult 
item for individuals undergoing total shoulder arthroplasty or rotator cuff repair, and Item 10: 
tingling is the easiest item.224 The QuickDASH has been used in the HNC literature as a measure 
of shoulder function,87 in a study looking at function of the upper extremity in the setting of ulnar 
forearm flap harvest.289  
DASH & QuickDASH: Rasch Analysis 
The DASH and the QuickDASH have been analyzed with Rasch methodology. While the 
majority of the analysis has occurred on the DASH, recent studies have focused on the 
QuickDASH.10,283 Franchignoni and colleagues question the usefulness of the QuickDASH 
based on unresolved weaknesses found in their analysis of the DASH specific to misfit of two 
items, Item 26: tingling and Item 21: sexual activity, one of which, Item 21: tingling, is also used 
in the QuickDASH (Item 1).10,14 Although both tools have demonstrated excellent psychometric 
properties under the CTT model across many populations, Rasch analysis suggests limitations in 
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construct validity related to step calibration and scale structure, scale hierarchy, item misfit, and 
violations of the assumptions of item interdependence and unidimensionality in patients with 
musculoskeletal complaints,10,13-17 stroke,18 and in patients with MS.11 Three of these studies are 
specific to hand-related symptoms and will not be discussed further.13,16,17 Preliminary Rasch 
analysis of the DASH and QuickDASH in 131 subjects undergoing neck dissection for treatment 
of HNC confirms weakness in the construct validity of the measures with similar limitations.19  
The step calibration and scale structure for the DASH are described for a population of 
patients with MS,11 general musculoskeletal complaints,14 and patients with HNC.19 The 
QuickDASH is also analyzed in the HNC population.19 Disordered response option thresholds 
were found for 9-15 items on the DASH and 2-3 items on the QuickDASH, suggesting that the 
scoring system is not working as intended for the scales.11,19,283 While specific information was 
not provided in one study consisting of subjects with upper extremity disorders, the authors 
report limitations for all items in response scale structure, specifically related to threshold 
separation or step calibration.14 Each study reports underutilization of response options, with 
some of the studies attempting to collapse the response options for more accurate person 
discrimination.10,13,14,19,283 The MS study found underutilization of the fourth response option 
(‘severe difficulty’),11 while the HNC study found underutilization of the fourth and fifth 
(‘unable’) response options.19 The stroke study suggests the need to collapse categories but does 
not elaborate.18  
The DASH does offer a good ability to measure test responders with MS across the 
ability continuum, however test items were redundant in the middle ability level and gaps were 
present at the lower ability levels.11 Similar findings were identified in the HNC analysis, which 
demonstrated a good ability of both the DASH and QuickDASH to measure ability level at the 
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moderate to high disability levels and an inability to measure ability at the low end of the scale. 
The DASH was found to have nine areas of item redundancy, and two areas on the 
QuickDASH.19 Ceiling effects are also reported for both scales.19 In a population of 1030 
individuals with shoulder pain, Rasch analysis of the QuickDASH shows good targeting of 
ability levels with some skew toward higher ability and gaps in the scale structure for the more 
able persons (easier items).283 
Item misfit was found across patient populations. The greatest number of misfitting 
DASH items was found in the MS patient population, in which seven items demonstrated 
significant item misfit: Item 7: heavy chores, Item 11: carry heavy objects, Item 5: open door, 
Item 18: recreational activities requiring force or impact, Item 28: stiffness, Item 30: feel less 
capable, and Item 26: tingling.11 In the HNC study, Item 26: tingling, Item 21: sexual activities, 
and Item 30: feel less capable misfit the model for the DASH.19 Of these items, the only retained 
item in the QuickDASH, Item 10: tingling, consistently misfits the model.10,19,283 Item 26: 
tingling and Item 21: sexual activities also misfit the model for the DASH in upper extremity 
musculoskeletal populations.14 Lehman and colleagues note that Item 21: sexual activities and 
Item 20: manage transportation fail to load during exploratory factor analysis, and report item 
misfit for Item 29: sleeping, Item 26: tingling and Item 21: sexual activities in a similar 
population.15 Dalton and colleagues found misfit with Item 21: sexual activities and Item 27: 
weakness in arm, shoulder or hand in a population of individuals with stroke, however 
eliminated the misfit issue with separate calibrations for purposed subscales of pain and impact 
scales.18 QuickDASH Items 5: use a knife to cut food and 11: sleeping misfit the model in the 
large sample of individuals with shoulder pain. The authors suggest that when cutting food, the 
arm is usually held by the side and does not impact the shoulder. They question the sleeping item 
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as misfit because sleep impairment is a common complaint amongst individuals with shoulder 
impairment.283 
The assumptions for IRT and Rasch analysis are unidimensionality and item 
interdependence. The unidimensionality of the DASH has been disputed. Factor analysis 
suggests multiple dimensions, however, analysis by the developing authors found sufficient 
evidence to support a single dimension and therefore inclusion of all 30 items within the 
composite score.242 Lehman and colleagues performed exploratory and confirmatory factor 
analysis of the DASH and found three conceptually distinct groups– gross motor activities 
requiring whole-body movements, fine motor items, and symptom items. The authors were able 
to provide evidence to support the DASH as both a unidimensional tool and a multidimensional 
tool, however ultimately recommended utilizing the three-factor scale to assist with scale 
interpretation.15 Dalton and colleagues also found three subscales: pain, impact, and function; 
however found that the pain and impact items can be combined appropriately, leaving a bi-
dimensional scale.18 The authors of the HNC study report a unidimensional scale with 2 distinct 
subdomains of symptoms and activities which require greater functional demand of the upper 
extremity.19 On the other hand, other authors report evidence to support a multidimensional scale 
structure.11,14 An analysis of the QuickDASH using parallel analysis and exploratory factor 
analysis supported a unidimensional scale with one misfitting item (Item 10: tingling) failing to 
load meaningfully.10 However, Jerosch-Herold and colleagues did not find unidimensionality.283 
Rasch analysis also uncovers potential violation to the assumption of item interdependence. In 
the MS study, six item pairs were found to be highly correlated suggesting item dependency and 
ordering effect,11 and 10 item pairs were found in the study assessing the DASH in general upper 
extremity diagnoses.14 In the QuickDASH, two testlets have been recommended due to item 
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interdependence – ‘household activities’ (items 1, 2 and 3) and ‘participation’ (items 7 and 8). 
DIF is also reported based on age and sex.283 
Because the DASH and QuickDASH are region-specific, rather than joint-specific, their 
specificity and responsiveness may be lower than other instruments that measure the shoulder 
joint only.217,258 Medical management of HNC rarely affects function at the elbow, wrist and 
hand; therefore, the DASH and QuickDASH may not be specific enough to the limitations of 
activity and participation specific to this unique population. A potential strength of the measures 
is seen in recent research suggesting the DASH and QuickDASH may be appropriate for 
quantifying disability in patients with symptoms in the neck and upper extremity.247,254,255 These 
studies may prove relevant to the management of HNC with neck dissection procedures and 
resulting upper extremity dysfunction.  
Neck Dissection Impairment Index 
 
The NDII, first published in 2002, is a 10-item PRO designed to quantify HRQOL 
secondary to shoulder impairment. Test items are scored on a 5-point Likert scale, with response 
options including ‘not at all,’ ‘a little bit,’ ‘a moderate amount,’ ‘quite a bit,’ and ‘a lot.’ A 
response of ‘not at all’ is given an item score of five points. The raw NDII score is scaled to a 
cumulative score of 100 using the equation: [(raw score – 10)/40] x 100. A higher score suggests 
higher QOL, and therefore less neck and shoulder impairment. Test item recall is four weeks.4 
Factors that contribute most to the total NDII test score include age, weight, type of neck 
dissection performed, and treatment with radiotherapy.4 Techniques to manage missing data are 
not reported. The NDII has low responder burden, and takes only five minutes to complete.3  
The measure was developed in a sample of 54 patients (64 neck dissections) - 32 of 
which were SAN-sparing MRND and 32 of which were SND procedures - who were an average 
80 
 
of 33.7 months (range, 11-120 months) from surgery. The sample is representative of the typical 
HNC patient, however patients who have had surgery for HNC within the past 11 months, have a 
known recurrent cancer at the time of the study, or an unrelated neck or shoulder condition were 
excluded. Most of the patients had previously undergone radiation therapy. Test items were 
derived from a review of the literature, patient interviews, expert opinion of otolaryngologists, 
physical therapists, and survey specialists, and pilot testing in a group of 25 patients undergoing 
neck dissection surgery. Item reduction eliminated five test items based on poor test-retest 
reliability, leaving 10 items addressing one domain related to physical abilities and activities.4  
The population mean for all patients in the validation study is 67.8±17.4 (range, 7.5-
100.0).4 This is similar to the population mean found in Goldstein’s study of 96 subjects aged 
62.7 (range not provided) who underwent RND, SAN-sparing MRND, or SND greater than 11 
months prior to enrollment who scored on average 74.3±25.79 (range, 2.5-100);196 and 
significantly lower than the NDII score for subjects aged 57.28 (range, 46-70) years who are 18 
months following bilateral neck dissection and total or partial laryngectomy or hemiglossectomy 
who scored a mean ± SD of 98.2 ± 1.98 (range, 95 – 100).38 Wang and colleagues utilized the 
NDII to assess shoulder-related QOL in a cohort of individuals undergoing super-selective or 
SND for HNC after receiving chemoradiotherapy. In this population, subjects scored a mean 
87.4 (SD, 12.3) prior to surgery, 80.2 (20.5) approximately 1.4 (range, 1-3.5) months after 
surgery, and 88.0 (13.8) 18 months (range, 10-37) months after surgery.95 Gallagher and 
colleagues report a median (range) NDII score of 85 (30-100) following MRND (with dissection 
of level V) and 92 (10-100) following SND in a population of patients at least 12 month 
following neck dissection and completion of adjuvant treatments.129 
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Concurrent validity of the NDII was established with the SF-36 and criterion validity was 
supported through the establishment of convergent validity with the CS. The correlation between 
the NDII and the CS is 0.854 and 0.64.129 The NDII demonstrates statistically significant 
correlation with the following SF-36 domains: physical functioning (0.50), role-physical 
functioning (0.60), role-emotional (0.59), social functioning (0.62), mental health (0.56), vitality 
(0.44), and general health perceptions (0.55).  Bodily pain was not significantly correlated (0.32, 
p = 0.005).4 Subsequent research has further established the convergent validity of the NDII 
through correlation with other shoulder-related measures, including the SDQ (r = -0.77),290 
shoulder subscale of the UW-QoL (r = 0.75),290 and the DASH (r = -0.86).196 Discriminative 
(clinical) validity of the NDII has been calculated using AUC of the ROC-curve with patient-
reported need for physical therapy as the criterion. It was assumed that discriminative validity 
was confirmed if the questionnaire correctly classified patients with a self-reported need for 
shoulder therapy. At 1-3 months from surgery the AUC for the NDII was 0.85 (95% confidence 
interval, CI, 0.77-0.94). Six months later, the discriminative ability of the NDII is less, 0.74 
(95% CI 0.58 – 0.90).21 Rasch analysis of the NDII suggests limitations in the construct validity 
of the NDII secondary to disordered response option step categories, gaps in item difficulty, and 
item redundancy.21 No ceiling effect, defined in the NDII as having the worst possible 
impairment of zero, has been reported. However, 5% of the sample scored the best possible 
score, a floor effect, of 100 at 1-3 months and 20% at 8 months following surgery.21 
Reliability of the NDII has been established through test-retest reliability and internal 
consistency. Single-item (r = 0.41-1.00) and total score test-retest reliability (r = 0.91) and 
internal consistency (α = 0.95) have been reported in the original validation study.4 Stuiver and 
colleagues report similar reliability for a sample of patients 1-3 months from neck dissection 
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surgery with a test-retest reliability of ICC(2,1) = 0.93 (95% CI, 0.87-0.96) and internal 
consistency of α = 0.94.21 Stuvier and colleagues suggest responsiveness to change based on a 
“visual assessment of change in mean scores” and “a strong association over time with a change 
of shoulder active ROM for abduction.” Although not reported, the SEM and MDC can be 
calculated from the Stuvier paper (SEM = 5.56, MDC95% = 4.67).21 
A limitation of the NDII is that it does not differentiate between neck and shoulder 
symptoms,3,115 resulting in a risk of error in score interpretation. In addition, the sample utilized 
to establish reliability and validity only included those who had received a nerve-sparing 
procedure and therefore may not accurately reflect all individuals in the HNC population for 
whom the NDII will be provided.3 The Stuiver study suggests limitations in the NDII’s ability to 
accurately quantify subject ability level along the continuum of item difficulty levels, a limitation 
in the measure’s construct validity.21 The NDII has been used in HNC-related 
research,4,21,38,71,115,128-130,195,196,239,290-292 however requires additional research to establish more 
robust psychometric properties including ICC for reliability, cross-cultural evaluation, 
responsiveness to change, normative values, and cut off scores to assist in interpretation of 
shoulder impairment in the HNC population.3  
Shoulder Disability Questionnaire 
 
The original version of the SDQ was developed in the United Kingdom (SDQ-UK) in 
1994 as an “assessment of restriction in everyday activities resulting from shoulder 
symptoms.”293(p 525) The 22-test items in the SDQ-UK were generated through the expert opinion 
of physical and occupational therapist, patient interviews, and item selection from a database of 
shoulder-related interview-based questions validated for use in the general population.293 The 
SDQ-UK was rarely used,205 and in 1998 was modified into the 16-item SDQ-Netherlands 
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(SDQ-NL).294 The rationale for the modification and reduction of test items is not described, 
however. The SDQ-NL was developed in a cohort of patients with shoulder disorders in general 
practice with a minimum age of 18 years (mean 49.6, SD 14.4). Patients could not have 
neurological or vascular disorders, neoplasms, and referred pain from internal organs or systemic 
rheumatic conditions, fractures, or subluxations.294 The 16 items in the SDQ-NL are right or left-
shoulder specific and refer to the functional tasks performed in the preceding 24 hours.294 
Thirteen of the items relate to pain with activities and three items consider difficulty sleeping, the 
need to rub the shoulder, and irritability due to shoulder pain. The SDQ-NL was further modified 
in 2000. This version retained the same 16 items and scoring methodology and made only minor 
changes in wording based on expert opinion and patient interviews.295  
When answering the questionnaire, the responder is required to answer ‘yes,’ ‘no,’ or ‘not 
applicable’ based upon if the situation has not occurred within the past 24 hours. ‘Not applicable’ 
test items, items that have not occurred, are excluded from scoring. To obtain a test score, the 
total number of ‘yes’ responses is divided by the number of applicable items, and then multiplied 
by 100 to provide a score on a scale of 0-100.294 A score of zero is interpreted as no disability 
and a score of 100 is interpreted as maximum disability.205 In the SDQ-NL, Items 7: write or 
type, 8: hold steering wheel or bike handle bars, 11: open or close door and 16: irritability are 
most often scored as ‘not applicable,’ meaning that the responder had not performed or 
experienced that activity within the past 24 hours.295 The SDQ has minimal responder and tester 
burden, taking only three minutes to complete and one minute to score.149,205 van der Heijden, 
however, reports a longer time (5-10 minutes) to complete the SDQ.295 The SDQ is available in 
several languages, including English, Spanish, Korean and Turkish.205,296-298 
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Schmidt and colleagues suggest that the main limitation of the SDQ is the limited 
evidence to support the measure’s reliability.229 Reliability has been reported in populations of 
patients with shoulder pain, with internal consistency ranges from α = 0.76 to 0.82,297-299 and 
test-retest reliability has been reported as r = 0.88297 and ICC (95% CI) of 0.79 (0.53-0.91).298 
The validity of the SDQ has been questioned when compared with other shoulder-related 
outcome measures.204 The SDQ has been reported as having a significant ceiling effect in 
subjects with soft tissue shoulder disorders, with an inability of the SDQ to distinguish between 
deteriorated and non-deteriorated subjects when test scores are relatively high at baseline.204,295 
In addition, low correlation coefficients comparing the SDQ to other instruments suggest limited 
convergent validity. Correlation coefficients have been reported as follows: VAS for function 
(0.58), VAS for pain (0.41), SPADI (0.33),300 Korean SPADI (0.71-0.72) and Numeric Rating 
Scale (0.65-0.71),298 and ROM (0.27-0.41).205 In a population of patients presenting to primary 
and secondary care for shoulder pain, de Winter and colleagues propose content validity based 
on acceptable correlations with assessments of pain, ROM, strength, performance of ADLs, and 
disability quantified with a VAS. They also established content validity by comparing patient 
complaints with the items of the SDQ, and demonstrated the discriminative validity of the SDQ 
in the primary care setting, but not in the secondary care setting.299 Of interest, in a comparison 
of the SDQ-NL, SDQ-UK, SPADI, and the Shoulder Rating Questionnaire in a population of 
patients presenting with shoulder pain in a primary care setting, subjects ranked the SDQ-NL as 
the most relevant of the four measures to their shoulder symptoms.300  
Responsiveness to change for the SDQ has not been established. MDC, SEM, and MCID 
values are not reported,3,205 however, ES and SRM for various orthopedic shoulder complaints 
are published in the literature.205 In the primary care setting, an ES of 1.56 and a SRM of 0.95 
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are reported.300 In a population of Korean patients with shoulder impairment an ES of 1.55 and 
SRM of 1.30 is reported.298 Mean change scores for subjects who had improved are 29.2 points 
and 2.8 for those who remained stable.300 A cut-off score of 18.75 balances sensitivity (74%) and 
specificity (66%).301 The limited response options may limit the sensitivity of the measure in 
detecting change over time, or differences between groups, therefore limiting applicability in 
both clinical and research settings.3  
The SDQ has been used in research related to SAN-injury236 and HNC,21,82,290,302,303 and 
relevant psychometric properties have been reported. In 2015, Cho and colleagues published a 
manuscript detailing the difference in trapezius muscle volume following neck dissection for 
HNC. The authors utilized a computed tomography (CT) scan and the original version of the 
SDQ, SDQ-UK, in their study. Because this review focuses on the revised SDQ-NL, additional 
details will not be provided.304 Mean (SD) scores of the SDQ for neck dissection procedures 
have been reported as follows: posterolateral neck dissection (dissection of levels II-V) 48.6 
points (35.1), MRND 22.2 (28.6), and SND 11.6 (26.1).303 Normative values in another sample 
of patients with HNC reports a mean (SD) score of 33 (29) for those receiving neck dissection 
and 13 (27) for those who received non-surgical management via chemoradiation.82 Subjects 
were most likely to endorse Item 10: reach above shoulder level (38%), Item 15: rub the 
shoulder more than once per day (34%), Item 4: daily activities (31%), Item 9: lift or carry an 
object (31%), Item 14: reach the back of the neck (29%), and Item 2: lying on the affected 
shoulder (29%).303 VAS pain score, shoulder stiffness, ROM (abduction, flexion), receiving 
physical therapy, shoulder drooping, and surgical treatment of the neck were predictive of 
shoulder dysfunction (SDQ score > 0) as measured by the SDQ.82  
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Test-retest reliability is reported as ICC(2,1) = 0.84 (95% CI, 0.74-0.90), and internal 
consistency as α = 0.91.21 Stuiver and colleagues found a significant floor effect in their sample 
of patients who had undergoing neck dissection procedure, with 18% scoring the best score (no 
limitation) at one to three months following surgery and 52% of the sample reporting no 
limitation six months later.21 
Convergent validity of the SDQ has been demonstrated with correlation between the 
SDQ and the NDII (-0.77),290 shoulder subscale of the UW-QoL (-0.75),290 and the VAS for pain 
(0.631).82 Discriminative validity of the SDQ has been supported using AUC of the ROC-curve 
with patient-reported need for physical therapy as the criterion. At 1-3 months from surgery the 
AUC for the SDQ was 0.85 (95% confidence interval, CI, 0.78-0.94) and 6 months later 0.77 
(95% CI 0.63 – 0.91).21 In other words, at 1-3 months from surgery the SDQ is able to accurately 
discriminate between those who believe they need physical therapy and those who do not 85% of 
the time. The discriminative validity decreases to 77% six months later.178 There is evidence to 
support that the SDQ is unable to discriminate between neck dissection types, between subjects 
receiving adjuvant radiotherapy and those who are not, and those receiving primary radiation and 
those receiving chemoradiation.82 Stuvier and colleagues suggest responsiveness to change based 
on a “visual assessment of change in mean scores” and “a strong association over time with a 
change of shoulder active ROM for abduction.” Although not reported, the SEM and MDC for 
the SDQ can be calculated from the Stuvier paper (SEM = 11.36, MDC95% = 31.49).21  
Shoulder Pain and Disability Index 
 
The SPADI was first published in 1991 by Roach and colleagues as a patient-reported 
measure of shoulder pain and disability. The SPADI was developed through the generation of 20 
items based on the expertise of rheumatologists and physical therapists. Seven test items were 
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then eliminated based on low test-retest reliability and correlation with active shoulder ROM 
measurements in a sample of 23 male patients with shoulder pain of musculoskeletal, neurogenic 
or undetermined origin that were on average 58 years old (range 23-76).305 The measure 
therefore consists of 13 items that assess the two dimensions (subscales) of pain (five items) and 
functional activities that require the use of the upper extremity (eight items).305  
There are two versions of the SPADI, which can be used interchangeably.306 The original 
version utilizes a VAS with anchors of ‘no pain’ or ‘no difficulty,’ and ‘worst pain imaginable’ 
or ‘so difficult required help.’ Test items are scored by “arbitrarily dividing the horizontal line 
into 12 segments of equal length,” each representing a score of 0-11.305 On the second version 
the responder answers using an 11-point Likert scale in which a score of zero indicates ‘no pain’ 
or ‘no difficulty’ and a score of 10 indicates ‘the worst pain imaginable’ or ‘so difficult it 
requires help.’307 The recall period is one week. Scoring provides a total pain score, a total 
disability score, and a total SPADI score, which are each expressed as a percentage of 0-100%. 
The total SPADI score is the mean of the pain and disability scores. Responders can mark one 
item in each subscale as not applicable and that item is subsequently removed from scoring. No 
score can be calculated if more than two items are missing or marked as not applicable. A score 
of 100% indicates the highest level of impairment or disability.305 Cut off points to reflect 
severity of disability are not reported.205 The SPADI takes 5-10 minutes to complete, and is 
scored in 1-8 minutes (based on which version of the scale is used).149,305,306,308 The SPADI is 
widely used across multiple patient populations, including general upper extremity diagnoses, 
general shoulder diagnoses, adhesive capsulitis, rotator cuff disorder, and shoulder surgery.205 It 
has also been utilized in a cross-cultural validation study using a population of women within six 
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months of breast cancer treatment.309 In addition, it has been translated and validated in several 
languages.194,202,205,216,234,268,298,309-313  
The SPADI has been shown to have good reproducibility. Test-retest reliability (ICC) 
ranges from 0.66 to 0.953,149,234,256,265,305,306 and internal consistency (α) ranges between 0.86 and 
0.98.3,149,265,305,306,309,314 Internal consistency (α) for the pain subscale is reported as 0.85 and the 
disability pain scale is 0.90.315 On the Chinese version, the ICC is 0.836 for both scales.234 The 
original study reported a test-retest reliability of ICC = 0.66. In this study, test-retest reliability 
was assessed based upon responses obtained within a 48-hour period, during which 91% of the 
subjects began interventions such as corticosteroid injections and pain medications. The accuracy 
of the test-retest reliability statistic should be questioned because the researchers did not provide 
evidence to suggest elimination of subjects based on reported change in symptoms during that 
timeframe.305 Membrilla-Mesa and colleagues report a test-retest reliability statistic of the 
Spanish version of the SPADI as r = 0.89-0.93,268 and the Chinese version is reported as ICC 
0.85-0.90.234 SEM (95% CI) for the SPADI pain subscale is reported as 7.82 ± 15.3, disability 
subscale 5.78 ±11.3 and for the total score 23.8 ± 9.3. The high SEM and confidence intervals 
suggest that the SPADI, while appropriate for group level research, may not be precise enough 
on an individual level.314 Roy and colleagues performed a review of shoulder-related 
questionnaires, and report a SEM of 6.2 to 7.8 (mean 6.8 points).256,265 In a population of women 
undergoing breast cancer treatment, an ES of 0.59 and SRM of 0.78 on the disability scale and an 
ES of 0.82 and SRM of 1.13 on the pain subscale.309  
The convergent validity of the SPADI has been well established through assessment of 
the scale’s correlation with other measures of shoulder function, with correlation coefficients as 
follows: pASES (0.81-0.92)3,202,205,216; CS (0.69 and 0.82)216,234; DASH (0.55-0.93)90,205,216,268; 
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SST (-0.71-0.80)205,268; SDQ-K (Korean version, 0.71-0.72)298; Oxford Shoulder Scale 
(0.674)309; and VAS (0.40 – 0.67).234,258,268 The SDQ-NL has a fair correlation with the SPADI, 
whereas the SDQ-UK is moderately correlated (0.573).300 Correlation with active shoulder ROM 
measurements for the SPADI have been reported in two studies, with correlations for various 
shoulder movements ranging from -0.55 to -0.80,305 and -0.090 to -0.251.300 The tendency 
toward low correlations with active ROM has led to some discussion regarding the development 
and item reduction of the SPADI based on low correlations with active ROM measurements.204 
The SPADI has also demonstrated discriminant validity.3 Williams and colleagues report a AUC 
of 0.91, where a AUC of 1.0 indicates 100% accuracy in ability to discriminate between health 
states.307 Thoomes-de Graaf report and AUC of 0.81 (95% CI, 0.75-0.87).316 Similar findings are 
reported in a sample of individuals undergoing physical therapy for shoulder pain. At the 6-week 
follow-up the AUC is reported as 0.81 (0.78, 0.84) and at the 6-month follow-up 0.85 (0.82, 
0.88).288 The SPADI has been found to have no to low floor or ceiling effects for the total 
score,204,205,234,265,306,309,312,313 however, the pain subscale did demonstrate ceiling effect in 
patients receiving total shoulder arthroplasty,216 and several items on the pain and disability 
subscales were reported to have relatively high ceiling effects in a Chinese population of patients 
with chronic shoulder pain.234 
Scale developers intended to develop a 2-dimensional scale, which was subsequently 
supported in other studies234,268; however factor analysis and other psychometric studies have 
provided evidence to suggest that the pain and function subscales of the SPADI represent only 
one dimension.305,314 It can be suggested that the construct of pain is impacting how responders 
are answering these function-based test items. Roddey and colleagues postulate that responders 
do not differentiate between pain and disability when responding to test items, citing the 
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following findings: (1) a high internal consistency (α = 0.96); (2) principal-component factor 
analysis resulted in a one-factor solution; and (3) the subscales of the SPADI (pain and function) 
are highly correlated (r = 0.77).314 The necessity of having two subscales within the SPADI has 
therefore been questioned.314  
Rasch analysis of the SPADI has uncovered unequal interval measures, and poor 
precision measuring shoulder dysfunction at the low and high ends of the scale. In fact, the 
SPADI performed worse than the ASES and the Penn Shoulder Scale (function subscale) for 
capturing subjects with low and high levels of disability. The SPADI did however perform better 
than the ASES, the Penn Shoulder Scale, and the SST, in measuring middle range scores. This 
imprecision at the high and low ends of the scale negatively impacts the ability of the scale to 
measure the construct of shoulder dysfunction at low and high ability levels, therefore decreasing 
the construct validity of the measure.20 Thoomes-de Graaf supports this finding of poor precision 
at the high and low ends of ability, where only 2.2% of the sample scored in the upper range (85-
100%) and 8.1% scored in the low range 0-15%).312 Rasch analysis has also uncovered some 
concerns with item misfit for Item 13: removing something from back pocket, Item 12: carrying 
a heavy object of 10 pounds or more, and Item 9: putting on a shirt that buttons down the front in 
a population of individuals with shoulder impairment.20 
The SPADI’s responsiveness to change in the general musculoskeletal populations has 
also been established. MDC90% is reported as 13-18 points,256,305 and an MDC95% ranges from 
13.2 to 21.5 points.205 MCID scores range from 8 to 23.1 points based on the sample.205,300 
Thoomes-de Graaf and colleagues report a limitation in interpretability of the SPADI in a 
population of patients with should complaints presenting to a primary care physical therapy 
setting. Although a minimal important change, the smallest change that patients perceive as 
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important, is reported as 16 points, the authors suggest that a change score of less than 20 points 
could be due to measurement error. According to the authors, a change score of 43% in 
individuals is clinically relevant.312 Whereas, other studies indicate an improvement of 10 points 
on the SPADI is indicative of a 12% improvement in shoulder function (likelihood ratio = 34), 
and a worsening of 10 points on the SPADI is indicative of a 31% decline in function (likelihood 
ratio = 12.9).307 ES and SRM for various orthopedic patient populations have been 
reported.205,258,265 Of these, the most relevant to the HNC population include: patients referred to 
outpatient physical therapy clinics for a wide variety of shoulder impairments (ES 1.26, SRM 
1.38)308; patients attending a walk-in clinic at two large medical centers with complaints of 
shoulder discomfort (ES 0.34)307; and a population of patients presenting to a primary care 
setting with shoulder complaints (ES of 1.52, SRM of 1.17).300  
The SPADI has been used in HNC-related research21,79,109,114,115,128,194,195,199 and has been 
translated into an Italian version and specifically validated in a population of patients with 
HNC.194 Swisher utilized the SPADI to study QOL and shoulder impairment in a sample of 37 
subjects [84% male, 63.7 (SD, 11.4; range, 30-82) years old] following surgery, radiation, and/or 
chemotherapy for HNC. Normative values were established with a mean (SD) total, pain, and 
disability scores for the SPADI reported as 19.71% (23.70%), 23.89% (27.72%), and 18.59% 
(23.10%), respectively. According to the authors, the subjects had the greatest difficulty with the 
following items: Item 7: washing the back, Item 11: placing an object on a high shelf, and Item 
12: carrying a heavy object.109 A significant floor effect has been found in a population of 
patients with HNC who are 1-3 months following surgery with 17% of subjects reporting no 
disability. A larger floor effect of 43% was found 6-8 months following surgery.302 Ghiam and 
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colleagues utilized a cut off score of greater than 30 on the SPADI subscales to define high 
levels of shoulder pain and disability.199 
The SPADI has been found to be reliable and valid in the HNC population. Test-retest 
reliability is reported as ICC(2,1) = 0.91 (95% CI, 0.85-0.95), and internal consistency of α = 
0.96.21 Convergent validity was established with the SPADI and the Neck Disability Index (r = 
0.86) and the composite score of the UW-QoL (r = -0.73).109 The SPADI also has good 
convergent validity with other measures of shoulder function in the HNC population, including 
the NDII (r = -0.75) and the SDQ (r= 0.78), and the Rand-36 (SF-36) in which correlations 
ranged from -0.19 to -0.55.21 Discriminative validity of the SPADI has been supported using 
AUC of the ROC-curve with patient-reported need for physical therapy as the criterion. At 1-3 
months from surgery the AUC for the SPADI was 0.85 (95% confidence interval, CI, 0.77-0.94) 
and six months later 0.74 (95% CI 0.58 – 0.90).21 Rasch analysis of the SPADI in a population of 
patients with HNC, however, suggests limitations in the construct validity of the scale secondary 
to disordered response option step categories, gaps in item difficulty, and item redundancy.21 
Stuvier and colleagues suggest responsiveness to change based on a “visual assessment of 
change in mean scores” and “a strong association over time with a change of shoulder active 
ROM for abduction.” Although not reported, the SEM and MDC for the SPADI can be 
calculated from the Stuvier paper (SEM = 6.54, MDC95% = 18.13).21 
Simple Shoulder Test 
 
The SST was developed by the Shoulder Service at the University of Washington with 
questions obtained from Neer’s evaluation, the ASES evaluation, and observations of patient 
complaints by the test developers.200,205,317 It includes 12 dichotomous ‘yes’ or ‘no’ items which 
address the domain of function.149 Two items are related to pain, seven are related to function 
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and strength, and three items are related to ROM.318 The recall period is at the moment of 
assessment. The test items are scored one point for an answer of ‘yes’ and zero points for an 
answer of ‘no.’ The test score is based on a 0-12 point range, which is then converted to a 
percentage. A 100% indicates no shoulder limitation. The SST takes three minutes to complete 
and one minute to score.149 The SST has been translated into an Italian version and specifically 
validated in a population of patients with HNC.194 It is also available in Dutch,319 Brazilian 
Portuguese,320 Persian,321,322 and Spanish.323 A study of young, active adults, mean age 28.8 
(range 17-50 years), scored an average score of 11.79 points (SD, 0.60) on the SST.220 Pre-
operatively for reverse total shoulder arthroplasty or rotator cuff repair, individuals aged 25-89 
years scored 2.30 (SD, 2.31; range, 0-11); and post-operatively, individuals aged 37-88 scored 
6.10 (SD, 3.15; range, 0-12).324 
The SST has been utilized in populations with various shoulder conditions including 
impingement,318 OA,318,320 and instability,318,325 rotator cuff injuries,225,320,325 rotator cuff surgery, 
and total shoulder arthroplasty.221,324,326 It has also been utilized in general orthopedic practice.314 
The SST has not been used in interventional studies related to HNC with the exception of the 
cross-cultural adaptation and validation of the Italian version of the scale.194 Test-retest 
reliability has been reported as ICC = 0.61-0.99149,221,320-323,325 and internal consistency has been 
reported as (α) 0.73 - 0.85314,320,322 Person reliability, consistent with Cronbach’s α, is reported 
in a study that used partial credit Rasch analysis as 0.6620 and 0.71.225 An SEM of 11.65 and an 
MDC95% of 32.3 points have been reported.314 A systematic review of PROs for individuals 
presenting with rotator cuff disorder reports an MDC of 3.27 and a minimal important difference 
(MID) of 2.05.315 
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Convergent validity of the SST has been supported through established relationships with 
other shoulder-related PROs as follows: DASH (- 0.596 to -0.73),322,323,327 SPADI (- 0.71 to -
0.80),268,314,318 ASES (0.54-0.81),209,225,318,325 CS (0.49 – 0.70),226,327 Patient Reported Outcomes 
Measurement Information System (PROMIS) Physical Function Computerized Adaptive Test 
(0.64),225 and the SF-36 physical functioning scale (r = 0.47 - 0.58), physical component score (r 
= 0.54) and bodily pain scale (r = 0.57 - 0.62).318,326 ES and SRM for several orthopedic 
populations are also reported in the literature.205,326 Low to no floor and ceiling effects have been 
reported,205,321 however Hsu and colleagues report a floor effect in 9% of their sample 
(individuals receiving total shoulder arthroplasty) and a ceiling effect for 15.3%.326 A floor effect 
of 21% and ceiling effect of 6.1% is reported in a sample of 187 individuals with rotator cuff 
pathology.225 
There is discrepancy in the literature related to dimensionality of the SST. Beckmann 
reports that the SST is “largely unidimensional,” where 8.4% unexplained variance remains after 
the first dimension is accounted for.225 Roddey and colleagues found a 2-factor solution when 
performing principal-components factor analysis on the SST, suggesting domains related to 
‘what a person can do with his or her shoulder’ and ‘a person’s comfort with the shoulder at 
rest.’314(p 766) Neto and colleagues found three well-defined factors through factor analysis: ‘arm 
elevation,’ ‘shoulder movement,’ and ‘comfort with the shoulder in rest position.’320 Several 
other studies have confirmed a three-factor solution for the SST.321,323  
The SST has been tested using Rasch analysis.20,225,324 In a sample of 187 individuals 
with rotator cuff pathology, item reliability is reported as 0.97 and person reliability as 0.71.225 
Rasch analysis has suggested problems in item misfit. In 2017, Raman and colleagues published 
a study of a population of individuals prior to reverse total shoulder arthroplasty or rotator cuff 
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repair and another group of individuals 6-12 months following surgery using Rasch analysis. 
Analysis showed misfit of three items: Item 4: Can you place your hand behind your head with 
the elbow straight out to the side?, Item 5: Can you place a coin on a shelf at the level of your 
shoulder without bending your elbow?, and Item 8: Can you carry 20 pounds at your side with 
the affected extremity?. Item 8 was found to have DIF based upon gender. In addition, local 
dependency was found for Items 4 and 5 and 5 and 6: Can you lift on pound (full pint container) 
to the level of your shoulder without bending your elbow?. The authors suggest combining items 
5 and 6 to create a super item that addresses lifting an unspecified weight to shoulder level, and 
splitting Item 8 to a female and male item to address these limitations. With these modifications, 
the authors claim that misfit is negated.324 Another study using Rasch analysis found the SST to 
have two different items that misfit the model with high infit statistics - Item 2: Does your 
shoulder allow you to sleep comfortably? and Item 1: Is your shoulder comfortable with your 
arm at rest by your side?. Rasch analysis found a failure of the SST to adequately separate 
subjects at the high and low end of the scale. The analysis suggests that the SST does not have 
equal interval measures, suggesting a limitation in responsiveness to change over time.20 
Limitations of the SST include limited responsiveness to change and discriminative 
validity due to the dichotomous response options, lack of normative data, large floor effect, and 
moderate person reliability. Another limitation is the inclusion of test items to require the 
responder to speculate on their ability to perform a task.3,205,225 For example, item 9 asks “Do you 
think you can toss a softball under-hand twenty yards with the affected extremity?”  
University of Washington Quality of Life Questionnaire 
 The UW-QoL was first published in 1993 as a QOL instrument applicable to “the broad 
group of head and neck cancer patients encountered at any institution or in multi-institutional 
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trials.”328(p 487) The PRO has since become one of the most commonly used QOL scales in HNC 
research and is often selected to establish convergent validity with other measures of 
QOL.5,301,329,330 The original version consists of nine categories (pain, disfigurement, activity, 
recreation/entertainment, employment, eating-chewing, eating-swallowing, speech, and shoulder 
disability), each of which has 4-5 response options. Each category has a total possible point 
value of 100, and therefore a total summary score of 0-900 points. A higher score indicates 
“normal function” and higher QOL.328 Information regarding test development has not been 
published.5,331 According to Pusic and colleagues, personal communication with the developers 
of the UW-QoL reveals that scale development was based upon expert opinion and did not 
include patient interviews.5  
 The UW-QoL has subsequently undergone several major revisions based on shortcomings 
observed in the scale. Published in 1997, Version 2 added an importance rating scale, which 
requires the responder to rank the importance of each domain (‘not important’, ‘a little bit 
important’, ‘somewhat important’, ‘quite important’, or ‘extremely important’), three single-item 
QOL scales, and a free-text opportunity in which the responder can elaborate on any medical or 
non-medical condition impacting perceived QOL.332 Weymuller and colleagues describe a 
limitation in the concurrent validity of the UW-QoL composite score – the sum of each of the 
domains weighted for level of importance placed by the responder - with the addition of the 
importance rating scale in 1995. The authors also suggest a limitation in the sensitivity of the 
composite score based on the tendency of specific domains within the composite score to 
improve while others worsen during treatment and as a result of variations in treatment. The 
summary score may therefore not provide an accurate interpretation of QOL and responsiveness 
to change.333 Version 3, also known as the UW-QOL-R, was published in 2001. Upon 
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consideration of internal consistency across domains, the authors of the scale removed the 
employment domain, and added the taste and saliva domains. Internal consistency for Version 3 
ranges from α = 0.74-0.84. Version 3 also includes a modification of the importance rating from 
ranking each of the domains to selecting the three most important domains in the past seven 
days.334 The most current version of the UW-QoL, version 4 (UW-QoLv4), was published in 
2002 with the addition of domains for mood and anxiety.335 A 2012 paper published by Ghazali, 
Lowe, and Rogers suggests using an additional item to specify whether each domain had 
worsened, stayed the same, or improved over the last month. The authors suggest that his 
modification to the UW-QoLv4 may be of benefit in directing need for intervention.336 
 The UW-QoLv4 contains 12 domains (pain, appearance, activity, recreation, swallowing, 
chewing, speech, shoulder, taste, saliva, mood, and anxiety), each with 3-6 response options. 
Scoring is achieved in the same way as the original version, using a scale of 0-100, with a 
composite score of 0-1200. UW-QoLv4 retains the three items that address HRQOL and overall 
QOL, each scored on a scale of 0-100, the importance rating scale, and the free-text item .335 
Based upon limitations described by Weymuller and colleagues in 2000, calculation of an overall 
summary score for the UW-QoL is not recommended.333,337 In 2010, Rogers and colleagues 
published evidence to support the presence of two UW-QoLv4 subscales based on the results of 
factor analysis. The physical function subscale includes the chewing, swallowing, speech, taste, 
saliva, and appearance domains, and the social-emotional subscale includes the anxiety, mood, 
pain, activity, recreation, and shoulder function domains. Rogers and colleagues suggest that the 
wording of the shoulder function scale reflects more on the domain of work and hobbies, causing 
it to load on the social-emotional domain rather than the physical function domain. Based on the 
finding that specific domains load to each subscale, a summary score (a simple average of each 
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item score, scale of 0-100) can be calculated for each subscale. Scoring requires that at least four 
items are answered in the subscale.337 
 Normative values for 372 subjects without HNC are 95 ± 10 (mean ± SD) for physical 
function and 83 ± 19 for social-emotional function. In a sample of 517 patients 1-2 years after 
surgery for HNC, the physical function score is 71 ± 21, and the social-emotional function score 
is 74 ± 20. Normative values based on cancer staging, presence of surgical flap, and radiotherapy 
are also available. Older patients exhibit a weak tendency to report better scores for both 
subscales, with no significant difference between genders. A mean change score of four units in 
a subscale score is interpreted as a small change, 10 units for a moderate change, and 16 units for 
a large change. For patients with baseline data prior to surgery, a mean change score of three 
units would indicate a small change, and 7.5 units and 12 units a moderate and large change, 
respectively.337 
The original UW-QoL’s psychometric properties were established in a population of 75 
patients with HNC (69% male, mean age 55 years, range 23-83) through a comparison of two 
other QOL questionnaires, the Sickness Impact Profile (SIP) and the Karnofsky Performance 
scale, and are reported as 0.82-0.96 and 0.79-0.85 respectively.328 Convergent validity has been 
established with other measures of QOL for patients with HNC, including the European 
Organisation for Research and Treatment of Cancer (EORTC) coreQOQ-C30,335,338 the EORTC 
Head and Neck (H&N35),338 and the SF-36.338 Discriminant validity is supported based on the 
findings that individuals without HNC score significant higher on the UW-QoL than those with 
HNC.339 No notable floor or ceiling effects have been observed.340 The UW-QoL has not yet 
undergone psychometric testing using IRT or Rasch analysis, which would further strengthen the 
construct validity of the measure. 
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 Internal consistency has been reported as α = 0.86 for the 12-domain composite score, 
with the shoulder domain demonstrating the least correlation with the other 11 domains.335 Test-
retest reliability for the original version exceeded 0.94,328 and for Version 4 the test-retest 
reliability for the physical function subscale ICC is 0.86, and 0.81 for the social-emotional 
function subscale.337 Test item recall is seven days.335 The UW-QoLv4 has been translated into 
22 additional languages.341 The Chinese version is a 13-item measure due to the addition of the 
previously utilized employment test item.342 The tool is quick to complete (less than seven 
minutes) and easy to administer.5,343 Scoring instructions are available, however, scoring is not 
intuitive.328,340 
Because the UW-QoL is a multidimensional tool, the summary score may not be 
appropriately utilized to interpret impairment related to specific domains, such as shoulder 
dysfunction. As a result, some researchers have considered the utility of the shoulder question 
independent of the remainder of the UW-QoL in objectively quantifying shoulder 
impairment.73,83,290 The shoulder subscale of the UW-QoL is scored on a scale of 0-100 points, 
and has four response options: ‘I have no problems with my shoulder’ (100 points), ‘my shoulder 
is stiff but it has not affected my activity or strength’ (70 points), ‘pain or weakness in my 
shoulder has caused me to change my work/hobbies” (30 points), and ‘I cannot work or do my 
hobbies due to problems with my shoulder’ (0 points).328 The subscale has remained unchanged 
across each of the 4 versions of the UW-QoL. 
Rogers and colleagues compared the relationship between the shoulder subscale of the 
UW-QoL, SDQ, and NDII in a sample of 100 patients (54% male, median age 61 years, range 
54-68) who were an average of 12 (range 3-38) months following surgery. The authors found 
that the subscale was strongly correlated with both the SDQ and the NDII (-0.75 for both 
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scales).290 It should be pointed out that the scoring and interpretation of the NDII in the Rogers 
article varies from what was originally reported by Taylor and colleagues in the development and 
validation of the NDII. Rogers defines a higher score as greater impairment, whereas Taylor uses 
the opposite interpretation. As a result, the negative correlation of r = -0.75 for the NDII and the 
UW-QoL should actually be r = 0.75 because a high score in both measures indicates lower 
impairment of QOL.4,290 Parikh and colleagues utilize the same interpretation as Rogers.290,292 
Nonetheless, results of the study demonstrate that the shoulder domain of the UW-QoL has 
positive predictive value for shoulder impairment, as determined by the NDII and the SDQ, 
when a score of lower than 100 points is reported, suggesting that the shoulder domain is an 
appropriate tool to screen for shoulder impairment in the HNC population.290 A lower score on 
the shoulder domain also has positive predictive value for the occurrence of myofascial pain 
syndrome.344 The shoulder domain also demonstrates strong correlations (r) with the following 
measures of QOL: SF-36 domains of role limitation physical (0.80), physical functioning (0.60), 
and pain (0.59); the UW-QoLv1 domains of activity (0.78), recreation (0.77), chewing (0.62), 
and disfigurement (0.62); EORTC C30 (+3) domain of role functioning new (0.59) and pain 
(0.58); and EORTC H&N35 domains of social contact with friends (0.62), pain in mouth (0.62), 
problems with teeth (0.57), and sticky saliva (0.56).338 
In 2009, Rogers and colleagues published single-domain cut-off scores to trigger the need 
for intervention. The cut-off scores were based on the desire to limit the trigger for intervention 
to 1 in 5 patients. For the shoulder domain, the cut-off is 30 points and/or selecting the shoulder 
as an important domain in QOL. The authors postulate that the suggested cut-off score can serve 
as an effective screen for patients with shoulder impairment.345 
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Kuntz and Weymuller supported the use of the shoulder domain in evaluating shoulder 
function after neck dissection procedures in 1999. The authors performed a descriptive study of 
QOL, as measured by the UW-QoL, in 149 consecutive patients receiving RND, MRND, and 
SND procedures at baseline, six, and 12 months following surgery. The authors found that the 
shoulder domain adequately described the patient population and was able to differentiate 
shoulder dysfunction between the three neck dissection procedures.83 Parikh and colleagues also 
consider the shoulder function domain independent of the physical function and social-emotional 
subscales in a surgery-based RCT.292 In 2015, Garzaro and colleagues utilized the UW-QoL to 
compare shoulder function in individuals six months after neck dissection with sacrifice or 
sparing of the cervical plexus. The authors were able to discriminate between the two groups 
using the shoulder scale alone, finding a statistically significant worsening of function in 
individuals in which the plexus was sacrificed.53 
Despite its increasing support in HNC literature, some authors suggest that the single 
item scale lacks “detail” and therefore has limited “usefulness in evaluating changes in shoulder 
complaints over time in the context of prevention and treatment trials.”21 Laverick and 
colleagues utilized the UW-QoL in a study to address QOL issues in patients receiving neck 
dissection surgery. As part of their analysis they individually considered the shoulder domain. 
The shoulder domain responded similar to the other domains of the UW-QoL scale across time 
points, however, the authors suggest that the 4-item scale offers a “crude assessment of shoulder 
function,” and suggest that other shoulder-specific questionnaires may be more responsive, 
especially in the case of bilateral neck dissection surgeries.73 
The UW-QoLv4 does have some limitations. The original scale was developed based on 
expert opinion with no published evidence to support item generation and reduction using sound 
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methodologies.331 However, the extensive and robust psychometric studies that have been 
performed across the four revisions lend excellent evidence to support its validity and utility for 
assessing QOL in the HNC population. The appropriateness of the single domain shoulder 
function however remains to be determined. Another limitation of the UW-QoL reported in the 
literature is the scales applicability to individuals who have undergone surgery, rather than those 
receiving radiotherapy.343 Rampling suggests added domains of voice and tiredness to better 
target individuals receiving radiotherapy.343 Further research is needed to strengthen the 
construct validity of the UW-QoL, and to determine if the shoulder function domain should be 
used independently; however given the single-item nature of the UW-QoL (shoulder subscale) it 
cannot be analyzed using the partial credit Rasch methodologies employed in this study. 
Rationale for PRO Inclusion in the Research Study 
Of the shoulder-related PROs reviewed by Goldstein,3 and recommended by the PULA 
Task Force190 and the APTA EDGE Task Force,2 the NDII and the UW-QoL (shoulder subscale) 
are the only measures which were specifically developed for the HNC population. The SPADI, 
SDQ, CS, ASES, SST, and DASH have been used in the HNC literature, however were 
originally developed for orthopedic and rheumatologic conditions. The QuickDASH has also 
been recommended despite its lack of use in the HNC population at this time.2 Each of these 
measures has psychometric properties derived through CTT methodology, which are well 
documented in the literature through literature and systematic 
reviews.149,200,204,205,228,229,235,265,306,315,346  
The lack of extensive research in this patient population related to shoulder-related PROs 
makes the development and comparison to other measures difficult and confusing. 
Recommendations are often clouded by personal researcher bias and incomplete information 
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regarding a PRO’s psychometric properties. The DASH is frequently recommended over other 
shoulder-related outcome measures for use in multiple patient populations, including those with 
oncology diagnoses.2,3,190,204,347 In a systematic review, Roy and colleagues recommend the use 
of the DASH and the ASES over the SPADI and the SST in the clinic and research settings when 
various shoulder disorders are evaluated. The ASES and SPADI are recommended if shoulder 
pain and physical function are being assessed. The ASES, however, cannot be used to provide a 
health utility score,348 therefore the DASH is recommended if emotional and social function are 
of interest.265 The DASH has been found to correlate highly with generic measures such as the 
SF-36, and may be able to decrease responder burden when a generic health utility score is 
needed.349 Angst and colleagues recommend that the QuickDASH, along with the SPADI, 
pASES, and CS, be used for clinical use and the DASH, along with the SPADI, cASES, and CS, 
be used for research.205 The NDII and SPADI demonstrate comparable reliability, while the 
SPADI provides more detail related to pain, the NDII provides more detail on more difficult 
items required for activity and social participation. The NDII has demonstrated superior 
sensitivity to type of neck dissection surgery received, and demonstrates the lowest floor effects 
when compared to the SPADI and the SDQ.21 Thoomes-Graaf completed a systematic review of 
the literature with the intent to critically appraise and compare the measurement properties of the 
original and translated versions of PROs, which address shoulder-related activity limitations in 
individuals with non-specific shoulder pain. For the English language, the authors recommend 
the use of the SPADI due to its superior psychometric properties. The authors however suggest 
that their recommendations could be biased based upon the strict exclusion criteria. For example, 
many studies of the DASH or QuickDASH were excluded from their review because they 
reported results for individuals with elbow and/or hand impairment.346 
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In 2001 the ICF switched the focus from the medical disablement model to a model that 
classifies function and health through impairments in body function and structure, activity 
limitations and participation restrictions, all in the setting of environmental and personal 
factors.89 In 2013, Roe and colleagues performed a systematic review of 40 shoulder-related 
outcome measures to identify which aspects of functioning were most frequently addressed. The 
authors found the concepts of pain, mobility related body functions and structures, sleep, hand 
and arm use, employment, recreation and leisure, and self-care to be the most frequently 
addressed. The authors found that the DASH and the ASES addressed the greatest number of 
ICF categories, nearly twice as many as the CS, SST and SPADI.350  
The intent of this research study is to assess the appropriateness of the recommendations 
provided by the APTA EDGE Task Force for HNC.2 It is recognized that this will be an 
incomplete analysis of the shoulder-related measures available to medical providers, but it will 
offer a framework from which to continue future research. For completeness, all shoulder-related 
PROs utilized in the HNC have been reviewed here.3 Rationale as to why additional measures 
are not included in this study were considered. The CS includes a clinician-rated component that 
is included in the test score, and therefore does not constitute a true PRO. The SST and the SDQ 
both include dichotomous response options and therefore represent different scale structures than 
the measures recommended by the Task Force. The ASES is the most similar to the Task Force’s 
recommended measures, however requires the responder to answer the questions separately for 
the right and left upper extremity. This methodology varies from the other recommended 
outcome measures and was therefore not included in the study. 
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Summary of What is Known and Unknown About PROs in the HNC Patient Population  
 
With the greater than 50 shoulder-related outcome measures found in the literature,2 the 
need for additional shoulder-related measures has been refuted based on the understanding that 
there will never be a “perfect” measure, and that too many measures will only confuse and 
hinder comparison across interventions or in research.149,329,331 In 2007, Rogers and colleagues 
published a thematic review of HNC-related literature published on QOL and called for 
“ongoing validation to improve our understanding of existing questionnaires and also to develop 
subsite or function specific measures.”329(p 861) Subsequently, Rogers published a similar paper in 
2016 for literature published between 2006 and 2013 and called for “agreement about a specific 
group of functional outcomes” to “enable data to be pooled and compared across units” and to 
“improve the quality of data used to inform patients and the multiprofessional team about likely 
outcomes.”351(p e47) When considering the unique presentation of patients presenting with SAN 
palsy and trapezius muscle atrophy in the setting of HNC, scales not originally intended for the 
HNC population, such as the DASH, QuickDASH and SPADI, may prove inappropriate.  
 Despite strong reported psychometric properties for the DASH, QuickDASH, and the 
SPADI across various patient populations, appropriateness of their use in the HNC population 
has not been fully supported. Rasch analysis of the DASH in various musculoskeletal and MS 
patient populations has uncovered limitations in construct validity related to item fit, 
dimensionality, item response option thresholds, response scale structure, and residual 
correlations.10,11,13,14 The usefulness of the QuickDASH has also been questioned based on 
unresolved weaknesses found in the analysis of the DASH specific to misfit of two items, Item 
26: tingling and Item 21: sexual activity, one of which, tingling (Item 10), was retained in the 
QuickDASH.10,14 The SPADI, when tested with Rasch analysis in a population of patients with 
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general orthopedic complaints, was also found to have item misfit and poor precision at the low 
and high ends of the scale.20 
Preliminary studies have utilized Rasch analysis to study PRO functionality in the HNC 
patient population. One study analyzed the DASH and QuickDASH, and found minor item misfit 
and ceiling effects, in addition to a large weakness in scale precision at the mild to moderate 
disability levels, suggesting a limitation in the scales’ ability to discriminate between ability 
levels and demonstrate change.19 Another study utilized Rasch analysis to analyze the 
psychometric properties of a measure that combines the SPADI and the NDII in a population of 
subjects following neck dissection surgery.21 The analysis supported the unidimensionality of the 
combined scales, but showed disordered response scale structure, gaps in item difficulty 
coverage, and redundancies. The authors were able to resolve the disordered response options 
with dichotomization of response options on both scales, and were able decrease the gaps in item 
difficulty by combining the two scales.21 The psychometric properties of the NDII has not been 
assessed using Rasch analysis at this time. Utilization of the single-item UW-QoL (shoulder 
subscale) does not allow for analysis using Rasch methodologies, however data will be included 
to allow for comparison of its summary score to the other PROs selected. This will allow for 
further consideration of the item’s usability as a screening tool. 
Summary of the Chapter 
 
 Survivors of HNC are often left with disfiguring impairments in body function and 
structure, resulting in activity limitations, participation restrictions, and overall disability. 
Shoulder dysfunction in the setting of SAN palsy and trapezius muscle atrophy is a common 
complaint among individuals who undergo a surgical neck dissection procedure. Although 
physical activity and exercise are recommended for all cancer survivors, HNC survivors tend to 
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be sedentary before, during and after cancer treatments. HNC survivors are infrequently referred 
to physical therapy to address functional deficits related to pain, decreased ROM and strength.  
Progression toward reimbursement to pay for performance models requires physical 
therapists to demonstrate and document value for the care that is provided. Value is determined 
by the cost of the intervention divided by the outcome. Outcome measures, that are reliable and 
that have demonstrated validity in the population of interest, are necessary to show value. The 
inability of physical therapists to show the value of the interventions provided may have serious 
financial consequences related to the ability of HNC survivors to receive skilled physical therapy 
services, and for clinicians to be reimbursed for the care provided.  
Although there are many PROs available to the physical therapist to quantify shoulder 
dysfunction, many have not been adequately studied in the HNC population. Therefore, the 
appropriateness of test score interpretation is unknown. The DASH, QuickDASH, NDII, SPADI, 
and the UW-QoL (shoulder subscale) have been suggested as appropriate PROs to quantify 
shoulder dysfunction in this patient population.2 These recommendations are based upon expert 
opinion and sample-specific psychometric properties derived from CTT methodology, which in 
most cases, are not generalizable to the HNC population. Recent studies utilizing Rasch analysis 
suggest several limitations in scale item hierarchy, response scale structure, and item fit for the 
DASH, QuickDASH, NDII, and the SPADI in patients with HNC.19,21 Similar findings have 
been reported for the DASH, QuickDASH and SPADI in other patient populations.10,11,13-15,20 
These limitations suggest weakness of the construct validity and precision of the scales. Further 
research is, therefore, needed to validate the Academy of Oncologic Physical Therapy EDGE 
Task Force’s recommendations for PROs to quantify shoulder function in patients following 
neck dissection surgery for HNC. 
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This research study seeks to add to the construct validity of the recommended PROs by 
demonstrating that each test’s items adequately measure the latent construct of interest - shoulder 
function/dysfunction. Person and item measures will provide information related to how well the 
tests target the population of individuals who have received neck dissection surgery for HNC. 
They will also provide information related to floor and/or ceiling effects, gaps in measuring 
individual ability levels, and redundant test items that increase responder burden. Fit statistics 
will allow us to determine how each item contributes to the latent construct, and whether the 
assumptions of unidimensionality and item interdependence are violated. Unidimensionality will 
be further assessed through PCA, item fit and DIF. Scale reliability will be reported through 
person and item reliability estimates.  
The results of this study will further the work of the APTA’s Academy of Oncologic 
Physical Therapy Head & Neck EDGE Task Force2 by increasing the ability of clinicians and 
researchers to interpret an individual’s disability level, in addition to the PRO’s ability to 
measure change. While assessment of scale responsiveness is outside the scope of this research 
study, findings within our analysis of large floor or ceiling effects could negate the need to 
perform further studies, allowing focus on more relevant measures to the HNC patient 
population.  
  
109 
 
Chapter 3: Methodology    
Introduction to the Chapter 
 Chapter 3 describes the methodology for this research study. The research design 
including a description of the sample recruiting and the study personnel, research setting, 
recruitment methods, enrollment process including informed consent, data collection, and data 
analysis will be discussed. Formats for presenting results will be described, in addition to 
resources used for this study.   
Research Method 
 This research study was a multi-site, cross sectional, questionnaire-based psychometric 
study. Participants were recruited using convenience sampling from a population of patients with 
a history of neck dissection procedures for management of head and neck cancer (HNC). 
Specific Procedures Employed 
Ethical Approval and Study Registration 
Prior approval from the Institutional Review Boards (IRB) at the Mayo Clinic and Nova 
Southeastern University was obtained (Appendix 1). The Mayo Clinic IRB served as the IRB of 
Record (IRB number 15-005266). This research was presented at the Neurology Discipline 
Oriented Group Committee at the Mayo Clinic on August 25, 2015, which oversees research 
studies generated from the Neurology and Physical Medicine and Rehabilitation departments at 
the Mayo Clinic that involve the Clinical Studies Unit. The study is listed on ClinicalTrials.gov 
(NCT02554968).  
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Participants 
To be eligible for this study, subjects must have had either a unilateral or bilateral neck 
dissection procedure for management of HNC within the past two weeks to 18 months, and 
endorse some level of shoulder impairment (i.e. Answer “yes” when asked “are you currently 
experiencing any shoulder weakness, stiffness or discomfort as a result of your neck surgery?”). 
Eligible subjects were between 18-90 years of age and fluent in the English language allowing 
for completion of the study-related forms and questionnaires. Subjects were excluded if they 
denied shoulder impairment as a result of the recent neck dissection surgery (i.e. answered “no” 
to the previously stated screening question). Rasch analysis requires a heterogeneous sample and 
range of ability levels related to shoulder function, therefore subjects with a severed Spinal 
Accessory Nerve (SAN) and those who were current receiving or who had already received 
radiotherapy, chemotherapy or combined modality treatments were not excluded.  In addition, 
subjects with any stage or type of HNC were eligible, as long as a selective neck dissection 
(SND), modified radical neck dissection (MRND), or radical neck dissection (RND) procedure 
was included as part of the medical management.  
Recruitment 
One hundred and eighty-two subjects were enrolled in this study. According to Linacre, 
108 – 243 subjects are required to gain a 99% confidence that the estimated item difficulty is 
within ±½ logit of its stable value.352 Pilot data of 131 questionnaires demonstrates poor response 
option utilization by HNC survivors for Disability of the Arm, Shoulder and Hand (DASH) and 
QuickDASH test items which were more difficult to endorse (response options 4 and 5),19 
therefore we aimed to recruit a larger sample in an attempt to gain a more heterogeneous sample 
related to ability level, and to account for incomplete questionnaires. Attrition was not 
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considered as a factor in recruitment planning for this study because subjects were only asked to 
complete the questionnaires on one occasion with no scheduled follow-up required. 
Subject recruitment was completed using two methods: (1) in-office recruitment from the 
Otolaryngology, Radiation Oncology, and Physical Medicine and Rehabilitation departments at 
the Mayo Clinic in Phoenix, Arizona, Jacksonville, Florida, and Rochester, Minnesota; and (2) 
mailed questionnaires. We first attempted to complete enrollment through in-office recruitment, 
however slow recruitment prompted the addition of mailed questionnaires. Goldstein and 
colleagues report an 80% response rate in a questionnaire-based study of individuals with 
HNC.353 During in-office recruitment, potential subjects were screened for eligibility by 
designated medical providers at the time of their medical appointment. If deemed eligible, the 
potential subject was provided with an Oral Consent Template (Appendix 2), Health Insurance 
Portability and Accountability Act (HIPAA) Authorization to Use and Disclose Protected Health 
Information forma (Appendix 3), and questionnaires to complete. In an effort to prevent 
enrollment of the same subject twice, the Oral Consent Template asks the participants to return 
the uncompleted questionnaires if they have already completed them at another appointment. 
The second method of recruitment utilized quarterly electronic reports generated by the Mayo 
Clinic Health Sciences Research Department, which included any patient billed for a neck 
dissection procedure within the Mayo Clinic Enterprise. The report did not include individuals 
outside of the eligible age range, or those with legal, financial or deceased administrative flags. 
This report was screened by the Primary Investigator to confirm accuracy and remove 
                                                     
a Communication with the Mayo Clinic IRB has determined that a full-length consent form was 
not necessary for this minimal risk study. Study personnel provided a brief statement such as: 
“Your input about your shoulder pain or weakness is important to us. We would appreciate if 
you would complete these questionnaires.”  The study personnel would then offer the subjects 
the oral consent template, HIPAA release form, and questionnaires to complete.  
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individuals receiving neck dissection surgery for an indication other than HNC. Packets were 
subsequently mailed to the remainder of individuals on the list. Packets included the following 
information: informational letter (Appendix 4) modified from the Oral Consent Template, the 
HIPAA form, and questionnaires. A self-addressed, postage-paid envelope was also included. 
The order of forms within the packet was the same for each subject enrolled through in-office or 
mailed recruitment. 
Data Collection 
For in-office recruitment, after providing consent subjects were asked to complete a 
demographic questionnaire, which captured the following information: self-reported height and 
weight, ethnicity, hand dominance, and previous and/or current receipt of treatment for shoulder 
dysfunction (Appendix 5). Additional information was gleaned from the electronic health record 
(EHR) by the Primary Investigator to further describe the sample including the subject’s age and 
gender, state of residence, location of treatment (Arizona, Florida, or Minnesota), date of 
surgery, tumor type and stage, surgery received (including bilateral/unilateral neck dissection, 
levels dissected, and status of the SAN), and additional treatments received (including 
radiotherapy, chemotherapy, or combined treatments) (Appendix 6). Subjects then completed the 
four shoulder-related patient-reported outcome measures (PRO): DASH, Shoulder Pain and 
Disability Index (SPADI), Neck Dissection Impairment Index (NDII), and the University of 
Washington Quality of Life (UW-QoL) (shoulder subscale). The single item UW-QoL (shoulder 
subscale) was placed on the demographics questionnaire document in an effort to decrease 
responder burden and the number of forms to complete (Appendix 5). Test items for the 
QuickDASH were obtained directly from the DASH, and therefore were not completed by the 
subject. Derivation of QuickDASH scores from DASH scores has been described previously in 
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the literature.10,245 All questionnaires were collected and sent to data coordinators who were 
responsible for uploading and storing data in REDcap (Research Electronic Data Capture) hosted 
at the Mayo Clinic.354 Upon completion of data collection, a data coordinator completed a 
random quality check for data entry for 10% of subjects. 
This research study utilized two data coordinators. The first was employed as an 
Associate Clinical Research Coordinator by the Mayo Clinic Clinical Studies Unit. Her time was 
funded by grant money described later. The second was a rehabilitation technician in the 
Department of Physical Medicine and Rehabilitation. 
Outcome Measures 
The DASH, QuickDASH, SPADI, NDII and the UW-QoL (shoulder subscale) were 
utilized for this study. Each of these were described in detail previously, and therefore are not 
described here. For the purposes of this study, there are a few considerations to mention. The 
subjects in this study were not asked to complete the two optional work and performing arts 
modules for the DASH and QuickDASH. The NDII rating scale is inverted when compared to 
the other PROs in this study. The test score with the regular rating scale was used for Classical 
Test Theory (CTT) comparisons, however individual test item responses were transformed to be 
consistent with the other measures for Rasch analysis. Techniques to manage missing data are 
not reported for the NDII, therefore the same requirement for the 11-item QuickDASH of a 90% 
response rate was required (nine items) for calculating the test score.  
Data Analysis 
 Descriptive statistics were calculated using JMP® Pro 13.0.0 (Copyright © 2016 SAS 
Institute Inc., Cary, North Carolina) to report sample characteristics and mean population test 
score values. A correlational analysis was also utilized to compare the relationships between 
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each of the PROs and the single-item UW-QoL (shoulder subscale). Prior to Rasch analysis, 
NDII item responses were transformed to coincide with the response structures of the other 
measures. A high score on the DASH, QuickDASH, SPADI and the UW-QoL (shoulder 
subscale) indicate greater disability, whereas a high score on the NDII suggests lower disability. 
Rasch analysis will be performed using Winsteps Rasch Measurement computer program, 
version 3.81.0 (Winsteps, Beaverton, Oregon, USA) to assess the reliability, construct validity, 
and overall appropriateness of test score interpretation of the DASH, QuickDASH, SPADI, and 
the NDII in patients experiencing shoulder dysfunction following neck dissection surgery for 
HNC. Specifically, we assessed scale dimensionality, through consideration of principal 
components analysis (PCA), item and person fit, and Differential Item Functioning (DIF), 
response scale structure, and item and person separation and reliability. The analysis was guided 
by the previously mentioned investigational questions. 
Scale Dimensionality 
  Dimensionality of the scales was first assessed using PCA, then though consideration of 
item fit and DIF. PCA standardized residuals with an eigenvalue of 2.0 or higher in the first 
contrast triggered further assessment of item loading coefficients. Specifically, groups of items 
with a loading coefficient of  ≥ 0.40 were compared to the model for the presence of additional 
dimensions. Exploratory analysis of PCA, item fit and summary statistics was subsequently 
utilized to consider whether subscales should be utilized for further analysis. 
Further consideration of scale dimensionality included analysis of item and person fit and 
DIF. Person or item misfit was determined by analysis of person or item infit and outfit statistics 
(Mean-Square , MNSQ; z-standard, ZSTD). For this study a MNSQ range of 0.6 to 1.4 was 
deemed acceptable. When the MNSQ fell outside of this range, the ZSTD statistic was analyzed. 
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When the ZSTD was > ±2, person or item misfit was present.177 A qualitative assessment of 
misfitting items was then performed. Further exploration of misfitting items occurred through 
analysis of PCA, item fit and summary statistics with misfitting items eliminated to determine 
impact of overall scale functionality. Person misfit was also considered to determine whether 
there is a relevant cause or reason that the person answered test items differently than expected.  
The presence of DIF may also suggest the presence of additional constructs or 
dimensions in a measure. DIF by age, which was arbitrarily set at 18-64 years and 65-85 years, 
and gender (male and female) was considered in this analysis. For the purposes of this study, 
items with a DIF contrast (effect size) of >0.64 (p < 0.05) were considered for potential DIF.180 
Positive findings of items with DIF were qualitatively considered based upon the 
recommendations of Linacre.181 
Response Scale Structure 
To assess response scale structure for the DASH, QuickDASH, SPADI, and NDII, this 
study considered response category utilization, distribution of responses across options, scale 
calibration, average measure values and item fit through the category structure output provided 
by Winsteps.8,183 Step calibration and average measures should sequentially increase or decrease 
with item difficulty for each response option. A response category outfit value of greater than 2.0 
suggests that there is more unexplained variance than explained variance in a category, and 
therefore limits the accuracy, stability and interpretability of the measure.182  
In the case of unequal utilization of response categories, the presence of disordered 
response options and excess response option variance, this study considered the appropriateness 
of collapsing the scale structure to improve the precision of the measure and decrease responder 
burden. Subsequently, Rasch analysis, including item and person separation and reliability, 
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person and item fit, scale hierarchy, and scale dimensionality, were run using the optimized 
response scale structure. If collapsing categories failed to improve scale reliability and separation 
indices, analysis proceeded using the original response scale structure. 
Scale Hierarchy 
Rasch half-point threshold maps were analyzed to describe the scale hierarchy of the 
PROs. For the purposes of this study, a floor or ceiling effect occurred when 5% of the sample 
scored the lowest or highest possible score.355 The presence of gaps or item redundancies are 
reported for each measure. The easiest and most difficult items for each PRO for this sample are 
also reported based upon logit (standard error, SE) measures. 
Item and Person Separation and Reliability 
The ‘REAL’ estimate was utilized for this study when reporting reliability estimates. In 
Winsteps, the ‘REAL’ estimate provides the person reliability coefficient with extreme scores 
removed. The ‘MODEL’ estimate does not remove extreme scores, therefore Boone and 
colleagues suggest using the REAL estimate when reporting.185 A person separation of greater 
than 2 with a person reliability of greater than 0.8, and an item separation of greater than 3 with 
an item reliability of greater than 0.9 were utilized as a cutoff for this study.186  
Formats for Presenting Results 
Description of the Sample 
 Sample demographics, including mean, standard deviation (SD) and range for continuous 
data and frequencies for categorical data, are reported for the following characteristics: age, 
gender, state of residence, ethnicity, body mass index (BMI), tumor type and stage, time since 
surgery, surgery characteristics (unilateral or bilateral neck dissection, levels dissected, status of 
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SAN), and additional interventions received (radiotherapy, chemotherapy, chemoradiotherapy, 
physical and/or occupational therapy). 
Description of PRO Test Score Results 
 A description of the number of questionnaires completed, the number of incomplete 
questionnaires subsequently removed from analysis, and the number of questionnaires analyzed 
using Rasch are provided. Descriptive statistics including mean, SD, and range for the DASH, 
QuickDASH, NDII, SPADI and UW-QoL (subscale) test scores are reported. Results of a 
correlational study of the five measures are reported.  
Examination of the Research Question 
The results of the Rasch analysis, related to scale dimensionality, response scale structure, 
and reliability are presented for each PRO to answer the research questions. A combination of 
text, tables and figures are utilized. Information regarding response category utilization and item 
fit are provided in table format; and a description of scale hierarchy including gaps, redundancies 
and floor/ceiling effects are shown using figures of the half-point threshold maps for each PRO.  
Examination of Additional Research Questions 
 A secondary aim of this research study was to either confirm or modify the 
recommendations made by the Academy of Oncologic Physical Therapy Head & Neck 
Evaluation Database to Guide Effectiveness (EDGE) Task Force for shoulder-related PROs best 
utilized in the HNC population.2 If the preliminary analysis of the five recommended PROs fails 
to provide a single PRO that can be used appropriately, secondary analysis may continue with 
the aim to provide a recommendation for a combination of PROs that can adequately quantify 
shoulder dysfunction in this patient population.  
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Dissemination of Results 
 Pilot work for the dissertation was presented at the American Physical Therapy 
Association’s (APTA) Combined Section Meeting in Indianapolis, Indiana in 2015,19 and initial 
analysis of the DASH, QuickDASH, SPADI and NDII of this work (sample of 90 subjects) was 
presented at the APTA’s Combined Section’s Meeting in San Antonio, Texas in 2017.356 A full-
length manuscript detailing the pilot work presented in 2015 is under peer-review. Upon 
completion of the dissertation and defense, it is anticipated that 4-5 additional manuscripts will 
be submitted for publication, which detail the results of Rasch analysis for the DASH, 
QuickDASH, SPADI, and NDII, as well as the usability of the UW-QoL (shoulder subscale) as a 
screening tool An additional manuscript suggesting a combination of measures for quantification 
of shoulder-related dysfunction in the HNC population will also be considered. Educational 
sessions, platform and poster presentations at national and international meetings will also be 
considered. 
Resources Used 
 Grant support of $5000 was awarded through the APTA’s Academy of Oncologic 
Physical Therapy (Appendix 7). This funding helped to cover costs associated with mailed 
questionnaires and research coordinator time through the Mayo Clinic Clinical Studies Unit. The 
Mayo Clinic Department of Physical Medicine and Rehabilitation supported costs once the grant 
award was utilized, including fees for reports, generated quarterly, from which potential subjects 
were recruited, cost of mailed questionnaires, and personnel support for data entry. Resources 
were not allocated for the time it took the Primary Investigator to perform clerical tasks such as 
putting together and mailing questionnaires, or data mining of the EHR. Data coordinators were 
responsible for inputting data into the computer-based data management system (REDcap).  
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 Other required resources included software and supplies. Software requirements for this 
study included Winsteps, REDcap, and JMP. Winsteps is provided at no cost by Nova 
Southeastern University, and REDcap and JMP are provided at no cost by the Mayo Clinic.  
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Chapter 4: Results 
Introduction to the Chapter 
 Chapter 4 details the results to the study. The individual research questions and study 
aims are addressed. Tables and figures are utilized to help organize the chapter. 
Description of the Sample 
Sample Size 
Subjects were recruited between September 2015 and August 2017. Fifty subjects were 
enrolled through in-office recruitment. A total of 721 questionnaire packets were mailed and 229 
were returned (31% response rate). Of the 229 packets returned, 75 declined participation, 19 
individuals signed the Health Insurance Portability and Accountability Act (HIPAA, Appendix 
3) form but denied shoulder pain and therefore were considered screen failures, one individual 
with shoulder impairment completed and returned the packet but the date of signature was 
outside of the eligibility timeframe of 18 months and was also considered a screen failure. Two 
returned packets were notifications of patient expiration. One hundred and thirty-two individuals 
were accrued through a mailed questionnaire.  A total of 182 individuals were accrued for this 
study. Informed consent was implied through completion of the questionnaires and signing of the 
HIPAA form (Figure 1).  
Of the 182 returned packets, three packets were incomplete. Two packets did not include 
completed demographic information. On each PRO, participants skipped test items, and in very 
rare cases skipped the entire questionnaire [Disability of the Arm, Shoulder and Hand 
(DASH)/QuickDASH, N=2; Shoulder Pain and Disability Index (SPADI), N=4; Neck Dissection 
Impairment Index (NDII=1)]. The University of Washington Quality of Life (UW-QoL) 
(shoulder subscale) was skipped by five participants. See Table 2 for details regarding skipped 
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test items and skipped questionnaires. Because Rasch analysis focuses on independent items 
within a test rather than a test summary score, incomplete packets were retained for data 
analysis. However, when reporting mean summary test scores for each of the PROs 
questionnaires with missing items were eliminated consistent with scoring requirements. 
Figure 1. Research Study Recruitment
 
 
 
 
 
 
Total Accured 
N=182 
In-Office 
Recruitment, N=50 
Mailed 
Questionnaire 
Recruitment, N=132 
Total packets 
mailed, N=721 
Total packets 
returned, N=229 
Patient deceased 
notification, N=2 
Declined 
Participation, N=75 
Screen Failures, 
N=20 
Signed HIPAA Form, 
Denied shoulder 
pain, N=19 
Outside of elligibility 
timeframe, N=1 
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Table 2. Description of Incomplete Questionnaires and Skipped Items 
 # of incomplete 
questionnaires 
# of skipped items # of questionnaires 
eliminated from analysis 
DASH 31 1: 12 
2: 8 
3: 2 
4: 2 
5:1 
6: 2 
11: 1 
12: 1 
All: 2 
9 (27 items required for 
calculation of summary 
score) 
QuickDASH 18 1: 12 
2: 3 
4: 1 
All: 2 
6 (10 items required for 
calculation of summary 
score) 
SPADI-pain 5 1: 1 
All: 4 
4 (no guideline based upon 
number needed to score for 
SPADI) 
SPADI-disability 9 1: 3 
2: 1 
3: 1 
All: 4 
4 
SPADI-total 9 1:2 
2:2 
3:1 
All: 4 
4 
NDII 7 1: 5 
2: 1 
All: 2 
3 
UW-QOL (shoulder 
subscale) 
6 N/A 0 
*Italics indicate number of test items missing, that result in removal from analysis for test score 
reporting. 
Demographics 
  
Table 3. Sample Demographics 
Age at enrollment 
(mean, SD, range) 
 62.67 (11.47, 33-87) 
Gender (N,%) Male 
Female 
143 
39 
79% 
21% 
Ethnicity (N, %) African American 
Asian American 
White, Non-Hispanic 
White, Hispanic 
3 
2 
161 
13 
2% 
1% 
88% 
7% 
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Middle Eastern 
Other 
0 
3 
0% 
2% 
Height – cm (mean, 
SD, range) 
 175.48 cm (10.84, 97-198.12) 
Weight – kg (mean, 
SD, range) 
 81.18 kg (16.13, 44-145) 
BMI – kg/m2 (mean, 
SD, range) 
 26.38 kg/m2 (5.02, 17.63-53.26) 
Hand dominance* 
(N, %) 
Right 
Left 
Ambidextrous 
156 
14 
7 
88% 
8% 
4% 
Days since surgery 
(mean, SD, range) 
 174.07 (138.43, 14-567) 
Abbreviations: standard deviation (SD), number (N), centimeters (cm), kilograms (kg), body 
mass index (BMI), meters (m) 
*N=177 (5 did not report hand dominance) 
 
Twenty-five states within the United States were represented in the sample. The majority 
of individuals enrolled held primary residency in Arizona (N = 58) or Minnesota (N = 52). The 
remainder of the sample was fairly representative of the United States regions, with the 
exception of the Northeast, with 23 participants from the South [Florida (13), Georgia (6), 
Tennessee (1), Texas (1), Arkansas (1), Mississippi (1)], 36 additional participants from the 
Midwest [Iowa (16), Wisconsin (5), Michigan (5), North Dakota (4), Illinois (3), Indiana (1), 
Nebraska (1), and South Dakota (1)], and 11 additional participants from the West [Montana (3), 
New Mexico (2), Nevada (2), California (1), Colorado (1), Idaho (1) and Wyoming (1)]. Hawaii 
and Alaska were represented with one participant each. Consistent with the greatest 
representation being from the Midwest states, the majority of cancer care occurred at Mayo 
Clinic in Rochester, Minnesota (N = 98, 54%). Sixty-six individuals (36%) received their cancer 
treatment at Mayo Clinic in Phoenix, Arizona and 17 individuals (9%) received care at Mayo 
Clinic in Jacksonville, Florida. 
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Cancer Diagnosis 
Any individual receiving a neck dissection procedure was eligible for this study. The 
majority of individuals enrolled were diagnosed with cancer of the oropharynx or hypopharynx 
(N = 85). Cancers of the oral cavity and larynx (N = 49), parotid (N = 17), nasopharynx (N = 1), 
nasal cavity and paranasal sinuses (N = 2) and thyroid (N = 6) were included. Some skin cancers 
of the head were also included (N = 11).  Eleven participants receiving neck dissection were 
characterized as having a cancer diagnosis of “other.” Details regarding levels dissected are 
available in Table 4 and tumor staging are available in Table 5. Of note, review of the electronic 
health record (EHR) in many cases revealed incomplete staging information. In many cases, lack 
of the TNM classification was for individuals with diagnoses staged differently than the cancers 
of the oropharynx, hypopharynx, oral cavity and larynx. In only 14 cases was the Spinal 
Accessory Nerve (SAN) sacrificed intraoperatively (right, N=5; left, N= 9). 
 
Table 4. Description of Surgery in the Study Population 
 Right Neck 
Dissection 
Left Neck 
Dissection 
Bilateral Neck 
Dissection 
Number of surgeries 
performed 
83 58 41 
   
Levels dissected N = 124 N = 99 
Level 1A/1B only 2 1 
Level 2A/2B only 2 2 
Level 1 & 2 4 1 
Levels 1 – 3 10 6 
Levels 1 – 4 28 27 
Levels 1 – 5 9 9 
Levels 2 & 3 3 7 
Levels 2 - 4 51 34 
Levels 2 – 5 11 10 
Levels 3 – 5 1 1 
Levels 4 – 5 0 0 
Other 3 1 
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Table 5. Classification of Cancer for Study Population 
TNM classification Number of 
Participants with 
Classification 
Percent of Sample 
T (N=155) TX 5 3% 
 T0 0 0% 
 Tis 0 0% 
 T1 47 30% 
 T2 53 34% 
 T3 21 13% 
 T4 29 19% 
N (N=151) NX 3 2% 
 N0 32 21% 
 N1 20 13% 
 N2 86 57% 
 N3 10 7% 
M (N=161) MX 5 3% 
 M0 156 97% 
 M1 0 0% 
Cancer Treatment 
Sixty-eight individuals received surgery as a single modality intervention for their head 
and neck cancer (HNC) treatment, whereas 52 individuals received adjuvant radiotherapy and 61 
individuals received combined modality radiation and chemotherapy. Adjuvant interventions for 
one individual are unknown. Although adjuvant radiotherapy was recommended for this 
individual, review of the EHR was unclear as to whether the intervention was actually pursued 
outside of the Mayo Clinic Enterprise.  
 Endorsing shoulder pain, weakness or stiffness was a requirement for eligibility in this 
study. Ninety-five participants (52.2%) reported right shoulder impairment, 70 (38.5%) reported 
left shoulder impairment and 17 individuals (9.3%) reported bilateral shoulder impairment. The 
majority did have their shoulder impairment addressed by a care provider through intervention or 
exercise prescription. Fifty-eight percent (N=105) reported receipt of care from a physical 
therapist. Physicians (13%), massage therapists (8%), nurses (7%), occupational therapists (7%), 
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chiropractors (7%), acupuncturists (1%) and personal trainers (1%) also participated in the 
management of shoulder impairment. Only 53 study participants (29%) reported receiving no 
interventions related to their shoulder pain, stiffness, or weakness.  
Data Analysis 
Classical Test Theory 
 
Descriptive Statistics of PROs 
 Classical Test Theory (CTT) methodology was utilized to report test score average 
(standard deviation, SD), standard error of the measure (SEM), and 95% confidence interval (CI) 
for each of the measures (Table 6). These statistics were generated after removing questionnaires 
that did not meet the minimum requirement for answered items for scoring, as indicated in Table 
2. Frequency of category utilization for the DASH, QuickDASH, SPADI and NDII will be 
reported later. Distribution of responses across response option for the UW-QoL (shoulder 
subscale) are outlined in Table 7. 
Table 6. PRO Average Test Scores, SEM and 95% CI using CTT 
 DASH Quick-
DASH 
SPADI-
Pain 
SPADI-
Disability 
SPADI-
Total 
NDII UW-QOL 
shoulder 
Mean 28.83  28.84 35.98 26.61 30.05 57.58 47.67 
(mean) 
70 (median, 
mode) 
SD 18.00 19.06 25.48 22.32 22.59 22.54 25.47 
SEM 1.37 1.44 1.91 1.67 1.69 1.68 1.92 
95% CI 26.13, 
31.53 
26.00, 
31.67 
32.21, 
39.75 
23.31, 29.91 26.71, 
33.39 
54.27, 
60.90 
43.88, 51.46 
Sample 
size 
173 176 178 178 178 179 176 
 
 
 
 
 
 
 
127 
 
Table 7. Distribution of Response for the UW-QoL (shoulder subscale) 
Shoulder (Item)  Scoring Value 
(points) 
Frequency of Use 
(N) 
1. I have no problem with my shoulder. 100 3 
2. My shoulder is stiff but it has not affected by activity 
or strength. 
70 86 
3. Pain or weakness in my shoulder has caused me to 
change my work/hobbies. 
30 69 
4. I cannot work or do my hobbies due to problems 
with my shoulder. 
0 18 
 
Correlational Analysis 
Correlational analysis of the five PROs was completed (Table 8). As expected, the DASH 
and QuickDASH were found to have a statistically significant, strongly positive relationship. 
Similarly, the SPADI-total score and the disability and pain subscores were found to have a 
strong positive correlation. A significant, but weak to moderate negative correlation was found 
for the NDII and the DASH, the NDII and the three SPADI scores, and the UW-QoL and the 
three SPADI scores.  
Table 8. Correlational Analysis of the PROs 
 DASH QuickDASH UWQOL SPADI-
Disability 
SPADI- 
pain 
SPADI-
total 
NDII 
DASH        
QuickDASH 0.98***       
UWQOL -0.0067 0.004      
SPADI-
disability 
0.11 0.12 -0.26***     
SPADI-pain 0.09 0.099 -0.19** 0.88***    
SPADI-total 0.10 0.11 -0.24** 0.96*** 0.98***   
NDII -0.15* -0.14 0.054 -0.19* -0.17* -0.18*  
*p<0.05; **p<0.01; ***p<0.001 
Because there was no correlation between the UW-QoL (shoulder subscale) and the 
DASH, QuickDASH and NDII, further analysis to determine the usability of the subscale as a 
screening tool, or predictor of shoulder impairment, was not pursued. The usability of the UW-
QoL (shoulder subscale) based upon its weak to moderate correlation with SPADI was then 
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considered. Because of the unequal distribution of category 1 and 4 utilization, it was decided 
that further analysis of the UW-QoL (shoulder subscale) as a screening tool was not appropriate. 
This sample does not provide a clear representation of shoulder impairment across ability levels.  
Rasch Analysis  
Disabilities of the Arm, Shoulder and Hand 
See Appendix 8 for DASH and QuickDASH data including: test items, item stems, item 
logit values, item fit statistics, and response category utilization.  
Scale Dimensionality 
 Principal component analysis (PCA) of the DASH showed that 60.9% of the variance in 
the scores was explained by the measure with an eigenvalue of 3.2, suggesting the presence of 
greater than one construct measured by the patient-reported outcome measure (PRO). 
Assessment of loading coefficients for the items meeting the criteria for further assessment 
(>0.40) revealed 5 items which loaded in the positive direction and 4 items which loaded in the 
negative direction (See Table 9). Comparison of these positive- and negative-loading items 
reveals 2 distinct subdomains: functional activities and symptoms. Subsequent analysis of scale 
dimensionality using PCA was completed on a 24-item function subscale (Items 1-23, 30) and a 
6-item symptom subscale (Items 24-29). PCA of the 6-item symptom subscale showed an 
eigenvalue of 1.6; however the 24-item function subscale showed an eigenvalue of 2.9. Five 
items loaded in the positive direction and one item in the negative direction.   
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Table 9. Assessment of Dimensionality Using Principal Component Analysis of the DASH 
Item Loading 
Item 07, heavy chores 0.58 
Item 06, object overhead 0.57 
Item 12, change bulb 0.57 
Item 15, don sweater 0.45 
Item 13, style hair 0.40 
  
Item 24, pain  -0.56 
Item 26, tingling -0.56 
Item 25, pain with activity -0.46 
Item 29, sleep -0.44 
 
To further examine the observed patterns of item loadings, exploratory factor analysis 
was completed using JMP® Pro 13.0.0 (Copyright © 2016 SAS Institute Inc., Cary, North 
Carolina). This did not show a clear pattern; therefore additional PCA was run based upon 
previously published work suggesting subscales of the DASH: manual functioning, disability 
secondary to limitation of motion, and symptoms.14 While the PCA for each of the three scales 
fell below an eigenvalue of 2.0, summary statistics for each were poor compared to the full test 
and analysis of item fit issues for each of the scales increased.  
 Five test items were found to misfit the model for item fit on the 30-item DASH 
(Appendix 8). Items 1: open jar, and 21: sexual activities were found to have problems with infit 
and outfit, whereas Items 4: prepare a meal, 26: tingling and 29: sleep only misfit the model 
with outfit statistics. Person misfit was substantial for this sample. Nineteen percent (n = 35) 
misfit the model with high (n=17) or low (n=18) infit statistics; and 16% (n = 28) misfit the 
model with high (n=13) or low (n=15) outfit statistics. Based upon these findings, and consistent 
with analysis of pilot data currently under peer-review (Eden, Kunze, Cheng, unpublished data, 
2018) it was determined that the DASH is not a suitable scale for the current sample of the HNC 
population and further analysis of the DASH or potential subscales did not occur.   
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 Scale Structure 
 To further explain the proposed argument that the DASH is not suitable for this sample of 
the population, a description of the 30-item DASH scale structure is provided here. 
Consideration of the Rasch half-point threshold map (Figure 2) indicates that the DASH is able 
to measure across the majority of ability levels, except for at the highest disability levels. No 
floor or ceiling effect was identified. Nine gaps in the scale structure and 26 areas of redundancy 
were also identified.   
In this population, Item 2: write and Item 16: cut food were the easiest items (hardest to 
endorse as being difficult) with a logit (standard error) value of 66.6 (1.5) and 66.5 (1.4) 
respectively. Item 18: recreation-force/impact (logit 38.7, SE 1.0) and Item 27: weakness (38.7, 
1.1) were the most difficult items. The DASH did not meet criteria for an optimal rating scale. 
Twenty-one (70%) of test items did not meet minimum criteria for response option utilization of 
10 responses each. Additionally, no test item was found to have uniformity of distribution across 
response options. Forty-three percent of test items were found to have either disordered step 
calibrations or average measures, or both. Five items were found to have a response category 
outfit mean square statistic (MNSQ) value exceeding 2.0 (Items 1: open jar, 2: write, 21: sexual 
activities, 26: tingling, and 29: sleep). 
Reliability 
The person separation and reliability index for the DASH (4.26, α = 0.95) are large 
enough to adequately classify individuals into ability levels. The item separation and reliability 
index (7.30, α = 0.98) is large enough to confirm scale hierarchy. Estimates for reliability for 
person separation in Winsteps is excellent (α = 0.96). 
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Figure 2. DASH Rasch Half-Point Threshold Map 
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QuickDASH 
Scale Dimensionality 
 PCA of the QuickDASH showed that 58.9% of the raw variance was explained by the 
measure, with an eigenvalue of 2.0. An eigenvalue of <2.0 is an acceptable cut-off for PCA, 
therefore further analysis was not performed.  
Dimensionality of the QuickDASH was further analyzed through consideration of item 
and person fit statistics and Differential Item Functioning (DIF) (age and gender).  The scale was 
found to have two misfitting items (Appendix 8). Item 1: open jar misfit the model for infit 
(MNSQ 1.42, z-standard, zstd 3.4) and outfit (1.49, 3.5), and Item 10: tingling misfit only for the 
outfit statistic (1.47, 2.2). Analysis of DIF for gender found issues on three items. Females 
answered Items 1: open jar and 3: carry bag as being more difficult than males, and males 
answered Item 4: wash back as more difficult than females. No items were found to be 
significant for DIF based upon age. Based upon concerns with item misfit and DIF by gender for 
Item 1: open jar, analysis of the test with removal of this item was performed. The eigenvalue 
for PCA remained at 2.0, and no significant changes in summary statistics were identified. 
Further analysis of item fit in the 10-item scale revealed item misfit (infit and outfit) for Item 10: 
tingling. DIF for gender with removal of Item 1: open jar continued for Item 3: carry bag but 
was no longer a concern for Item 4: wash back. At this point, it was decided to retain all 11 items 
for further analysis and reporting for the QuickDASH. 
Person misfit was identified in 16 cases (approximately 9%), 15 individuals (8%) misfit 
the model for infit (11 with high infit and four with low infit statistics) and nine individuals (5%) 
for outfit (seven with high infit and two with low infit statistics).  
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 Scale Structure 
 Analysis of the scale structure for the QuickDASH was completed through observation of 
the Rasch-half point threshold map (Figure 3), which demonstrates better ability of the scale to 
classify individuals with low to moderate levels of disability.  
Figure 3. QuickDASH Rasch Half-point Threshold Map 
 
Results showed that Item 5: cut food was the easiest item (least likely to be endorsed as being 
difficult) with a logit (standard error) value of 66.5 (1.5), and Item 6: recreation–force/impact 
was the hardest item (most likely to be endorsed as being difficult) with a logit value of 37.8 
(1.0). A floor and ceiling effect were not present. The Rasch-half point threshold map revealed 
10 gaps in the scale structure, and six occurrences in which more than one test item response 
option measures the same ability level (redundancies).   
 Analysis of category utilization of the QuickDASH identified eight of the 11 items had 
fewer than 10 responses in at least one of the response option categories. Items 1 and 7-11 did 
not achieve the required 10 responses in the fifth response option category, and Items 3: carry 
bag and 5: cut food lacked 10 responses in the fourth and fifth category. In fact, in Item 5: cut 
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food, response option 4 was not selected by any respondent. It was also noted that all items 
lacked uniform distribution of response category utilization; although the average measures did 
advance monotonically by category for each of the 11 test items. There were two occurrences in 
which disordered step calibration was identified, and one occurrence in which response category 
outfit MNSQ values exceed 2.0 (Item 1: open jar) (Appendix 8). 
Collapsing response options 4 and 5 improved category utilization to meet the 10-
response requirement for all items except for Items 3: carry bag and 5: cut food. One of the 11 
test items, Item 2: heavy chores, gained uniformity in utilization of response options (range 36 to 
50 responses per option). With collapsing response options 4 and 5, Item 3: carry bag was found 
to have disordered average measures; however prior occurrences of disordered step calibration 
and high outfit MNSQ values were alleviated. Person separation and reliability statistics did not 
change with collapsing response options (collapsed: 2.42, α = 0.52 versus no change: 2.49, α = 
0.86). The item separation index decreased to 6.19 (α = 0.97), keeping it well above the cut-off 
for an acceptable scale. PCA and item fit did not change with this modification.  
Reliability 
 The person separation and reliability index for the QuickDASH (2.49, α = 0.86) are large 
enough to adequately classify individuals into ability levels. The item separation and reliability 
index (6.60, α = 0.98) is large enough to confirm scale hierarchy. Estimates for reliability for 
person separation in Winsteps is excellent (α = 0.90).  
Shoulder Pain and Disability Index 
See Appendix 9 for SPADI data including: test items, item stems, item logit values, item 
fit statistics, and response category utilization.  
135 
 Scale Dimensionality 
 PCA of the SPADI was first run combining the pain and disability subscales. The 
measure explained 75.2% of the raw variance (eigenvalue 2.3). Two items were found to load in 
the positive direction, and four items were found to load in the negative direction (Table 10). 
PCA was subsequently run on the subscales separately. The measure explains 78.7% of the raw 
variance and yielded an eigenvalue of 1.8 for the first contrast of the pain subscale. For the 
disability subscale, 74.8% of the raw variance was explained by the measure, with an 
unexplained variance for the first contrast of an eigenvalue of 2.2. 
Table 10. Principal Components Analysis of SPADI (Pain and Disability) 
Item Loading 
Item 03: pain-shelf 0.65 
Item 01: pain-worst 0.58 
  
Item 10: disability-don pants -0.64 
Item 8: disability-don shirt -0.53 
Item 9: disability-buttons -0.52 
Item 13: disability-back pocket -0.42 
 
 Dimensionality of the SPADI was further analyzed through item and person fit. For the 
full scale, Item 12: disability-heavy object, misfit the model with high infit (MNSQ 1.51, zstd 
3.7) and outfit (1.68, 4.4) statistics (Appendix 9).  Removal of Item 12: disability-heavy object 
did not impact PCA findings or significantly impact summary statistics. The item was therefore 
retained for further analysis. When analyzing the SPADI-disability subscale, Item 12: disability-
heavy object was, again, found to misfit the model with high item infit (1.55, 4.0) and outfit 
(1.63, 4.3) statistics. No items misfit the SPADI-pain subscale model (Appendix 9). DIF for 
gender was found for Item 6: disability-wash hair, where females found the item to be more 
difficult than males. No items were found to have DIF for age.  
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 Person fit for the full SPADI scale found misfit for infit for 19% of the sample (n=33) 
and outfit for 15% (n=27). For infit, 14 individuals misfit the model with high statistics, and 19 
misfit with low statistics. For outfit, 11 misfit with high statistics and 16 misfit with low 
statistics. Analyzing the subscales also revealed instances of person misfit. Twelve percent 
(n=21) was found to misfit for both infit (high, n=11; low, n=10) and outfit (high, n=11; low, 
n=10) statistics on the pain subscale.  For the disability subscale, 16 individuals (9%) were found 
to misfit with high (n=12) or low (n=4) infit statistics, and 15 individuals (8%) were found to 
misfit with high (n=8) or low (n=7) outfit statistics. 
Scale Structure  
 Scale structure for the SPADI was analyzed using the full scale. Consideration of the 
Rasch half-point threshold map (Figure 4) demonstrates the scales ability to quantify the 
majority of ability levels, except for at the extremes. No floor or ceiling effect is present. The 
map reveals five gaps in the scale structure and 33 occurrences in which more than one response 
option measured an ability level (redundancy). In this population, Item 10: disability-don pants 
was the easiest item, or the hardest to endorse as being difficult, with a logit (SE) value of 60.8 
(0.7). Items 1: pain-worst and 11: disability-shelf were found to be the most difficult items 
(easiest to endorse as being difficult) with logit values of 43.9 (0.5) and 43.2 (0.5) respectively. 
 Response category utilization was analyzed. Each of the 13 test items had one or more 
response options that did not meet the 10 response requirement (Appendix 9). Response options 
9 and 10 were selected least frequently, followed by response options 6, 8 and 7. Uniform 
distribution of category utilization across the measure was, therefore, not achieved. Issues with 
disordered step calibration were found in all 13 test items, and failure to achieve monotonic 
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advancement of observed averages in nine test items. Four test items were found to have high 
outfit MNSQ values for one or more response categories. 
Figure 4. SPADI Rasch Half-point Threshold Map 
 
 In an effort to improve category utilization and scale structure, further analysis of the 
impact of collapsing response options 9 and 10 was performed. Eleven of the 12 test items failed 
to achieve greater than 10 responses per response option with this modification. Uniform 
distribution of category utilization remained an issue, and there was no change in the items with 
high response category outfit statistics. One item improved with respect to monotonicity, 
however continued to have disordered step calibration.  When comparing full scales to collapsed 
versions, minimal differences were overserved in person (3.66, α = 0.93) and item separation 
(8.26, α = 0.99), and item fit and PCA were not impacted. Observation of the Rasch half-point 
threshold map demonstrated decreased coverage of ability levels at the high (low ability) level of 
the scale. 
Next, response options 8-10 were collapsed. While factors related to scale structure 
including category utilization (10 test items did not meet criteria) and progression of average 
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measures improved (six of 11 items did not have expected progression), disordered step 
calibration increased to seven items, and five items were found to have high response category 
outfit MNSQ statistics. In addition, item misfit increased to include Item 1: pain-worst for outfit, 
in addition to the previous misfitting Item 12: disability-heavy object. Summary statistics for 
person separation remained stable, however item separation increased to 9.08 (α = 0.99). 
Observation of the Rasch half-point threshold showed further decrease in coverage of the lower 
ability levels as well. As a result of this and the increased instability of test items noted with item 
fit, further analysis of collapsing response options was discontinued. 
Reliability 
 Person separation index (person reliability) for the three SPADI scales are as follows: full 
3.74 (α = 0.93); disability 2.71 (α = 0.88); and pain 3.74 (α = 0.93). Each scale meets criteria for 
adequately classifying individuals into ability levels. Item separation (reliability) indices for all 
three scales also meet criteria to verify scale hierarchy (full 8.31, α = 0.99; disability 7.56, α = 
0.98; and pain 6.51, α = 0.98). Estimates for reliability for person separation in Winsteps is 
excellent for all three scales (full α = 0.97; disability α = 0.94; and pain α = 0.93). 
Neck Dissection Impairment Index 
Of note, the NDII response scale is the only reverse-scaled measure included in this 
study. To allow for accurate interpretation, responses were reversed coded to align the NDII 
scale with the other PROs being examined. For example, a response option of 5 indicating “not 
at all” or no difficulty was recoded to represent “a lot” of difficulty. See Appendix 10 for NDII 
data including: test items, item stems, item logit values, item fit statistics, and response category 
utilization.  
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 Scale Dimensionality 
 PCA of the NDII reveals 66.4% of the raw variance is explained by the measure 
(eigenvalue 2.1). The items that loaded in the positive direction (Items 1: pain/discomfort and 2: 
stiffness) relate to symptoms resulting from neck dissection, whereas the items that loaded 
negatively (Items 4: lift-light objects and 5: lift-heavy objects) relate to functional ability (Table 
11). Given the close proximity of this eigenvalue to the cutoff and the brevity of the scale (10 
items) further analysis of potential subscales was not pursued. In addition, no items misfit the 
model, and DIF was not found to be present for age or gender. 
 Similar to the other scales, person misfit was also an issue for the NDII. Seventeen 
percent (n=30) misfit the model with high (n=14) or outfit (n=16) statistics, and 13% (n=24) 
misfit the model with high (n=10) or low (n=4) outfit statistics.  
Table 11. Principal Components Analysis for the NDII 
Item Loading 
Item 02: stiffness 0.84 
Item 01: pain/discomfort 0.74 
  
Item 04: lift-light objects -0.50 
Item 05: lift-heavy objects -0.48 Scale Structure 
 Observation of the Rasch half-point threshold map (Figure 5) reveals no floor or ceiling 
effect for this sample. The measure covers most ability levels except for the very low end of the 
scale (high ability). There were 13 gaps in the measurement scale and two occurrences in which 
more than one response option targeted the same ability level. Item 8: participation-social was 
found to be the most difficult item (easiest to endorse as being difficult) with a logit value of 
38.1 (1.0). Item 2: stiffness was found to be the easiest item (most difficult to endorse as being 
difficult) with a logit value of 62.1 (1.1).  
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Five of the 10 test items did not meet criteria for 10 or more responses per response 
option. Items 1- 4 and 8 each had one option with less than 10 responses, three of which were 
option 1, and two were option 5 (Appendix 10). Because of this inconsistency, further 
consideration of collapsing the scale structure was not considered. Uniform distribution of 
response options across categories was not achieved for any test item; conversely the average 
measure progressed monotonically for each item, there were no issues with disordered step 
calibration or high outfit MNSQ values for response categories. 
Figure 5. NDII Rasch Half-point Threshold Map 
 
Reliability 
 Summary statistics for the NDII met requirements for population based analysis. Person 
separation was 3.16 (α = 0.91), and item separation was 8.09 (α = 0.98). Cronbach’s alpha for 
WINSTEPS was excellent (α =0.93).  
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Summary of the Results 
 A sample of 182 individuals was recruited for this study. The mean (SD, range) age is 63 
years (11.47, 33-87). The majority of the sample is white, non-Hispanic (88%) and male (79%). 
Participants were on average 174 days (5.8 months) from surgery, however the sample included 
individuals who were 14 to 567 days (2 weeks to 18 months) from surgery. Most of the cancer 
diagnoses were of the hypopharynx or oropharynx, and there was equal distribution of 
individuals receiving surgery only, surgery+radiation, and surgery+radiation+chemotherapy. The 
majority of cancer care was provided in Arizona and Minnesota, although the sample has good 
representation of the continental United States. All individuals enrolled, reported some level of 
shoulder impairment; and only 29% of these individuals had not received some intervention for 
their symptoms. 
 Test score means, SD, SEM and 95% CIs are reported for each of the scales. The DASH 
and QuickDASH are highly correlated as expected, as are the SPADI and its subscales. 
Significant, although weak, correlations are found between the NDII x DASH, NDII x SPADI, 
and the UW-QoL (shoulder subscale) x SPADI. Based upon findings of little to no correlation, 
the UW-QoL (shoulder subscale) was not further considered for usability as a screening tool.  
 Rasch analysis was utilized to study the validity and reliability of each measure. Scale 
structure was also considered. A comparison of the four measures is available in Table 12. The 
DASH did not meet Rasch analysis criteria for unidimensionality, and was deemed inappropriate 
for utilization in this sample of the population. The QuickDASH, SPADI and NDII were all 
determined to be unidimensional. The DASH, QuickDASH and SPADI each had issues with 
item misfit and DIF. All scales had similar issues with person fit, coverage of ability levels per 
the Rasch half-point threshold map, and gaps and redundancies in scale hierarchy. All scales 
142 
 
failed to meet the 10-response requirement for each response option for each item, and lacked 
uniform distribution of response category utilization. The DASH, QuickDASH and SPADI also 
were found to have issues in scale structure related to disordered step calibration and average 
measures, and high outfit MNSQ values for response categories. The NDII was found to meet 
most requirements of an optimal rating scale. All measures were found to meet thresholds for 
person and item separation and reliability statistics.  
Table 12. Summary of Findings for the DASH, QuickDASH, SPADI, and NDII 
 DASH QuickDASH SPADI NDII 
Unidimensional No Yes Yes Yes 
Item misfit 5 items (17%) 2 items (18%) 1 item (8%) 0 items (0%) 
Person misfit 40 persons 
(22%) 
16 persons (9%) 36 persons 
(20%) 
31 persons 
(17%) 
DIF (gender) Not tested 3 items (27%) 1 item (8%) 0 items (0%) 
Variable Map Lacks high 
disability 
Lacks high 
disability 
Lacks coverage 
at both extremes 
Lacks low 
disability 
Logit range  38.7 – 66.5 37.8 – 66.5 43.2 – 60.8 38.1 – 62.1 
Floor/ceiling No No No No 
Gaps 9 10 5 13 
Redundancies 26 6 33 2 
10-Responses? 30% 27% 0% 50% 
Uniform 
distribution? 
0% 0% 0% 0% 
Disordered step 
calibration? 
27% 18% 100% 0% 
Disordered 
average 
measures? 
17% 0% 69% 0% 
Response 
category outfit 
MNSQ >2.0? 
17% 9% 31% 0% 
Person Indices 4.26, α = 0.95 2.49, α = 0.86 3.74, α = 0.93 3.16, α = 0.91 
Item Indices 7.30, α = 0.98 6.60, α = 0.98 8.31, α = 0.99 8.09, α = 0.98 
Cronbach’s α α = 0.96 α = 0.90 α = 0.97 α = 0.93 
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Chapter 5: Discussion 
Introduction to the Chapter 
 This section provides an in-depth discussion of the study results and outcomes of the 
study aims outlined in Chapter 1. Clinical implications, recommendations, and limitations of this 
study are also discussed. 
Discussion 
 This study sought to answer the question, “Which of the recommended patient-reported 
outcome measures (PRO) demonstrates acceptable psychometric characteristics allowing for 
accurate test score interpretation in patients presenting with shoulder disability in the setting of 
head and neck cancer (HNC)?” The aims of the study were three-fold: (1) to assess, using Rasch 
analysis, the construct validity and overall appropriateness of test score interpretation of the 
Disability of the Arm, Shoulder and Hand (DASH), QuickDASH, Shoulder Pain and Disability 
Index (SPADI) and the Neck Dissection Impairment Index (NDII); (2) determine the 
appropriateness of use of the University of Washington Quality of Life (UW-QoL) shoulder 
subscale as a screening tool for shoulder-related impairment; and (3) suggest a combination of 
outcome measures or a new measure that most accurately portrays shoulder disability in this 
population. Through completion of these aims, the 2014 recommendations2 for outcome 
measures to quantify shoulder impairment in the HNC population would either be validated or 
challenged. In a 2014 systematic review, Eden and colleagues strongly recommended the 
following measures: DASH, SPADI, NDII and the UW-QoL (shoulder subscale), and 
recommended the QuickDASH.2 The results of this study strongly support the use of the NDII in 
this population. The SPADI, and the QuickDASH are recommended, and the DASH is not 
recommended. It is also not recommended that the shoulder subscale of the UW-QoL be utilized 
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as a single-item measure to quantify shoulder dysfunction, or to predict performance on the other 
shoulder-related PROs.  
Analysis of the four PROs through a combination of Rasch methodologies and qualitative 
analysis, shows that the NDII meets assumptions for unidimensionality, covers the majority of 
ability levels, does not have floor and ceiling effects, has appropriate person and item summary 
statistics, and meets most requirements for an optimal rating scale as described by Linacre.182 
Weaknesses of the NDII are primarily within the scale hierarchy and scale structure. 
Specifically, the measure lacks test items to adequately capture individuals with lower disability 
levels, and has 13 gaps in the rating scale structure, suggesting low scale sensitivity. This is not 
surprising given that this is the shortest of the four PROs included in this analysis. The results of 
this study vary from previous reports of Rasch analysis of the NDII, which found disordered 
response option step categories and floor effects.21 
Like the DASH, QuickDASH and SPADI, this population failed to achieve the required 
10 responses per response option for optimal analysis in the NDII, and therefore lacked uniform 
utilization of response options. Because this was a consistent finding in this study, it is assumed 
that this sample of the HNC population did not experience the level of disability that would 
warrant utilization of the response options indicating high disability.  
The QuickDASH and the SPADI were found to have some flaws which suggest that the 
user proceed with caution when using these scales in the HNC population. Both scales were 
deemed unidimensional, with minor issues with item misfit and DIF. Floor and ceiling effects do 
not exist for either scale. The QuickDASH does not possess test items to adequately capture 
individuals with high disability, whereas the SPADI fails to capture individuals at the extremes 
of ability levels. Both have gaps and item redundancies. The SPADI has fewer gaps, and more 
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redundancies due to the greater number of test items and response options inherent in the 
measure. Both scales also fail to meet all five criteria for optimal rating scales as outlined by 
Linacre.182 The SPADI has superior item and person summary statistics than the QuickDASH. 
QuickDASH scale structure varies slightly than in a sample of individuals who 
underwent surgery for musculoskeletal causes including total shoulder arthroplasty or rotator 
cuff repair.224  Individuals with shoulder impairment due to HNC are least challenged by Item 5: 
cut food, whereas the previously mentioned population is least impacted by Item 10: tingling. It 
is interesting that this was not the case for the HNC population, given that these individuals 
rarely experience this impairment, and that Item 10: tingling was found to misfit the model in 
this study. Future modifications to the QuickDASH could consider elimination of Item 10: 
tingling, because it is not a common complaint in the HNC population.  Both populations were 
most challenged by Item 6: recreation–force/impact. Item 1: open jar also misfit the model. 
Qualitative consideration as to why misfit would occur in this sample is less clear. This task 
occurs with the arm by the side, which is not a common limitation for individuals with SAN 
palsy. Removal of this item for further analysis did not impact results. It is possible that this Item 
1: open jar misfit based upon the presence of DIF by gender, specifically females finding this 
item to be more difficult than males. Females also found Item 3: carry bag to be more difficult 
than males, whereas males found Item 4: wash back to be more difficult than females. 
Results support the SPADI as a unidimensional scale as outlined in the literature,305,314 
suggesting that for test score interpretation utilization of the total score, rather than the pain and 
disability subscores, may be sufficient. Findings of no floor or ceiling effect contradict a 
previously reported study which found a floor effect of 17% one to three months following neck 
dissection surgery and a 43% six to eight months following surgery.302 This study also found 
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some variation in the item hierarchy. Prior studies report Items 7: disability-wash back, 11: 
disability-shelf, and 12: disability-heavy object as being the most difficult.109 In this sample, 
Items 1: pain-worst and 11: disability-shelf were found to be the most difficult items, and Item 
12: disability-heavy object was found to misfit the model. Interestingly, DASH Item 11: carry 
object did not misfit the DASH model. It is possible that this test item is answered differently 
based upon time since surgery. Individuals who are within the first two to three weeks of 
recovery from surgery, have a lifting restriction of 10 pounds due to risk of post-operative 
bleeding.  
While the DASH has been widely used in the literature, and recommended for use in the 
HNC population,3,66,190 Rasch analysis in this study did not support its use. This is consistent 
with recent findings in pilot data (Eden, Kunze, Cheng, unpublished data, 2018). Primary 
limitations of this measure include failure to satisfy the requirement of unidimensionality, and as 
found in this study, no clear evidence supporting delineated subscales for analysis. Exploratory 
factor analysis was completed to further consider the presence of additional constructs for 
consideration as recommended in the literature,14 without clear constructs identified. Similar to 
prior reports, the DASH was found to have item misfit, and gaps and redundancies in the scale 
hierarchy. Additional inconsistencies with the literature were uncovered with respect to item 
difficulty. Rogers and colleagues found Items 6: object overhead, 13: style hair and 15: don 
sweater to be the most difficult items; whereas Items 18: recreation-force/impact and 27: 
weakness were most difficult in this sample. In a general musculoskeletal population, Item 18: 
recreation-force/impact has been identified, along with Item 21: sexual activities and 20: 
manage transportation, as items needing further consideration in future iterations of the 
DASH.247 Based upon the findings that Item 18: recreation-force/impact is the most difficult 
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item for the HNC population, it is recommend that this item be retained based upon its value in 
capturing individuals with higher ability levels. This study supports removal of Item 21: sexual 
activities based upon issues with item misfit. Similar recommendations have been made by other 
authors 111,205 Of note, Kennedy and colleagues reported problems with Item 1: open jar, which 
was also problematic in this study for both the DASH and QuickDASH.247 This study uncovered 
flaws in the scale structure as defined by Linacre.182 Because of these findings, it was determined 
that the DASH score cannot be adequately interpreted for this population of patients and a more 
in-depth analysis of the measure, including consideration of DIF, alternate scale structures, or 
subscales, was not pursued. This research study supports the use of the QuickDASH over the 
DASH. Similar to the reports of MacDermid and colleagues, the QuickDASH covers the same 
range of ability levels as the DASH.224 
  The recommendation not to use the UW-QoL (shoulder subscale) as a screening tool in 
the HNC population varies from previous recommendations.290,345 One reason as to why our 
recommendations may vary from Rogers is that our sample had very low utilization of response 
options 1 and 4. Response option 1 (“I have no problems with my shoulder”) was rarely utilized 
(n = 3) because the inclusion criteria for the study required subjects to report some degree of 
shoulder impairment to be eligible for participation. Of significance is the little to no correlation 
with the other PROs in this study. The UW-QoL (shoulder subscale) was not found to have a 
statistically significant correlation with the DASH, QuickDASH or the NDII, however a weak, 
negative correlation was found with the single-item question and the SPADI. Of interest, the 
DASH, QuickDASH, SPADI and UW-QoL (shoulder subscale) have the same scale structure, so 
any correlation should be in the positive direction if present. In this case, the UW-QoL item did 
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not behave as expected. Future studies should consider the reliability and construct validity of 
the UW-QoL scale in its entirety using Rasch analysis. 
The lack of statistically significant correlation between the DASH/QuickDASH and the 
SPADI, and the weak correlation with the NDII and the DASH, and the NDII and the SPADI, 
were unexpected findings in this analysis. Our results found significant deviations from 
published findings for relationships between the other PROs included in this study. For instance, 
the DASH and NDII have been reported to have a strong negative relationship in the HNC 
population (r = -0.86),196 whereas our results found a weak, although significant, correlation. The 
NDII has also previously been found to have a strong correlation with the shoulder subscale of 
the UW-QoL (r = 0.75),290 and SPADI (r = -0.75)21 which was not the case in this study. 
All PROs lacked the requirements for an optimal rating scale as defined by Linacre.182 
Most notable in this sample was the failure to achieve a minimum of 10 responses per response 
option on each test item. Particular attention was paid to this through study recruitment. 
Although this sample includes a wide variety of HNC-related tumors, surgeries, adjuvant 
treatments, and time from surgery, we were unable to enroll subjects with very high levels of 
shoulder disability, as noted by low utilization of the higher response options across measures. A 
consideration for future studies would be to focus on individuals with higher levels of disability, 
although the incidence of this occurring is decreasing as surgical techniques improve. Another 
related limitation of scale structure across the measures is related to uniform distribution of 
responses across response options, which again is likely related to the sample and the captured 
ability levels. 
To address the limitation of low utilization of response options, this study included trials 
of collapsing response categories for the QuickDASH and the SPADI. Collapsing response 
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options was not performed for the NDII because a clear pattern of poor utilization did not exist. 
Future use of the PROs in the HNC population could consider collapsing response options 4 and 
5 in the QuickDASH. Upon collapsing these response options, response option utilization 
improved, as did the presence of disordered step calibration and average measures, and high 
response category outfit statistics. Additionally, scale summary statistics and PCA findings did 
not change significantly. Options for the SPADI require further analysis, however. Collapsing 
options 9 and 10 did not adequately address limitations in scale structure, and with a trial of 
combining response options 8, 9 and 10, the scale structure further deteriorated.  
 Another similar theme across measures is the presence of person misfit, which may have 
contributed to item misfit in the DASH, QuickDASH, and the SPADI. Person misfit was 
consistent across measures and therefore was attributed to the sample for this study. Given the 
absence of item misfit in the NDII, and the already low response category utilization for all 
measures a qualitative analysis of the misfitting persons for consideration of removal of 
misfitting persons was not performed.  
 The findings in this study may be related to variations between the PROs, including 
purpose, test item construction and recall period. The DASH and QuickDASH measure disability 
related to impairment of the entire upper extremity, whereas the SPADI measures disability and 
pain specific to the shoulder. Except for situations of radial forearm free flap harvest for surgical 
reconstruction, the entire upper extremity is rarely affected in the medical management of HNC. 
The NDII, a measure of health-related quality of life (HRQOL) due to shoulder impairment is the 
only measure included in the Rasch analysis designed specifically for the HNC population. It is 
also the only measure included in this analysis that includes questions related to the neck. 
Individual test items within each measure are written differently to capture the intent of the PRO. 
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Test items in the DASH/QuickDASH and SPADI are worded similarly and request the responder 
to indicate how much difficulty an activity would cause. The NDII test items address the same 
activities however each test item relates the impairment back to the shoulder or neck. In addition 
the NDII test items appear more personal because they address the respondent through the use of 
“you.” For example, Item 1 reads “Are you bothered by neck or shoulder pain or discomfort?” It 
is possible that the differences in test item construction, and specificity of the NDII to the HNC 
population impacted how the study participants answered, and therefore how the data fit the 
Rasch model.  Another inherent difference in the scales is the recall period. The 
DASH/QuickDASH, SPADI and the UW-QoL (shoulder subscale) ask respondents to consider 
the past week when answering test items, whereas the NDII recall period is four weeks. 
 Given the satisfactory performance of the SPADI, NDII and QuickDASH in this 
population, consideration of a combination of PROs for a new measure is not necessary. The 
idea not to create a new PRO is supported by the notion that there will never be one “perfect” 
measure. The availability of too many PROs can lead to confusion and limit the ability to 
compare outcomes in clinical or research settings.351 It is also not recommended that a therapist 
utilize more than one of the recommend PROs on a single patient. Consideration of individual 
test items within each scale reveals redundancy in content, and therefore would likely introduce 
redundancy in test items available to quantify ability levels. An attempt to decrease gaps in item 
difficulty through the use of two more scales would introduce unnecessary responder burden.  
Therefore the third aim of this study was not pursued. 
Implications 
 This study has significant clinical implications for medical providers working with 
individuals with HNC. Individuals receiving a neck dissection procedure for their diagnosis are 
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at increased risk for experiencing shoulder impairment, and decreased QOL. Referral to a 
physical therapist can help to minimize impairment. Utilization of PROs can provide a baseline 
level of function prior to surgery, or show progress of return to function following surgery. As 
payment models change to performance-based models, healthcare providers must be able to 
show value in the services provided through the utilization of valid and reliable instruments. This 
study provides valuable insight into previously recommended PROs for this population.3,66,190 
The most commonly utilized and recommended PROs, DASH, QuickDASH, and SPADI, have 
flaws which limit test score interpretation in this population. In addition, we have shown that the 
single-item shoulder question is not appropriate for use as a screening tool for this sample of the 
population. A strength of this study is the validation of the NDII as a measure of shoulder-related 
impairment in the HNC population. 
Recommendations 
The results of this study strongly support the use of the NDII. The SPADI, and the 
QuickDASH are recommended with reservation, and the DASH is not recommended. It is also 
not recommended that the shoulder subscale of the UW-QoL be utilized as a single-item measure 
to quantify shoulder dysfunction, or to predict performance on the other shoulder-related PROs. 
The EDGE Task Force recommendations2 have not been fully supported, therefore an updated 
recommendation should be made based upon the findings of this study. Future studies should 
further strive to validate the findings in this study related to correlational analysis between 
measures. Research is also needed to provide recommendations on alternative scale structures, 
related to collapsing response options, for the QuickDASH and the SPADI. Additional research 
should consider the responsiveness of the NDII in clinical settings. 
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Limitations and Delimitations 
Limitations 
 The primary limitation in this study is with respect to the sample of subjects enrolled, 
which contributed to issues of person misfit, underutilized response categories and lack of 
uninform distribution of category utilization for each PRO, and in some scales possibility of 
multiple constructs. The sample had high incidence of person misfit, indicating that 14-20% of 
the sample answered test questions in a way that was not predicted by the model. It is possible 
that the higher incidence of person misfit is because of our attempt to utilize PROs developed for 
a musculoskeletal population and apply this to a HNC population, however the lowest incidence 
of person misfit was found in the QuickDASH, and the highest in the DASH. If our hypothesis 
was correct, the NDII would have the lowest incidence. Other possibilities for high person misfit 
could be related to responder burden and guessing. Each participant was asked to complete a 
packet of documents which required quite a bit of reading and completion of a total of four 
questionnaires (greater than 60 test questions). The packets were provided to each participant in 
the same order, therefore if responder burden is present, we would expect to see higher person 
misfit in the PROs later in the packet (SPADI and NDII), which again was not the case.  
An additional limitation of this research study was the failure to obtain a heterogeneous 
sample of sufficient ability range to accurately assess the response scale structure and item 
calibration for each of the PROs. This occurred despite attempts to include subjects with greater 
disability levels including those undergoing bilateral neck dissections and those who’s SAN(s) 
was sacrificed during surgery.  Pilot data reflected a decreased tendency for utilization of 
response options (4 and 5) which suggest greater disability if endorsed on the DASH and 
QuickDASH.19 This was confirmed again in this study, and was also found in the SPADI and the 
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some items in the NDII. In addition, in most cases the PROs failed to achieve uniform 
distribution of category utilization. This is also likely sample-related. It is possible that the HNC 
population does not reach the necessary levels of disability to utilize the response options 
indicating lower ability levels. 
Delimitations 
 Delimitations are factors that impact the research study which are under the PI’s control. 
Delimitations for this study included slower than anticipated subject enrollment, incomplete or 
missing data, and minor errors in data entry. Slower than anticipated subject enrollment was the 
primary limitation and resulted from decreased awareness, decreased motivation, and time 
constraints of a busy clinical calendar for medical providers asked to participate in the study. 
This was addressed successfully through utilization of mailed questionnaires. Incomplete or 
missing data was present, but limited by regular communication with study staff for quality 
control during data entry. Because of the nature of mailed questionnaires it was impossible to 
ensure completeness of PROs, however care was taken to review accuracy in those that were 
finished in a one-on-one setting.  Additionally, data coordinators and the primary investigator 
completed data checks to verify accuracy of data in REDcap database. 
Summary 
 This chapter provides a discussion of the study results , limitations, and 
recommendations. Rasch analysis results indicate that the NDII is the most appropriate measure 
studied for use in a population of patients with HNC reporting shoulder impairment resulting 
from neck dissection procedure. The QuickDASH and SPADI are appropriate but do have some 
limitations. The DASH is not recommended, neither is the UW-QoL (shoulder subscale) as a 
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screening tool. Future research could address alternate scale structures, including collapsing 
response options, and further analysis of the correlational relationships between the PROs.  
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Appendix 1. Letter of Approval from the Mayo Clinic IRB 
Principal Investigator Notification: 
From: Mayo Clinic IRB 
To: Melissa Eden  
  Re: IRB Application #: 15-005266 
 Title: Reliability and Validity of Five Shoulder-Specific Patient Reported Outcome Measures for use in 
Patients with Head and Neck Cancer  
  
             IRBe Protocol Version: 0.01  
             IRBe Version Date: 8/4/2015 10:51 AM  
             IRB Approval Date: 9/15/2015  
             IRB Expiration Date: 9/14/2016  
The above referenced application is approved by expedited review procedures (45 CFR 46.110, item 5, 7). This 
approval is valid for a period of one year. The Reviewer conducted a risk-benefit analysis, and determined the study 
constitutes minimal risk research. The Reviewer determined that this research satisfies the requirements of 45 CFR 
46.111. This study has IRB approval to accrue 250 adult subjects. The Reviewer noted that oral consent with 
HIPAA authorization is appropriate for this study. The oral consent script and HIPAA form were reviewed and 
approved as written. The Reviewer approved waiver of the requirement for the Investigator to obtain a signed 
consent form in accordance with 45 CFR 46.117 as justified by the Investigator. The DASH, Shoulder Pain and 
Disability Index, Neck Dissection Impairment Index, and Demographics Questionnaires are approved. 
The Reviewer accepts the appointment of Mayo Clinic IRB as the IRB of record for the relying organization, Nova 
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Appendix 2. Oral Consent Template 
 
Mayo Clinic: Office for Human Research Protection 
Oral Consent Script 
 
 
Protocol Title: Reliability and Validity of Five Shoulder-Specific Patient Reported Outcome 
Measures for use in Patients with Head and Neck Cancer 
IRB #: 15-005266 
Principal Investigator: Melissa M. Eden PT, DPT, PhD(c), OCS 
 
You are being asked to participate in a research study that will compare several questionnaires 
that are often used to measure shoulder pain, stiffness or weakness in patients following surgery 
for head and neck cancer. You are being asked to participate in this study because you have had 
a neck dissection surgery within the past 18 months and are currently experiencing some level of 
shoulder dysfunction.  
 
If you do not have shoulder pain, stiffness or weakness, or if you have already completed this 
packet at another appointment, please do not complete these forms. Please return this packet to 
your medical provider now. 
 
If you agree to participate you will be asked to complete 4 questionnaires. One of the 
questionnaires asks you to provide basic information about yourself. The other 3 questionnaires 
require you to answer questions about your shoulder symptoms and your ability to perform 
various activities. It is anticipated that these questionnaires will take you 30 minutes to complete. 
All information collected will be stored in a secure database in order to protect your 
confidentiality. You will not receive payment for your participation. 
 
There are no known risks to you for taking part in this research study. This study may not 
directly benefit you, but it will benefit the medical providers who participate in your care and the 
care of future patients.  
 
Please understand your participation is voluntary and you have the right to withdraw your 
consent or discontinue participation at any time without penalty.  Specifically, your current or 
future medical care at the Mayo Clinic will not be jeopardized if you choose not to participate.  
 
If you have any questions about this research study you can contact me, the primary investigator, 
at (480) 342-0450. If you have any concerns, complaints, or general questions about research or 
your rights as a participant, please contact the Mayo Institutional Review Board (IRB) to speak 
to someone independent of the research team at 507-266-4000 or toll free at 866-273-4681.  
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Appendix 4. Patient Contact Letter 
(Date) 
 
( Name)  
(Street Address) 
(City, State  Zip) 
RE:     (first name) ( last name) 
MC#:  (mc #) 
 
 
Protocol Title: Reliability and Validity of Five Shoulder-Specific Patient Reported Outcome 
Measures for use in Patients with Head and Neck Cancer 
IRB #: 15-005266 
Principal Investigator: Melissa M. Eden PT, DPT, PhD(c), OCS 
 
Dear (Mr., Ms, or Mrs.)  
 
You are being asked to participate in a research study that will compare several questionnaires 
that are often used to measure shoulder pain, stiffness or weakness in patients following surgery 
for head and neck cancer. You are being asked to participate in this study because you have had 
a neck dissection surgery within the past 18 months and are currently experiencing some level of 
shoulder dysfunction.  
 
If you do not have shoulder pain, stiffness or weakness, or if you have already completed this 
packet at another appointment, please do not complete these forms.  
 
If you agree to participate you will be asked to complete 4 questionnaires. One of the 
questionnaires asks you to provide basic information about yourself. The other 3 questionnaires 
require you to answer questions about your shoulder symptoms and your ability to perform 
various activities. It is anticipated that these questionnaires will take you 30 minutes to complete. 
All information collected will be stored in a secure database in order to protect your 
confidentiality. You will not receive payment for your participation. We have enclosed the 
questionnaires for you to complete.  If you would like to, you may fill it out and return in the 
enclosed stamped envelope. 
 
There are no known risks to you for taking part in this research study. This study may not 
directly benefit you, but it will benefit the medical providers who participate in your care and the 
care of future patients.  
 
Please understand your participation is voluntary and you have the right to withdraw your 
consent or discontinue participation at any time without penalty.  Specifically, your current or 
future medical care at the Mayo Clinic will not be jeopardized if you choose not to participate.  
 
If you decide to participate, please read and sign the Authorization to Use and Disclose Protected 
Health Information form and return it with the questionnaire.  We are not allowed to use the 
answers without your signature on the Authorization to Use and Disclose Protected Health 
Information form.  A copy will be available through your Mayo Clinic patient portal if you have 
a portal account. Otherwise, a copy is available upon your request by marking the appropriate 
box on the last page.   
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Contact me at (480) 342-0450 if you have any questions about:  
 Study tests and procedures 
 Withdrawing from the research study 
 Materials you receive 
 
If you prefer, you may write to me at the address given below: 
 
Melissa Eden PT, DPT 
Physical Medicine and Rehabilitation 
5777 East Mayo Boulevard 
Phoenix, Arizona 85054 
 
Contact the Mayo Institutional Review Board (IRB) to speak to someone independent of the 
research team at 507-266-4000 or toll free at 866-273-4681 if you have questions about:  
 Rights of a research participant 
 Use of your Protected Health Information 
 Stopping your authorization to use your Protected Health Information 
 
Research-related questions not listed above, or any research-related complaints may also 
be addressed to me. If you prefer to speak with someone independent of the research team, 
you may contact the Mayo Institutional Review Board (IRB). 
 
If you prefer to complete the survey over the phone, or if you do not wish to participate, please 
indicate on the next page and return this letter since it will make a follow-up telephone call 
unnecessary.  Thank you very much for your time and consideration.  
 
Sincerely, 
 
 
________________   
Melissa M. Eden PT, DPT 
Primary Investigator 
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RE:  (first name) (last name) 
MC#:  (mc #) 
 
 
 
  I would prefer to complete the survey over the phone.  I am enclosing the Authorization to 
Use and Disclose Protected Health Information form only.  Please call me. 
 
 Your name: _____________  
Telephone number: (___)___-_____  
Today’s date: __/__/__ 
 Best time to call:  Morning    Afternoon    Evening     
Best day(s) to call:______________ 
 
  I am requesting that a copy of the Authorization to Use and Disclose Protected Health 
Information form be mailed to me. 
 
  I am not willing to participate in this research study. 
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Appendix 5. Demographics Questionnaire 
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Appendix 6. Data Mining Form 
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Appendix 8. DASH & QuickDASH Summary Table 
  DASH Fit Statistics (Item)   QuickDASH Fit Statistics 
(Item) 
Response Category 
Frequency  
DASH Item (item stem) Measure 
(Model 
S.E.) 
Infit 
Statistic (z-
score) 
Outfit 
Statistic 
(z-score) 
Quick 
DASH 
Item 
Measure 
(Model 
S.E.) 
Infit 
Statistic 
(z-score) 
Outfit 
Statistic 
(z-score) 
1 2 3 4 5 
1. Open a tight or new jar (open jar) 49.3 (1.0)  1.46 (3.7)  1.59 (4.2)  1 49.1 (1.0) 1.42 (3.4) 1.49 (3.5) 61 61 32 18 7 
2. Write (write) 66.6 (1.5)  1.30 (1.6)  1.60 (1.6)     141 26  9  2  1 
3. Turn a key (turn key) 61.4 (1.7)  1.03 (0.2)  0.93 (-0.1)     144 26  7  0  0 
4. Prepare a meal (prepare meal) 64.2 (1.4) 0.81 (-1.4) 0.58 (-2.4)     111 49  3  2  1 
5. Push open a heavy door (open door) 52.9 (1.1) 0.94 (0.51) 0.98 (-0.1)      67 67 30 12  4 
6. Place an object on a shelf above 
your head (object overhead) 
40.0 ( 1.0) 1.10 (1.0) 1.05 (0.5)      20 59 56 32 12 
7. Do heavy household chores (heavy 
chores) 
42.2 (0.9) 1.02 (0.3) 0.99 (0.0) 2 41.7 (1.0) 1.13 (1.3) 1.18 (1.6)  36 50 50 24 16 
8. Garden or do yard work 
(garden/yard work) 
42.2 (1.0) 0.75 (-2.5) 0.74 (-2.5)      32 64 40 23 16 
9. Make a bed (make bed) 56.7 (1.2) 0.84 (-1.3) 0.76 (-1.7)      83 59 28  3  3 
10. Carry a shopping bag or briefcase 
(carry bag) 
57.1 (1.2) 0.88 (-1.1) 0.84 (-1.2) 3 57.0 (1.2) 0.92 (-0.7) 0.88  (-0.9)  76 63 34  4  2 
11. Carry a heavy object (over 10 lbs.) 
(carry object) 
45.9 (1.0) 1.16 (1.4) 1.19 (1.7)      44 61 47 17 10 
12. Change a light bulb overhead 
(change bulb) 
40.0 (1.0) 0.91 (-0.8) 0.89 (-1.0)      26 58 41 32 17 
13. Wash or blow dry your hair (style 
hair) 
52.2 (1.0) 1.04 (0.4) 1.01 (0.1)      77 45 37  9  6 
14. Wash your back (wash back) 44.2 (0.9) 0.87 (-1.2) 0.83 (-1.5) 4 43.8 (1.0) 0.93 (-0.5) 0.94 (-0.5)  44 61 34 23 13 
15. Put on a pullover sweater (don 
sweater) 
49.2 (1.1) 0.95 (-0.5) 0.95 (-0.4)      45 71 41 15  5 
16. Use a knife to cut food (cut food) 66.5 (1.4) 0.89 (-0.8) 0.65 (-1.3) 5 66.5 (1.5) 0.91(-1.5) 0.61 (-1.5)  127 34 14  0  1 
17. Recreational activities which 
require little effort (recreation – light) 
60.7 (1.3) 0.98 (-0.1) 1.04 (0.2)      133 30  9 2  3 
18. Recreational activities in which 
you take some force or impact through 
your arm, shoulder or hand (recreation 
– force/impact) 
38.7 ( 1.0) 0.87 (-1.2) 0.83 (-1.6) 6 37.8 (1.0) 0.93 (-0.7) 0.88 (-1.1)  16 62 49 34 14 
19. Recreational activities in which 
you move your arm freely (recreation 
– free movement) 
39.7 (1.0) 0.94 (-0.5) 0.95 (-0.4)      29 43 51 33 17 
20. Manage transportation needs 
(manage transportation) 
59.0 (1.2) 1.11 (0.7) 0.94 (-.01)      122 34 12 2 4 
21. Sexual activities (sexual activities) 53.1 (1.0) 1.40 (2.5) 2.84 (4.7)      109 30 13  7 10 
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22. During the past week, to what 
extent has your arm, shoulder, or hand 
problem interfered with your normal 
social activities? (interfere - social) 
53.5 (1.0) 0.89 (-0.9) 0.87 (-0.8) 7 53.3 (1.0) 0.82 (-1.5) 0.72 (0.67)  83 54 28 10  5 
23. During the past week, were you 
limited in your work or other regular 
daily activities as a result of your arm, 
shoulder or hand problem? (limit 
activities) 
48.3 (1.0) 0.81 (-1.8) 0.86 (-1.3) 8 48.0 (1.0) 0.78 (-2.2) 0.86 (-1.3)  52 
 
59 45 16  7 
24. Arm, shoulder or hand pain (pain) 48.7 (1.1) 0.88 (-1.2) 0.90 (-0.9) 9 48.2 (1.1) 0.80 (-2.0) 0.82 (-1.8)  30 80 49 18  3 
25. Arm, shoulder or hand pain when 
you performed any specific activity 
(pain with activity) 
42.5 (1.1) 0.78 (-2.2) 0.77 (-2.4)      21 65 60 25   8 
26. Tingling (pins and needles) in your 
arm, shoulder or hand (tingling) 
54.4 (1.0) 1.36 (2.7) 1.85 (3.7) 10 54.3 (1.0) 1.24 (1.9) 1.47 (2.2)  97 41 25 12  5 
27. Weakness in your arm, shoulder or 
hand (weakness) 
38.7 (1.1) 0.94 (-0.6) 0.93 (-0.6)      9 66 69 26  9 
28. Stiffness in your arm, shoulder or 
hand (stiffness) 
40.8 (1.1) 0.97 (-0.3) 0.97 (-0.2)      13 66 64 28  7 
29. During the past week, how much 
difficulty have you had sleeping 
because of the pain in your arm, 
shoulder or hand? (sleep) 
50.6 (1.0) 1.17 (1.4) 1.42 (2.8) 11 50.3 (1.0) 1.04 (0.4) 1.04 (0.4) 69 55 37 11  7 
30. I feel less capable, less confident or 
less useful because of my arm, 
shoulder or hand problem (self-
efficacy) 
40.5 (0.9) 1.23 (2.0) 1.17 (1.3)      41 32 33 60 14 
Italicized text indicates item misfit, defined as Infit or Outfit statistic < 0.6 or > 1.4, z-score > 2.0 
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Appendix 9. SPADI Summary Table 
 Full Scale Subscales* Response Category Frequency  
SPADI Item 
(item stem) 
Measure 
(Model 
S.E.) 
Item Infit 
Statistic 
(z-score) 
Item Outfit 
Statistic 
(z-score) 
Measure 
(Model 
S.E.) 
Item Infit 
Statistic 
(z-score) 
Item 
Outfit 
Statistic 
(z-score) 
0 1 2 3 4 5 6 7 8 9 10 
Pain (How severe is your pain?)       
1. At its worst? 
(pain-worst) 
43.9 (0.5) 1.08 (0.7) 1.19 (1.6) 43.3 (0.6) 0.89 (-0.9) 0.96 (-0.3) 16 13 24 29 15 24 8 11 23 7 8 
2. When lying on 
the involved 
side? (pain-
involved side) 
48.4 (0.5) 1.20 (1.6) 1.27 (0.8) 51.2 (0.6) 0.88 (-1.0) 0.79 (-1.7) 36 20 31 20 10 13 13 10 14 6 5 
3. Reaching for 
something on a 
high shelf? 
(pain-shelf) 
44.4 (0.5) 0.74 (-2.5) 0.71 (-2.8) 50.8 (0.6) 1.14 (1.1) 1.06 (0.5) 14 20 28 28 11 20 12 13 12 11 8 
4. Touching the 
back of your 
neck? (pain-
touch neck) 
50.1 (0.5) 0.85 (-1.2) 0.78 (-1.6) 51.2 (0.6) 0.95 (-0.3) 0.96 (-0.2) 42 22 28 27 12 12 11 10 6 1 6 
5. Pushing with 
the involved 
arm? (pain-
pushing) 
49.8 (0.5) 1.02 (0.2) 0.88 (-1.0) 48.7 (0.6) 1.17 (1.3) 1.15 (1.2) 34 30 34 19 15 10 10 9 10 2 5 
Disability (How much difficulty do you have?)       
6. Washing your 
hair? (disability-
wash hair) 
53.6 (0.6) 0.99 (0.0) 0.85 (-1.0) 52.9 (0.6) 1.01 (0.1) 0.80 (-1.3) 65 30 22 17 10 13 5 7 3 1 4 
7. Washing your 
back? (disability-
wash back) 
48.2 (0.5) 1.09 (0.8) 1.08 (0.6) 46.8 (0.5) 1.01 (0.2) 0.96 (-1.3) 36 29 26 22 10 12 7 10 9 5 10 
8. Putting on an 
undershirt or 
jumper? 
(disability–don 
shirt) 
51.6 (0.6) 0.69 (-2.9) 0.71 (-2.5) 50.6 (0.6) 0.65 (-3.2) 0.67 (-3.1) 36 30 31 25 15 14 4 12 7 0 3 
9. Putting on a 
shirt that buttons 
55.4 (0.6) 0.89 (-0.9) 0.88 (-0.7) 55.1 (0.6) 0.89 (-0.9) 0.81 (-1.1) 72 28 20 23 10 9 6 7 1 2 0 
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down the front? 
(disability-
buttons) 
10. Putting on 
your pants? 
(disability-don 
pants) 
60.8 (0.7) 0.87 (-1.0) 0.70 (-1.6) 55.3 (0.7) 0.80 (-1.5) 0.66 (-1.7) 93 27 24 13 8 4 5 3 0 1 0 
11. Placing an 
object on a high 
shelf? 
(disability-shelf) 
43.2 (0.5) 1.19 (1.7) 1.22 (1.7) 40.7 (0.6) 1.23 (1.9) 1.18 (1.5) 10 22 29 30 17 16 8 10 17 4 14 
12. Carrying a 
heavy object of 
10 pounds? 
(disability-heavy 
object) 
47.5 (0.5) 1.51 (3.7) 1.68 (4.4) 46.0 (0.5) 1.55 (4.0) 1.63 (4.3) 32 15 33 26 8 11 12 7 20 3 7 
13. Removing 
something from 
your back 
pocket? 
(disability-back 
pocket) 
53.3 (0.6) 0.97 (-0.2) 0.79 (-1.3) 52.6 (0.6) 0.99 (0.0) 0.85 (-0.9) 72 26 24 12 15 8 7 3 7 4 0 
Italicized text indicates item misfit, defined as Infit or Outfit statistic < 0.6 or > 1.4, z-score > 2.0 
*Disability and Pain subscales analyzed separately 
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Appendix 10. NDII Summary Table 
 
NDII Item (item stem) 
 
 
  
Full Scale Response Category 
Frequency * 
Measure 
(Model 
S.E.) 
Item Infit 
Statistic 
(z-score) 
Item 
Outfit 
Statistic 
(z-score) 
1 2 3 4 5 
1. Are you bothered by neck or shoulder pain or discomfort? (pain/discomfort) 59.3 (1.1) 0.92 (-0.8) 0.94 (-0.6) 25 43 47 57 8 
2. Are you bothered by neck or shoulder stiffness? (stiffness) 62.1 (1.1) 0.97 (-0.3) 0.97 (-0.3) 26 38 59 52 4 
3. Are you bothered by difficulty with self-care activities because of your neck or shoulder? 
(self-care) 
40.0 (1.1) 1.08 (0.8) 1.01 (0.1) 4 21 39 66 49 
4. Have you been limited in your ability to lift light objects because of your shoulder or 
neck? (lift-light objects) 
38.8 (1.1) 1.13 (1.1) 0.99 (0.0) 5 22 30 59 64 
5. Have you been limited in your ability to lift heavy objects because of your shoulder or 
neck? (lift-heavy objects) 
58.5 (1.0) 1.20 (1.9) 1.16 (1.5) 29 40 55 39 15 
6. Have you been limited in your ability to reach above for objects because of your shoulder 
or neck? (reach above) 
59.2 (1.0) 1.38 (3.3) 1.35 (2.9) 33 40 48 45 14 
7. Are you bothered by your overall activity level because of your shoulder or neck? 
(overall activity) 
50.8 (1.1) 0.73 (-2.9) 0.73 (-2.8) 12 35 49 63 21 
8. Has the treatment of your neck affected your participation in social activities? 
(participation-social) 
38.1 (1.0) 0.91 (-0.7) 0.78 (-1.2) 7 19 25 47 80 
9. Have you been limited in your ability to do leisure or recreational activities because of 
your neck or shoulder? (participation-leisure/recreation) 
46.1 (1.0) 0.84 (-1.5) 0.77 (-2.2) 13 26 37 60 43 
10. Have you been limited in your ability to do work (including work at home) because of 
your neck or shoulder? (participation-work) 
47.1 (1.0) 0.80 (-1.9) 0.74 (-2.3) 17 26 37 54 45 
Italicized text indicates item misfit, defined as Infit or Outfit statistic < 0.6 or > 1.4, z-score > 2.0 
*Recall response categories were flipped for analysis. Here 1 =Not at all, 2= a little bit, 3 = a moderate amount, 4= quite a bit, 5 = a 
lot 
 
 
 
 
